text
stringlengths 65
123k
| url
stringlengths 25
420
| crawl_date
timestamp[us, tz=UTC]date 2022-04-01 01:00:57
2022-09-19 04:34:04
|
|---|---|---|
At Secured.22 Customer Conference Barracuda showcases innovations in Email Protection, Zero Trust Access, and Managed XDR
CAMPBELL, Calif., Sept. 13, 2022 /PRNewswire/ -- Barracuda Secured.22 Conference -- Barracuda, a trusted partner and leading provider of cloud-first security solutions, coming off its recent in person customer event, TechSummit22, kicks off Secured.22, the company's annual, virtual worldwide customer conference, with several product announcements. New capabilities protect against persistent and evolving threats like ransomware, and help customers solve complex digital business transformation challenges in the areas of Email Protection, Zero Trust Access, Managed XDR, and Data Protection.
Barracuda Secured.22 Customer Conference presents technical security scenarios that teach practitioners how to identify, prevent, recover, and respond quickly to cybersecurity attacks. Each scenario includes multiple sessions that cover the type of attack and why it happens, how it happens, and how to optimally use Barracuda products in preparation for and in response to the attack.
"At Secured.22, we're sharing with our customers pragmatic security advice on how to protect their organizations in various technical scenarios, ranging from recovery from new ransomware variants to a day in the life of our Security Operations Center," said Brian Babineau, Chief Customer Officer at Barracuda.
Alongside the conference, Barracuda is announcing several product innovations that help customers stay protected against the most frequent and sophisticated cyberattacks. Today's announcements include:
- Zero Trust Access: as part of Barracuda's SASE platform, Barracuda CloudGen Access now includes web security to protect users no matter where they work.
- Email Protection: now with Zero Trust Access, Barracuda Email Protection hardens the Microsoft 365 environment by continuously verifying and only allowing the right users to access the right resources.
- XDR: now integrated with Barracuda CloudGen Firewall, MSPs can gain visibility and insights by offering 24x7 SOC services, and increase efficiency by reducing product silos, mitigating alert fatigue, and streamlining management of their customers' environments.
- Data Protection: now available, Barracuda Cloud-to-Cloud Backup is transactable in Azure Marketplace. Barracuda's Data Protection business momentum was boosted by the growth in its Cloud-to-Cloud Backup SaaS product line that protects data stored in Microsoft 365.
"Our conference spans IT security scenarios that cannot go ignored," said Fleming Shi, CTO at Barracuda. "The announcements we've made today provide a broad set of capabilities across our email protection, Zero Trust, and XDR platforms to help customers proactively protect their businesses in today's increasingly complex threat landscape while also helping to maintain user productivity."
Resources:
Read the blog posts:
Four ways Barracuda is helping customers accelerate digital business transformation: http://cuda.co/bg09134ways
Enhancing security with Zero Trust Access: http://cuda.co/bg0913zta
Expanded XDR capabilities strengthen Barracuda's security offering to MSPs: http://cuda.co/bg0913xdr
Barracuda Data Protection innovation and momentum: http://cuda.co/bg0913data
Get more information about Barracuda solutions:
About Barracuda Secured.22
Barracuda Secured.22 Customer Conference, happening this week September 13 and 14, is the company's annual global virtual conference for Barracuda customers. Barracuda Secured.22 is an informative event covering technical security scenarios that enable practitioners to identify, prevent, recover, and respond quickly to cyber security attacks. For more information, please visit: https://barracuda.events/secured.22/.
About Barracuda
At Barracuda we strive to make the world a safer place. We believe every business deserves access to cloud-first, enterprise-grade security solutions that are easy to buy, deploy, and use. We protect email, networks, data, and applications with innovative solutions that grow and adapt with our customers' journey. More than 200,000 organizations worldwide trust Barracuda to protect them — in ways they may not even know they are at risk — so they can focus on taking their business to the next level. For more information, visit barracuda.com.
Barracuda Networks, Barracuda and the Barracuda Networks logo are registered trademarks or trademarks of Barracuda Networks, Inc. in the U.S. and other countries.
Contacts
Anne Campbell
Barracuda Networks, Inc.
978-328-1642
acampbell@barracuda.com
View original content to download multimedia:
SOURCE Barracuda Networks, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/barracuda-helps-customers-accelerate-their-digital-business-transformation-with-cybersecurity-data-protection-solutions/
| 2022-09-13T11:31:19Z
|
BD EffivaxTM Glass Prefillable Syringe Features Enhanced Technology that Builds on Company's Decades of Expertise in the Prefillable Syringe Market and Supports Customers' Manufacturing Needs
FRANKLIN LAKES, N.J., Sept. 13, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1
The new BD EffivaxTM Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.
"As biopharmaceutical companies continue to rapidly grow their vaccine pipelines, demand for PFS is accelerating across the globe – given their proven ability to facilitate faster administration, support dose sparing and reduce vaccine waste." said Eric Borin, Worldwide President of BD Pharmaceutical Systems. "The launch of BD EffivaxTM Glass Prefillable Syringe strategically supports this growth and will create needed efficiencies in end-to-end production."
Approximately 70 percent of the top 100 biopharmaceutical companies rely on BD for supply of PFS.2 BD EffivaxTM Glass Prefillable Syringe will further help customers meet the stringent demands of today's vaccine manufacturing through design enhancements focused on fill/finish and container reliability. Through improved quality specifications, BD EffivaxTM is designed to reduce the risk of line stoppage3 and improve the total cost of ownership,4 manufacturing capacity and supply availability.
The BD Effivax™ Glass Prefillable Syringe will benefit from the $1.2 billion, four-year investment that BD announced in late 2020 to expand and upgrade manufacturing capacity and technology for PFS. As BD plans for the future of vaccinations, including mRNA and those used for COVID-19, the company remains committed to maintaining robust capacity for PFS to help reduce the time and labor required for vaccine preparation with traditional vial formats.
About PFS
Prefillable syringes (PFS) are an important option in the packaging and delivery of injectable drug products, including vaccines, biologics and anticoagulants. PFS help enable the administration of a drug in two ways. First, a PFS is a drug delivery system designed to administer the appropriate amount of the drug to the patient both safely and reliably. Second, PFS packaging helps assure that there are no adverse effects on the quality, purity or potency of the drug over its full shelf life.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
View original content to download multimedia:
SOURCE BD (Becton, Dickinson and Company)
|
https://www.whsv.com/prnewswire/2022/09/13/bd-launches-next-generation-prefillable-vaccine-syringe-designed-reliability-efficiency/
| 2022-09-13T11:31:26Z
|
Doctors Attest to Advanced Energy Technology Device's Transformative Solutions to Achieve Desired Results in Patients
CLEARWATER, Fla. , Sept. 13, 2022 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the release of a new surgeon testimonial video featuring its Renuvion Helium Plasma Technology.
Leading plastic surgeons across the country are sharing the transformative results they've achieved using Renuvion, a proprietary helium plasma and radiofrequency technology, on patients for cosmetic procedures in their practices.
In a video featuring celebrity plastic surgeon and co-host of the hit television series, 'Botched' Dr. Paul Nassif, New York City facial surgeon Dr. Tabasum Mir, Beverly Hills plastic and reconstructive surgeon Dr. Leif Rogers and board certified plastic surgeon Dr. Gregory Buford of Denver, CO, doctors reveal the unmatched benefits of using Renuvion technology in their cosmetic/aesthetic procedures.
In the video Dr. Nassif discloses that his practice uses the device four-to-five times a week in cosmetic procedures. Dr. Mir states that she gets impressive tissue contraction in areas she previously was only able to achieve through surgery, while Dr. Rogers testifies that he has tried every device on the market, and now only uses Renuvion for his procedures because it's far superior to those other devices. Finally, Dr. Buford declares he'd stake his reputation on the safety and effectiveness of Renuvion.
Watch the video here:
Renuvion Review | Top Plastic Surgeons Talk Cutting-Edge Technology - YouTube
Renuvion is the only product that is FDA-cleared to improve the appearance of lax (loose) skin on the neck and submental region (chin). It was also recently cleared for specific dermatological procedures for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick skin types I, II or III. These clearances highlight the safety and efficacy of the Renuvion technology.
To date, hundreds of physicians across the U.S. use Renuvion in their practices. For a list, by state, of physicians using the device visit: https://renuvionfinder.com.
For additional information visit Renuvion.com.
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company's Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion® offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma® system allows surgeons to operate with a high level of precision while minimizing unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
Certain matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.
All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to, any statements regarding the potential impact of the COVID-19 pandemic and the actions by governments, businesses and individuals in response to the situation; projections of net revenue, margins, expenses, net earnings, net earnings per share, or other financial items; projections or assumptions concerning the possible receipt by the Company of any regulatory approvals from any government agency or instrumentality including but not limited to the U.S. Food and Drug Administration, supply chain disruptions, component shortages, manufacturing disruptions or logistics challenges; or macroeconomic or geopolitical matters and the impact of those matters on the Company's financial performance.
Forward-looking statements and information are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause the Company's actual results to differ materially and that could impact the Company and the statements contained in this release include but are not limited to risks, uncertainties and assumptions relating to the regulatory environment in which the Company is subject to, including the Company's ability to gain requisite approvals for its products from the U.S. Food and Drug Administration and other governmental and regulatory bodies, both domestically and internationally; the impact of the recent FDA Safety Communication on our business and operations; factors relating to the effects of the COVID-19 pandemic; sudden or extreme volatility in commodity prices and availability, including supply chain disruptions; changes in general economic, business or demographic conditions or trends; changes in and effects of the geopolitical environment; liabilities and costs which the Company may incur from pending or threatened litigations, claims, disputes or investigations; and other risks that are described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and the Company's other filings with the Securities and Exchange Commission. For forward-looking statements in this release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
Media Contact:
Jane Sparango
Coterie Media on behalf of Apyx Medical Corporation
jane@coteriemedia.com
310-339-1214
Investor Relations Contact:
ICR Westwicke on behalf of Apyx Medical Corporation
Mike Piccinino, CFA
investor.relations@apyxmedical.com
View original content to download multimedia:
SOURCE Renuvion
|
https://www.whsv.com/prnewswire/2022/09/13/botched-tv-star-dr-paul-nassif-among-top-us-plastic-surgeons-using-renuvion-helium-plasma-technology-cosmetic-procedures/
| 2022-09-13T11:31:33Z
|
The Best SaaS Product for Communication, Collaboration or Conferencing.
LONDON, Sept. 13, 2022 /PRNewswire/ -- Dstny Automate (formerly Qunifi), with its Call2Teams solution, has been declared the winner of the Best SaaS Product for Communication, Collaboration, or Conferencing this week in the international SaaS Awards program.
Earlier this year, Dstny announced the acquisition of the leading UK-based Microsoft Teams integration specialist Qunifi, now Dstny Automate. The 2022 SaaS Award reinforces that the unit is an essential part of Dstny's strategy in business integrations and a perfect example of how Dstny brings business value to end users by playing well with others.
Call2Teams is a Unified Communications as a Service (UCaaS) solution developed and maintained by Dstny Automate (formerly Qunifi). With extensive interoperability and ongoing innovation, Call2Teams gives Voice, Telco, and IT partners a leading go-to-market solution for voice-enabling Teams. Call2Teams comes with multi-tenant, multi-tiered subscription management, is Microsoft approved, with enterprise-grade encryption and security built-in.
This year's SaaS praises, now in its seventh edition, received hundreds of entries from across the globe, covering the Americas, Australia, Europe, and the Middle East.
Jeannie Arthur, Dstny Automate CEO, said: "It is an incredible honor to win this international SaaS Award for best Communication, Collaboration, or Conferencing product. The last few years have seen huge disruption in how organizations use technology to enable remote, home, and hybrid working. We are proud to work with the biggest global communications and collaboration companies to voice-enable workers wherever they are - in the office, in the field, on the frontline, or at home. It is also a huge honor to work with an incredible team of people. With a remote-first team spread across eight time zones, I'm proud of what we deliver today and excited about what we will deliver tomorrow."
Lead Judge Annabelle Whittall commented, "The leading experts on telephone middleware truly are Call2Teams. A creative way to integrate Microsoft Teams with your current telephony system. Call2Teams deserves to be a winner at SaaS Awards 2022 given its flawless streamlining and cutting-edge integration!"
Head of Operations for the Cloud Awards, James Williams, said: "Call2Teams is a worthy winner of the SaaS Awards, offering something truly and effectively stand-out in an incredibly competitive category.
You can view the full shortlist for the SaaS Awards here: https://www.cloud-awards.com/2022-saas-awards-shortlist/
For further information
For Call2Teams
Helen Johnstone – Marketing Manager
helen.johnstone@qunifi.com
For the SaaS Awards
James Williams – head of operations
james@cloud-awards.com
About the SaaS Awards
The SaaS Awards is a sister program to the Cloud Awards, which was founded in 2011. The SaaS Awards focuses on recognizing excellence and innovation in software solutions. Categories range from Best Enterprise-Level SaaS to Best UX or UI Design in a SaaS Product.
For more information about the SaaS Awards, please visit www.cloud-awards.com/software-as-a-service-awards/.
About Call2Teams
Call2Teams easily voice-enables Microsoft Teams around existing enterprise-grade telephony. Call2Teams is a cloud-native, middleware product that sits between any phone system, PBX or SIP Trunk provider, and Microsoft Teams. No hardware or software is needed - there is no need to port numbers, change carrier, or throw away an existing phone system.
Call2Teams is a Unified Communications as a Service (UCaaS) solution developed and maintained by Dstny Automate (formerly Qunifi). Call2Teams gives Voice, Telco, and IT partners a leading go-to-market solution for voice-enabling Teams. Call2Teams comes with multi-tenant, multi-tiered subscription management, is Microsoft approved, with enterprise-grade encryption and security built-in.
With scalable per-user, per-month pricing, Call2Teams gives businesses a low-cost, flexible, and immediate solution for making and receiving calls in Microsoft Teams. Call2Teams is available worldwide and can be deployed in minutes.
For more information, visit www.call2teams.com
Contact - Helen Johnstone, +44 (0)330 008 4523, helen.johnstone@qunifi.com
Photo - https://mma.prnewswire.com/media/1895633/Saas_awards_winner.jpg
View original content to download multimedia:
SOURCE Dstny
|
https://www.whsv.com/prnewswire/2022/09/13/call2teams-wins-2022-saas-awards/
| 2022-09-13T11:31:39Z
|
GUELPH, ON, Sept. 13, 2022 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that its majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar") will launch the EP Cube, a lightweight and sleek all-in-one residential energy storage solution, at the RE+ trade show to be held on September 19-22, 2022, in Anaheim, California. The official launch will be at 3pm PT on September 21.
Key features of the EP Cube include:
- Scalable and customizable from 9.9 kWh to 19.9-kWh capacities.
- All-in-one design with hybrid inverter and stackable battery modules, requiring minimal wall space.
- Lightweight and easy to install, featuring all-inclusive components and self-configuration for fast commissioning.
- The EP Cube works with both new and retrofit, AC and DC-coupled PV systems.
Dr. Shawn Qu, Chairman and CEO of Canadian Solar commented, "We are pleased to expand our clean energy offering into the residential energy storage market by launching the EP Cube, leveraging our existing partnerships and channels. The recently enacted Inflation Reduction Act will help the U.S. market transition faster towards clean power by increasing renewable energy accessibility through tax breaks and rebates. The EP Cube is a perfect solution for homeowners to use these incentives and invest in clean energy."
The EP Cube solution can be stacked for 9.9 kWh to 19.9 kWh capacities. Up to six units can be connected in parallel to deliver up to 119.9 kWh of storage and 45.6 kW output, which is more than enough to fully power the average home with high-surge-current appliances and AC units. The EP Cube's thin design, 6.25 inches at the thinnest, requires minimal space and is fully compatible with indoor or outdoor installation thanks to its NEMA 4X rated resistance to dust and moisture.
Each EP Cube battery module weighs less than 70 pounds, meaningfully lower than most residential storage devices that weigh upwards of 300 pounds. This makes the EP Cube simpler to install and less costly to transport, requiring a minimal installation team to carry and install each unit. The EP Cube is also more customizable to individual needs due to its modular approach. In addition, the energy storage system incorporates the Smart Gateway, an intelligent technology platform that enables automatic and seamless energy transfers for on- or off-grid use without user disruption.
The EP Cube is highly customizable and was designed with both homeowners' and installers' diverse needs in mind. Homeowners no longer have to pick and choose what to power, as the full home can be powered with the EP Cube. Installers can efficiently install the full unit, ultimately driving growth and cost savings.
Canadian Solar is also releasing an app to help homeowners manage their energy storage systems. The EP Cube app will allow for easy, real-time monitoring of energy production and consumption. Homeowners will have access to home energy management and over-the-air (OTA) software update services. Installers use the app to set up and troubleshoot systems.
Canadian Solar will be debuting and exhibiting the EP Cube at RE+ booth #2204 in Anaheim, California, in September 19-22.
About Canadian Solar Inc. Canadian Solar was founded in 2001 in Canada and is one of the world's largest solar technology and renewable energy companies. It is a leading manufacturer of solar photovoltaic modules, provider of solar energy and battery storage solutions, and developer of utility-scale solar power and battery storage projects with a geographically diversified pipeline in various stages of development. Over the past 21 years, Canadian Solar has successfully delivered around 76 GW of premium-quality, solar photovoltaic modules to customers across the world. Likewise, since entering the project development business in 2010, Canadian Solar has developed, built and connected over 6.8 GWp in over 20 countries across the world. Currently, the Company has around 311 MWp of solar projects in operation, 5.3 GWp of projects under construction or in backlog (late-stage), and an additional 21 GWp of projects in pipeline (mid- to early-stage). Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.
Safe Harbor/Forward-Looking Statements Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "believes," "expects," "anticipates," "intends," "estimates," the negative of these terms, or other comparable terminology. Factors that could cause actual results to differ include general business, regulatory and economic conditions and the state of the solar and battery storage market and industry; geopolitical tensions and conflicts, including impasses, sanctions and export controls; volatility, uncertainty, delays and disruptions related to the COVID-19 pandemic; supply chain disruptions; governmental support for the deployment of solar power; future available supplies of high-purity silicon; demand for end-use products by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets, such as Japan, the U.S., China, Brazil and India; changes in effective tax rates; changes in customer order patterns; changes in product mix; changes in corporate responsibility, especially environmental, social and governance ("ESG") requirements; capacity utilization; level of competition; pricing pressure and declines in or failure to timely adjust average selling prices; delays in new product introduction; delays in utility-scale project approval process; delays in utility-scale project construction; delays in the completion of project sales; continued success in technological innovations and delivery of products with the features that customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange and inflation rate fluctuations; uncertainties related to the CSI Solar carve-out listing; litigation and other risks as described in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 28, 2022. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.
View original content:
SOURCE Canadian Solar Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/canadian-solars-subsidiary-csi-solar-releases-ep-cube-residential-energy-storage-solution-power-entire-homes-provide-complete-power-management-control/
| 2022-09-13T11:31:46Z
|
Portugal-based GroVida licenses two of Canonic's cannabis varieties for cultivation and commercialization in Europe
REHOVOT, Israel , Sept. 13, 2022 /PRNewswire/ -- Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announced today that it has signed a non-exclusive licensing agreement with leading Portugal-based cannabis cultivation and manufacturing company, GroVida Lda. Under the agreement, GroVida will cultivate, market and sell products based on Canonic's cannabis varieties in Europe and the United Kingdom, and will pay Canonic royalties on its sales based on these products.
This is Canonic's initial licensing agreement for the European market, a key target market for Canonic, with total medical cannabis market sales estimated at approximately €400 million[i] for 2021, while still at an early stage in its development.
GroVida is a vertically integrated medical cannabis company located in Portugal and currently selling medical cannabis products in the EU. GroVida owns 20,000 square meters of high-tech greenhouses which have been operational since November 2020 and has collaborated with Canonic since January 2022, to cultivate Canonic's cannabis varieties. This has been done on a semi-commercial scale at its cultivation facilities in Portugal, to meet regulatory standards under European growing conditions.
Canonic's proprietary cannabis varieties development was supported by Evogene's GeneRator AI engine.
Euan Keenan, Chief Executive Officer of GroVida, commented, "As a company operating for several years in the EU cannabis market, we have been impressed with the quality of the cannabis varieties developed by Canonic and especially with their performance under our growing conditions in Portugal. We see significant sales potential for these varieties throughout our home market in Europe, and we are pleased with this new licensing agreement. We look forward to initiating and growing sales of products based on these varieties."
Arnon Heyman, Chief Executive Officer of Canonic, commented, "We are very pleased with this first licensing agreement, a significant pillar in our European go-to-market sales strategy. GroVida has been our partner for cultivation and testing of our cannabis varieties in the EU since early 2022. Their interest in broadening our relationship to a new stage is a testament to the quality of Canonic's varieties and to GroVida's belief in their commercial success in the European market. Canonic also plans to launch direct sales into the European market starting with Germany."
About Canonic Ltd.:
Canonic is a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), developing medical cannabis products utilizing Evogene's proprietary GeneRator AI engine. The Company's products in development are aimed at improving active compounds, genetic stability, and cannabis varieties for specific medical effects. The Company's strategy includes the development of cannabis varieties in order to commercialize medical cannabis products independently or through collaborations. Canonic has exclusive access to Evogene's genomic assets and technology for the development of medical cannabis products.
For more information, please visit: https://www.canonicbio.com/.
About GroVida Lda:
GroVida is a licenced medical cannabis cultivator and manufacturer in Portugal. GroVida offers active pharmaceutical ingredient (API) and finished products to medical clients worldwide. GroVida's state-of-the-art cultivation facility allows it to collaborate with clients to offer truly bespoke products, for their evolving patients' needs.
For more information, please visit: www.gro-vida.com.
About Evogene Ltd.:
Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase probability of success while reducing development time and cost. Evogene established three unique technological engines - MicroBoost AI, ChemPass AI and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each technological engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI). Evogene uses its technological engines to develop products through subsidiaries and with strategic partners. Currently, Evogene's main subsidiaries utilize the technological engines to develop human microbiome-based therapeutics by Biomica Ltd., medical cannabis products by Canonic Ltd., ag-chemicals by AgPlenus Ltd. and ag-biologicals by Lavie Bio Ltd.
For more information, please visit: www.evogene.com.
Forward Looking Statements:
This press release contains "forward-looking statements" relating to future events. These statements may be identified by words such as "may", "could", "expects", "intends", "anticipates", "plans", "believes", "scheduled", "estimates", "demonstrates", or words of similar meaning. For example, Evogene and Canonic are using forward-looking statements in this press release when they discuss the results of the cooperation between Canonic and GroVida, including potential royalties, the commercial success of Canonic's products in the European market, the estimated size of the European market and their expansion to the European market. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, and involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene and its subsidiaries may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond the control of Evogene and its subsidiaries, including, without limitation, those risk factors contained in Evogene's reports filed with applicable securities authorities. Evogene and its subsidiaries disclaim any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.
Evogene Investor Contact:
Kenny Green
Email: kenny.green@evogene.com
Tel: +1 212 378 8040
Logo - https://mma.prnewswire.com/media/1605436/Canonic.jpg
Logo - https://mma.prnewswire.com/media/890385/Evogene.jpg
View original content:
SOURCE Canonic
|
https://www.whsv.com/prnewswire/2022/09/13/canonic-advances-its-penetration-into-europe-by-signing-its-first-licensing-agreement-with-grovida/
| 2022-09-13T11:31:53Z
|
With more than one-third of new employees' job hopping within a year, skills-based assessments and recruitment tools have never been more important; Visit Cappfinity Booth #1607 at HR Tech Event in Las Vegas, Sept 13-16, 2022
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Talent acquisition and management solutions provider Cappfinity today announced its newly expanded suite of solutions. Talent leaders around the globe face the uncertainty of an impending recession, inflation, fallout from the Great Resignation and a competitive hiring environment. As a result, many are actively seeking ways to accelerate hiring. According to the Society for Human Resource Management (SHRM), 78 percent of HR professionals say the quality of their organization's hires has improved due to their use of assessments.
One-Stop by Cappfinity is a new assessment that combines behavioral and cognitive skills with motivational interviewing into one easy-to-use integrated solution. One-Stop is quick to complete, elevates the candidate experience, and provides deep, unbiased insights for hiring managers.
Also new, Preparation Plus by Cappfinity delivers year-round pre-skilling and upskilling insight. "Preparation Plus is an on-demand pre-application resource to help demystify the recruitment process and level the playing field for candidates less familiar with the online assessments and interviewing," said Nicky Garcea, co-founder and head of America at Cappfinity. "Global organizations like HSBC and EY have incorporated Preparation Plus to help candidates interview, secure a role, and start successful careers within their organizations."
According to a survey conducted for The Wall Street Journal by pollsters YouGov and Cappfinity, 38% of Americans landing jobs since January 2021 quit within a year. Millennials, followed by GenZ, are the most likely to job hop. As such, talent leaders are moving away from traditional strategies and seeking solutions that can help them evaluate skills and existing capabilities, highlight motivation or untapped potential, and foster internal mobility.
Cappfinity's end-to -end skills suite of talent solutions will be demonstrated September 13-16, 2022 at the HR Technology Conference and Expo at Mandalay Bay in Las Vegas, booth #1607. In addition to One-Stop and Preparation Plus, HR Tech attendees can take a closer look at Cappfinity's talent mapping, hiring insights reports, succession planning solutions, digital work simulations, and immersive life-like VR experiences.
About Cappfinity
Cappfinity is the global leader in skills-based and science-backed recruiting, hiring, and talent development solutions. Since 2005, Cappfinity has assisted forward-looking organizations with diversifying and revitalizing their workforces through recruiting, onboarding, talent development, VR experiences, and more. With teams in the U.S., UK, Ireland and Australia, Cappfinity is proud to be working with 250+ organizations and millions of individuals in service of our shared purpose – Strengthening the World.
View original content:
SOURCE Cappfinity
|
https://www.whsv.com/prnewswire/2022/09/13/cappfinity-dramatically-advances-skills-based-hiring-with-new-recruitment-solutions/
| 2022-09-13T11:31:59Z
|
Showcases Multiple T7-Enabled Storage Networking Solutions for NVMe/TCP, NVMe-oF, and iSCSI at Storage Development Conference 2022
SUNNYVALE, Calif., Sept. 13, 2022 /PRNewswire/ -- Chelsio Communications, Inc., a leading provider of high performance (1/2.5/10/25/40/50/100/200/400Gb) Ethernet Unified Wire Adapters and ASICs for storage networking, virtualized enterprise datacenters, cloud service installations, and cluster computing environments, today announced a set of storage demonstrations and performance benchmark results which showcase how T7 DPU enables optimal application performance and return-on-investment (ROI) for NVMe-TCP, NVMe-oF (RDMA) and iSCSI technologies at the annual Storage Developer Conference, which will be on September 12-15, 2022.
A highlight will be the demonstration of NVMe/TCP with Chelsio TCP/IP Offload Engine (TOE) using the NVMe protocol data unit (PDU) interface for highly efficient, low-latency access to NVMe SSD storage using the T7 DPU Emulation Platform. The T7 DPU Emulation Platform supports a 5U chassis that connects to a server host via a PCIe ribbon cable. It includes a mapping of all T7 logic gates, supports the Linux boot process for running applications, and the host software of T7 predecessors, T5 & T6, as-is, thus demonstrating the ability of customers to leverage prior software investment. T7 Emulation Platform delivers an aggregate of 40 Gigabit Ethernet (40GbE) bandwidth via 4x10GbE or 2x40GbE connectivity options. The T7 Emulation Platform for software development is available to Chelsio T7 Early Access customers.
"The extreme performance requirements of modern applications require exceptional performance from the underlying storage networking for users to realize the best possible value of their data centers and the data they hold," stated Kianoosh Naghshineh, CEO at Chelsio Communications. T7 DPU provides such access using a variety of offloaded storage protocols including T7-powered NVMe/TCP, NVMe-oF and iSCSI to meet the needs of innovative applications."
"Continued growth of cloud and edge workloads are placing more demand on data infrastructure resources," said Greg Schulz, Sr. Analyst StorageIO. "Fast applications need fast I/O and compute including server, storage, and I/O network offloads to boost not only efficiency, also productivity effectiveness. TOEs are a great solution to offload core server compute freeing up those resources for other productive tasks like the value benefit GPUs provide in freeing up compute cycles through offloading graphics and AI/ML workloads."
During the Storage Developer Conference (September 12-15, 2022), Chelsio will demonstrate the following technologies that illustrate how T7 DPU solutions offering high-speed Ethernet storage networking complement modern application and storage architectures:
- NVMe/TCP with Chelsio TOE using the protocol data unit (PDU) interface for highly efficient, low-latency access to NVMe SSD storage.
- NVMe Over Fabrics (RDMA)-based network access with industry leading high-performance and low latency.
- iSCSI Protocol Offload-based access to flash storage with extremely high throughput and IOPs.
- Memory-free Server Offload functions optimized for datacenter networking applications.
- T6 legacy mode software running on T7 for iSCSI, iWARP, TOE, NIC, NVMe/TCP.
In addition, Chelsio will be participating in a Birds of a Feather (BoF) session entitled "NVMe/TCP Deployment Best Practices." NVMe over TCP has emerged to provide a more powerful, and compute resource friendly NVMe-oF technology deployment option. Not only does NVMe over TCP help with lower deployment costs and reducing design complexity, it also enables higher performance with lower latency. In essence, NVMe over TCP extends NVMe across the entire data center (from on-prem core to edge to cloud) using the simple, standard, and efficient well-known TCP/IP fabric networks. The BoF will be moderated by Greg Schulz, Independent Industry Analyst & Author, StorageIO™ and will include review of NVMe/TCP performance results using Chelsio T6 Unified Wire TCP Offload Engine (TOE) to illustrate the benefits in performance and efficiency of NVMe/TCP fabrics, opening the way to unprecedented storage performance and scale. The session is scheduled for Wednesday September 13th 8-9PM.
T7 DPU ASICs and the first two adapter SKUs will be in production in 1Q23. T7 DPU emulation platforms for software development are available to early access customers now. T7 reference design kit is also available now. Please contact Chelsio for more information.
Additional Resources
Chelsio is a recognized leader in high performance (1Gb/10Gb/25Gb/40Gb/50Gb/100Gb) Ethernet adapters for networking and storage within virtualized enterprise datacenters, public and private hyperscale clouds, and cluster computing environments. With a clear emphasis on performance and delivering the only robust offload solution, as opposed to simple speeds and feeds, Chelsio has set itself apart from the competition. The Chelsio Unified Wire fully offloads all protocol traffic, providing no-compromise performance with high packet processing capacity, sub-microsecond hardware latency and high bandwidth. Visit the company at www.chelsio.com and follow the company on Twitter and Facebook.
View original content to download multimedia:
SOURCE Chelsio Communications, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/chelsio-t7-dpu-promotes-broad-ethernet-storage-networking-enabling-highly-flexible-opex-optimized-enterprise-cloud-implementations/
| 2022-09-13T11:32:08Z
|
America's next great migration is underway – now we know where it's going.
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Climate Alpha announces the launch of its data-driven product suite, offering property developers, asset managers, and insurers risk-adjusted valuations, resilience scores, and site selection rankings for locations all across America and soon globally.
Climate Alpha is a software platform featuring three proprietary tools – Climate Price, Resilience Index and Alpha Finder – running on a patent-pending scenario forecaster. Climate Alpha's model covers 40,000 US ZIP codes, with bespoke algorithms for each property type: residential; commercial; industrial, and agricultural. It has already generated risk-adjusted valuations for more than 200,000 buildings.
Climate Alpha gives its clients an edge in the climate adaptation race by both identifying risks and uncovering opportunities. Unlike traditional real estate valuation products using simple financial models that ignore climate variables, Climate Alpha employs machine-learning techniques to integrate hundreds of socioeconomic and market variables as well as the latest climate models. And unlike climate risk firms that only suggest long-term value-at-risk, Climate Alpha forecasts real estate values for every year out to 2040 under multiple climate scenarios.
Its API function allows seamless and instant portfolio modeling, delivering Climate Price assessments and Resilience Index scores for an unlimited number of properties – with each customer receiving a secure microsite to rank asset performance and generate reports for ESG-related reporting. Simultaneously, Alpha Finder offers confident fund construction by screening dozens of datasets to target locations correlating to clients' investment mandates and time horizons.
Dr. Parag Khanna, founder and CEO of Climate Alpha, says, "Assessing climate risk has become a commodity. We take adaptation to the next level by locating and quantifying opportunities behind which investors and governments can deploy trillions of dollars. As millions of homeowners and businesses are recognizing, relocation is the best adaptation."
Customers of Climate Alpha include leading home builders, major asset managers, sizable pension funds, and prominent data partners. A full list is available on Climate Alpha's website: www.climatealpha.ai/customers.
Together with fintech pioneer Atlas Capital, Climate Alpha has built the world's first Sustainable REIT Index. "The backbone of Atlas Capital's novel systematic trading strategy is a Sustainable REIT Index which is powered by Climate Alpha's unique ability to blend a vast array of market drivers and climate variables to produce actionable valuations," says Atlas Capital founder and CEO Reza Bundy.
"It is vital that mayors and urban leaders are focused on investing more effectively in climate adaptation. Climate Alpha is the first sustainability themed resource on Mastercard City Insights, and its Resilience Index is an important policy decision-making resource," adds Alby Bocanegra of Mastercard.
"Property markets are lagging far behind the complexity of the real world," says Climate Alpha chairman and former president of Lennar International, Chris Marlin. "Climate Alpha's mission is to get ahead of that complexity and provide a roadmap for society to reorient around resilient locations."
Steve Weikal, Industry Chair of the Real Estate Technology Initiative at the MIT Center for Real Estate and a Climate Alpha board member, adds, "We all read the articles about how Boise, Denver, and Raleigh and other non-gateway cities are booming. But what will be the thriving Zoom towns of 2025, 2030 and beyond?"
Kathy Baughman McLeod, Climate Alpha board member and climate risk and resilience veteran, notes, "Climate tech is evolving at an astounding pace. Climate Alpha's high-frequency data feeds, construction of new indices around Covid, infrastructure, immigration and other themes, and global expansion of coverage have shown that this is the platform the market needs now."
Climate Alpha has been profitable since its soft launch earlier this year, and has completed a seed funding round with wide participation of prominent VCs, real estate professionals, angel investors, and family offices from around the world.
For media enquiries, please write to media@climatealpha.ai. Prospective investors and customers may contact Director of Strategy Mok Xiao You at: xiaoyou@climatealpha.ai.
CONTACT
Mr. Greg Lindsay
Chief Communications Officer (CCO)
greg@climatealpha.ai
View original content to download multimedia:
SOURCE Climate Alpha
|
https://www.whsv.com/prnewswire/2022/09/13/climate-alpha-launches-ai-powered-platform-steer-investment-toward-more-resilient-regions/
| 2022-09-13T11:32:14Z
|
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- RealClear Publishing, announces the release of Branding Democrats, a timely new book that gives Democratic candidates a blueprint for winning elections using branding strategies that former DNC Director Les Francis calls "crucial" for upcoming elections.
The Democratic Party has something to learn from the business world: branding and messaging matter. And with the turmoil created by the recent Supreme Court rulings and Democrats' disappointing and haphazard response—the 2022 elections hang in the balance.
Daryl Weber and his father—financial strategist Ken Weber, who co-wrote the book—lay out a step-by-step plan to revive a political party that should be easily winning elections. From George W. Bush's economic failures to an impeached incumbent in 2020, Republicans are still winning in the face of massive political missteps. This is inexcusable, according to the Webers. Things fundamentally must change—and the stakes couldn't be higher.
Branding Democrats offers Democrats a way forward: to build a stronger—and smarter—brand that works in the volatile political climate today. Using real world examples from past campaigns and years of branding expertise, Ken and Daryl Weber lay out a plan for taking the Democratic Party's brand from nonexistent to a consistent message that resonates with voters.
Daryl Weber is a brand strategist who has worked for some of the biggest brands in the world, including Coca-Cola, Nike, Johnnie Walker, Google, and many others. He was previously global director of creative strategy at The Coca-Cola Company and a strategy director at the brand consultancy Redscout. He is the author of Brand Seduction: How Neuroscience Can Help Marketers Build Memorable Brands. His father, Ken Weber is president of Weber Asset Management and author of the political blog, Sanity-First.com.
More information on Branding Democrats can be found at brandingdemocrats.com.
View original content to download multimedia:
SOURCE RealClear Publishing
|
https://www.whsv.com/prnewswire/2022/09/13/coca-colas-former-global-director-creative-strategy-daryl-weber-financial-strategist-ken-weber-comes-timely-new-book-branding-strategies-democratic-candidates/
| 2022-09-13T11:32:20Z
|
Five-time Entertainer of the Year invites people to visit metaphorical five-star hotel to address common myths about modern pig farming
DES MOINES, Iowa, Sept. 13, 2022 /PRNewswire/ -- As part of its ongoing effort to dispel common misconceptions about modern pig farming, the National Pork Board is teaming up with country music superstar and five-time Entertainer of the Year winner, Luke Bryan. Drawing on his childhood upbringing on a Georgia farm, Bryan understands and appreciates the hard work more than 60,000 pig farmers across the United States put in every day.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9078251-national-pork-board-luke-bryan-supports-pig-farmers-busts-myths/
"I have so much respect for pig farmers," said Bryan. "I know how hard they work – from sun-up to sundown, and it's exciting to be a part of a project helping show consumers the real care that happens on pig farms around the country."
The National Pork Board's latest campaign centers around a focus group video that metaphorically compares a modern pig farm to a five-star hotel. The focus group participants think they are providing feedback on a state-of-the-art hotel that includes strict cleaning protocols, well-balanced diets recommended by trained experts and reusing and recycling initiatives to use less land, water and energy. At the end of the conversation, participants realize that the discussion was not about a five-star hotel, but rather the real story of what happens every day on a modern pig farm.
As the gap continues to widen between the farm and the fork, there is an opportunity to help share the story of people and practices involved in pig farming today.
"Pig farmers are dedicated to people, pigs and the planet, and that means contributing to local communities, making sure their animals are well cared for and focusing on the environment for the next generation," Bryan said. "Farmers are the backbone of this country and with my 13th Farm Tour coming up, I can't wait to get back to visiting with farmers and fans."
Bryan's Farm Tour is a rural concert series held on farms throughout the Midwest during September. As part of this year's tour, the National Pork Board is partnering with Farmland®, a brand of Smithfield Foods, to donate a truckload of pork to local foodbanks in each of the states hosting the six tour stops. The donations will help provide high-quality protein, which is one of the most valuable resources food banks distribute - to help fight food insecurity across the Midwest. Supporting people and communities in this way are just a few of the We Care® ethical principles pig farmers live by.
Launching in early September with the social media debut of the Luke Bryan promotional spots and the hotel focus group video, the campaign will be supported by national, regional, local and trade media outreach and digital advertising.
"Last year, the National Pork Board launched its first campaign to take the biggest questions surrounding how pork is raised head-on," explained Heather Hill, president of the board of directors for the National Pork Board.
"This year we are taking our efforts to the next level by partnering with Luke Bryan," said Hill. "The topic of raising animals for food is personal to him, so he is a natural fit to help us share our passion for doing what's right."
Consumers can learn more about pig farming and the National Pork Board at http://go.pork.org/wecare and on the National Pork Board's Facebook, Instagram, Twitter and YouTube accounts.
The tour is sponsored by Fendt, Bayer, Farmland, National Pork Board, Citi and DISH.
The National Pork Board has responsibility for Pork Checkoff-funded research, promotion and consumer information projects and for communicating with pork producers and the public. The Pork Checkoff funds national and state programs in consumer education and marketing, retail and foodservice marketing, export market promotion, production improvement, science and technology, swine health, pork safety, and environmental management and sustainability. For the past half century, the U.S. pork industry has delivered on its commitment to sustainable production and has made significant strides in reducing the environmental impact of pig farming. Through a legislative national Pork Checkoff, pork producers invest $0.40 for each $100 value of hogs sold. Importers of pork products contribute a like amount, based on a formula. For information on Checkoff-funded programs, pork producers can call the Pork Checkoff Service Center at (800) 456-7675 or visit www.pork.org.
Since his debut, Bryan has garnered 29 No. 1 hits and has more RIAA certified digital singles than any other Country artist with 68.5 million. His worldwide global streams are over 18.9 billion and he has sold nearly 13 million albums. His headline concert tours have played sold-out shows for 12 million fans inclusive of 36 stadium concerts, Farm Tours, Spring Break shows, and seven sold-out 'Crash My Playa' destination concert events. The Georgia native is currently headlining his "Raised Up Right Tour." Bryan has won over 50 major music awards including five wins as Entertainer of the Year. His third and most recent Entertainer win was awarded by the Academy of Country Music in 2021. Additional awards include six recognitions as a CMT Artist of the Year, NSAI Artist/Songwriter of the Year, the first-ever recipient of the ACM Album of the Decade Award for Crash My Party, seven CMT Music Awards, five Billboard Music Awards, and four American Music Awards—as well as being named Billboard's Top Country Artist of the 2010s, the Most Heard Artist of the Decade by Country Aircheck, and the Artist Humanitarian Recipient by the Country Radio Broadcasters last year. On Nov.9, Luke and NFL superstar Peyton Manning will host "The 56th Annual CMA Awards" live from Nashville's Bridgestone Arena 8:00-11:00 PM/EST on ABC. In 2023, Luke, Katy Perry and Lionel Richie are back for their sixth season as celebrity judges on ABC's American Idol.
LukeBryan.com Facebook Twitter Instagram YouTube Tik Tok
Founded in 1959, Farmland is the maker of high-quality, flavorful meats. Rooted in rich traditions of America's heartland, Farmland is committed to a strong work ethic, community, substance over flash, and wholesome, quality food that people feel good about serving. Farmland's robust portfolio of products includes varieties of bacon, sausage, ham and lunch meat. For more information about our products and recipe inspiration, please visit www.FarmlandFoods.com or follow us on Facebook (@FarmlandFoods), Instagram (@farmlandfoods) or Twitter (@FarmlandFoods). Farmland is a brand of Smithfield Foods.
View original content:
SOURCE National Pork Board
|
https://www.whsv.com/prnewswire/2022/09/13/country-music-superstar-luke-bryan-goes-back-his-roots-support-pig-farmers/
| 2022-09-13T11:32:26Z
|
DALLAS, Sept. 13, 2022 /PRNewswire/ -- Crossroads Impact Corp (OTCQX: CRSS) ("Crossroads" or the "Company"), a holding company focused on investing in businesses that promote economic vitality and community development, reported financial results for its fiscal third quarter ended July 31, 2022.
During the quarter, Crossroads significantly expanded its balance sheet through two strategic equity investments of $180 million to be funded through January 31, 2023. This newly injected equity capital and the Company's ability to leverage responsibly well beyond the company's current leverage ratio of 1.08 will allow Crossroads to further extend its relationship and joint mission with Enhanced Capital Group to continue to make loans available across the core verticals of climate finance, impact real estate and small business lending to underserved businesses.
On the heels of an eventful second quarter 2022, Crossroads' third quarter yielded more modest results as we built a strong capital platform to support the $500 million-plus pipeline of environmental and social loans. Total revenue from operations was $13.5 million for the quarter ended July 31, 2022, compared with $487 million for the prior fiscal year's quarter ended July 31, 2021. This decrease can be attributed to one-time fees revenue from participating in the PPP in 2021.
During the quarter, the company recognized a noncash stock option compensation expense of $4.2 million related to the equity transactions, resulting in a net operating income before taxes and noncontrolling interest of $4,200, compared with $166 million the prior year. Adjusted net operating income after the one-time, noncash charge was $4.2 million. Net earnings per share from operations before taxes and after non-controlling interest for the quarter was a negative 2 cents, adjusted net earnings per share was $0.56 compared to $27.70 for the same period of 2021.
Management Commentary
As we mark the end of our fiscal third quarter in 2022, we celebrate the successful closing of our debt facility and capital raise and the impact loan pipeline. These strategic moves make it an exciting time at Crossroads, one that signals substantial growth of the business ahead. Since its inception just a year ago, as of the close of the third quarter, we have seen $121 million in impact loans and investments. In the third quarter alone, we added $68 million to our portfolio, maintaining our delinquency-free track record. The ripple effect of these loans can be felt deeply within the communities in which their businesses call home. The opportunity to support small businesses throughout a sustained volatile market is a privilege we covet tremendously.
Our mortgage portfolio reached $133 million with a 90-day delinquency rate of 1%. Our PPP loan portfolio balance was $1.2 billion, representing an 80% forgiveness rate with a net margin of 65 basis points and a net contribution of $2.6 million for the quarter. Our impact loan and investment portfolio reached $121.4 million generating interest income of $2.3 million in the quarter and no delinquencies to date.
2022 Fiscal Third Quarter Key Performance Indicators (KPIs)
Highlights for the quarter:
- PPP loan balance lowered to approximately $1.2 billion, with 80% of loans forgiven
- Addition of $68 million in impact loans and investments in the quarter
- Impact loans generated $2.3 million of income for the quarter ($4.6 million for the year)
- Fully diluted book value per share is $9.77 as currently reported, $11.09 upon the recognition of deferred PPP income
About Crossroads Impact Corp.
Crossroads Impact Corp (OTCQX: CRSS) Crossroads Impact Corp's mission is to promote economic vitality through community development and equitable access to capital; harnessing the power for good to tackle systemic issues within underserved communities. Building on our history of serving minority individuals and small businesses through environmental and responsible social lending, we look to be the leader in providing innovative and sustainable lending solutions.
Important Cautions Regarding Forward-Looking Statements
This press release includes forward-looking statements that relate to the business and expected future events or future performance of Crossroads Impact Corp and Capital Plus Financial involves known and unknown risks, uncertainties, and other factors that may cause its actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," and similar expressions or phrases identify forward-looking statements. Forward-looking statements include, but are not limited to, statements about Crossroads Impact's and Capital Plus Financial's ability to implement their business strategy, and their ability to achieve or maintain profitability. The future performance of Crossroads Impact and Capital Plus Financial may be adversely affected by the following risks and uncertainties: economic changes affecting homeownership in the geographies where Capital Plus Financial conducts business, developments in lending markets that may not align with Capital Plus Financial's expectations and that may affect Capital Plus Financial's plans to grow its portfolio, variations in quarterly results, developments in litigation to which we may be a party, technological change in the industry, future capital requirements, regulatory actions or delays and other factors that may cause actual results to be materially different from those described or anticipated by these forward-looking statements. For a more detailed discussion of these factors and risks, investors should review Crossroads Impact's annual and quarterly reports. Forward-looking statements in this press release are based on management's beliefs and opinions at the time the statements are made. All forward-looking statements are qualified in their entirety by this cautionary statement and Crossroads Impact undertakes no duty to update this information to reflect future events, information, or circumstances.
©2022 Crossroads Impact Corp.
Investor Relations & Media Contact:
dovetail solutions
Andy Boian
aboian@dovetailsolutions.com
(415) 404-2539
View original content to download multimedia:
SOURCE Crossroads Impact Corp
|
https://www.whsv.com/prnewswire/2022/09/13/crossroads-impact-corp-2022-fiscal-third-quarter-report/
| 2022-09-13T11:32:33Z
|
WOONSOCKET, R.I., Sept. 13, 2022 /PRNewswire/ -- CVS Health® (NYSE: CVS) has appointed Jeffrey R. Balser, M.D., Ph.D., to serve on the Board of Directors (the "Board") of CVS Health, effective immediately. He has also been named to the Board's Medical Affairs Committee.
"Dr. Balser's extensive experience in a wide range of roles across health care organizations will be an invaluable asset for the Board," said CVS Health President and CEO Karen S. Lynch. "His deep clinical expertise and leadership of a prestigious health system gives him the insight to help support our strategy to serve consumers and meet their health needs differently."
Dr. Balser serves as President and Chief Executive Officer of Vanderbilt University Medical Center ("VUMC") and has served as its chief executive since 2009, and has also served as Dean of the Vanderbilt University School of Medicine since 2008. VUMC is one of the largest and most prominent academic medical centers in the Southeast, with seven hospitals and 170 outpatient facilities across Tennessee and in neighboring states.
"On behalf of the Board, I want to welcome Dr. Balser to CVS Health," said Roger N. Farah, Independent Chair of the Board. "This is an exciting time for the Company, and we are confident he will be a valuable addition as we continue to redefine health care."
Dr. Balser is a member of the National Academy of Medicine and serves on its governing council. He also currently serves on the boards of VUMC, Tulane University, and the Nashville Health Care Council.
"I believe CVS Health's vision for primary care and its integrated approach to care delivery will help improve the health experience in our country," Dr. Balser said. "I look forward to working with the management team and the Board to help advance the company's strategy."
Dr. Balser completed his internship with the Osler Medical Service, residency training in anesthesiology, and fellowship training in both cardiac anesthesiology and critical care medicine at Johns Hopkins in Baltimore, MD. He joined the Hopkins faculty in 1995, practicing cardiac anesthesiology and ICU medicine while leading an NIH-funded research program aimed at the genomic underpinnings of cardiac rhythm disorders. He returned to Vanderbilt in 1998, was appointed chair of the Department of Anesthesiology in 2001 and became VUMC's chief research officer in 2004. In 2008/09, he was named Dean of the School of Medicine and Vice Chancellor for Health affairs with executive responsibility for Vanderbilt's medicine-related educational, research, and clinical service programs, responsibilities that continue since 2016 in his role as President and CEO.
About CVS Health
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
Media contact
T.J. Crawford
212-457-0583
CrawfordT2@CVSHealth.com
Investor contact
Larry McGrath
800-201-0938
investorinfo@CVSHealth.com
View original content to download multimedia:
SOURCE CVS Health
|
https://www.whsv.com/prnewswire/2022/09/13/cvs-health-appoints-dr-jeffrey-balser-board-directors/
| 2022-09-13T11:32:40Z
|
HOUSTON, Sept. 13, 2022 /PRNewswire/ -- Last month the Houston Business Journal announced DECISIO Health as a recipient of the Innovation Awards. The award honors Houston's most innovative companies at the fourth annual Innovation Awards. More than just a startup/tech awards program, Houston Business Journal recognizes innovation across all industries and all facets of business. The evaluation criteria ensures that all companies, regardless of industry, domain or innovation type can clearly communicate, affirm and support their nomination. DECISIO Health will be featured in a special section of the Houston Business Journal's September 23rd weekly edition.
DECISIO recently gained a patent related to a computer program product providing a novel patient dashboard system in a hospital setting. The flagship product, InsightIQ™, reduces clinical variation, improves patient outcomes while decreasing costs with digitized bundles of care that prioritizes clinicians' attention to at-risk patients requiring early intervention.
"We are excited and honored to receive this award. We feel this reflects the passion our company has for improving patients' outcomes and our customers' confidence in our products." said Co-CEO Dr. John Holcomb.
DECISIO is a Houston-based digital health company with a customizable clinical decision support platform designed to aggregate and prioritize real-time data, from any device, and present it visually in one place. The flagship product, InsightIQ, uses continuous smart bedside monitoring which enables clinical teams to efficiently identify patients at risk and comply with established clinical guidelines. InsightIQ improves patient outcomes and throughput, optimizes workflow, increases collaboration, thus reducing length of stay and "click" fatigue. Our solutions, including actionable analytics, can be scaled across an entire health system or used in a single care area. For more information, visit www.decisiohealth.com.
Contact Information
Paul Sinclair
DECISIO
contact@decisiohealth.com
View original content to download multimedia:
SOURCE Decisio Health
|
https://www.whsv.com/prnewswire/2022/09/13/decisio-health-selected-houston-business-journals-innovation-awards/
| 2022-09-13T11:32:47Z
|
SAN DIEGO, Sept. 13, 2022 /PRNewswire/ -- DERMALA, the only personalized, clinically proven treatment for acne powered by the human microbiome, extends its product range to include a daily-use body spray for blemish-prone skin.
Launching today, Baby Got BACNE™ is a gentle yet powerful body spray that banishes body breakouts in hard-to-reach areas like the chest, shoulders, and back. Utilizing DERMALA's unique SE Microbiome® and SE Sugar™ Complexes, Baby Got BACNE works to support beneficial skin bacteria while targeting acne-associated bacteria, balancing the skin microbiome to heal breakouts and stop them before they start.
Baby Got BACNE is the first product in the DERMALA Body Acne line, with future launches to follow. With twice-daily use, Baby Got BACNE gets excess oil under control while gently exfoliating the skin. In addition to the SE Microbiome and SE Sugar Complexes, it is formulated with powerful ingredients such as niacinamide, witch hazel extract, and salicylic acid to help open pores, exfoliate and target acne-causing bacteria.
"We know that acne does not just happen on the face only. In fact, body acne is a top concern for many of our current customers," said Lada Rasochova, Ph.D. MBA, Founder & CEO of DERMALA. "We decided to develop the Baby Got BACNE soothing spray to help our customers control body acne in hard-to reach-areas by targeting acne-causing bacteria, supporting the growth of beneficial bacteria, and getting the skin microbiome back into balance."
Baby got BACNE body spray is incorporated into the DERMALA personalization platform, a user-friendly digital engagement tool that DERMALA customers use to receive individual recommendations for the best combination of topical and ingestible products and product formulations for both the face and body acne.
Visit www.dermala.com to learn more about Baby Got BACNE, and all other products in the range. All DERMALA products are based on cutting-edge human microbiome science. They are formulated with patented microbiome-derived prebiotics, probiotics, and postbiotics that improve skin health naturally.
DERMALA, Inc. is a San Diego-based consumer dermatology company leveraging a scientific understanding of the human microbiome and data analytics to develop the next generation of science-backed, personalized, human microbiome-powered, clinically tested, and patented topical and ingestible products for chronic skin conditions and skin wellness. Visit www.dermala.com to learn more.
Press Contact:
Erica@LazarusPR.com
View original content to download multimedia:
SOURCE DERMALA
|
https://www.whsv.com/prnewswire/2022/09/13/dermala-consumer-dermatology-company-introduces-daily-use-body-spray-blemish-prone-skin/
| 2022-09-13T11:32:53Z
|
DAYTON, Ohio, Sept. 13, 2022 /PRNewswire/ -- DRT Holdings, Inc. ("DRT" or the "Company"), a leading manufacturer of highly complex systems and machined components for diverse end markets including metal packaging, aerospace, defense, space, power, medical, and building products, announced that it has appointed Larry Churchwell as President of DRT's Metal Packaging Systems and Precision divisions. DRT is a portfolio company of Mill Rock Capital, a leading growth and operations-oriented private investment firm.
Mr. Churchwell brings over 25 years of experience to this role, including 12 years of experience in the food and beverage packaging industry. Most recently, he led marketing and product management for automation and equipment at Sealed Air Corporation. Prior to Sealed Air, Mr. Churchwell held various roles in business leadership and marketing at Valspar Packaging Coatings, serving the food, beverage, and general packaging markets.
"DRT has a sterling reputation for high quality, innovation and strong customer partnership, and I am thrilled to join the Company at this exciting time," said Mr. Churchwell. "I look forward to working with the Metal Packaging Systems and Precision teams to continue delivering on our longstanding commitment to customer success."
DRT's Metal Packaging Systems division is a market leading provider of capital equipment, tooling, spare parts and services used in the production of aluminum or steel beverage and food cans. In 1959, the Company invented the integral rivet as the basis of the easy-open ends design for cans that the world knows today. This invention revolutionized the beverage and food manufacturing process and changed what could be packed in aluminum and steel cans. DRT's Precision division manufactures tooling and dies and provides precision machining for a diverse range of industries with exacting technical requirements.
CEO Rob Cohen stated, "I am delighted to welcome Larry to the team. With his leadership, we will continue to innovate and provide industry-leading solutions to our customers."
Executive Chairman and Mill Rock Senior Advisor Geoff Greulich added, "DRT is committed to growing this division organically and via acquisitions. Expanding its leadership is the first step, and I look forward to supporting Larry while he executes our growth strategy."
Founded in 1949 as the Dayton Reliable Tool & Mfg. Co., DRT Holdings, Inc. is a manufacturer and supplier of precision tools and specialized components for some of the most complex, technically demanding manufacturing applications in the world. The Company's full service solution supports customers from prototype through production where and when quality, efficiency, compliance and sustainability are paramount. DRT is organized in three business segments: Metal Packaging Systems, Aerospace and Precision. Metal Packaging Systems is the original developer of easy-open ("pull-top") ends principally used in food and beverage cans and continues to be one of the world's leading providers of equipment, aftermarket parts and services utilized in can production. Aerospace is a manufacturer of precision-machined parts for commercial and military aircraft, commercial space and land-based industrial gas turbine engines. Precision machines tooling and components for various industries, including medical imaging equipment, plastic injection molding and building products. DRT provides value-added services to supplement its core precision machining capabilities, including extensive engineering resources and design-for-manufacturability capabilities, go-to-market support and systems integration. The company currently operates ten locations in the United States and Europe. For more information, please visit https://drtholdingsllc.com/
Great Mill Rock LLC dba Mill Rock Capital is a growth and operations oriented private investment firm that invests in well-positioned middle market industrial businesses in North America. Founded by Christopher Whalen and Adi Pekmezovic, Mill Rock Capital is purpose-built to invest in family-owned businesses, owner-operators and founder-led companies across six industry verticals. Focus sectors include chemicals, materials and packaging; industrial distribution; services; metals and engineered materials; transportation and logistics; and specialty manufacturing & industrial technology. This strategy leverages the deep expertise of the firm's principals, a majority of whom have direct operating experience in these same industries. Mill Rock Capital supports business transformation through a dual-sourcing strategy encompassing majority equity and Activ Capital® – debt, senior equity or hybrid investments which provide business owners value-added financial partnership without relinquishing a controlling stake. For more information, please visit https://millrock-cap.com/.
Contact:
Lambert
Joanne Lessner
jlessner@lambert.com
212-222-7436
View original content to download multimedia:
SOURCE DRT Holdings, Inc.; Mill Rock Capital
|
https://www.whsv.com/prnewswire/2022/09/13/drt-holdings-appoints-larry-churchwell-president-metal-packaging-systems-precision/
| 2022-09-13T11:32:59Z
|
SAINT GALLEN, Switzerland and PARIS, Sept. 13, 2022 /PRNewswire/ -- Eligo Bioscience, a gene editing company, and Kantonsspital St. Gallen, one of Switzerland's leading hospitals, announced today their strategic alliance to develop a gene editing therapy for inflammatory cardiac diseases induced by bacterial mimicry. The collaboration builds on the foundational research conducted by Prof. Dr. Burkhard Ludewig and colleagues and published in Science (Gil-Cruz, et al, 2019), and leverages Eligo's proprietary technology for in vivo gene editing of the microbiome.
The Ludewig group demonstrated that a specific bacterial peptide mimics a human peptide and induces a pathogenic T cell response, which plays a key aggravating role in acute myocarditis and its often life-long debilitating sequelae. When the bacterial peptide mimic was eliminated in a preclinical mouse model, the acute myocarditis induced was effectively ablated, opening a valuable and potentially disease-modifying approach to treating this patient population. Indeed, symptomatic treatments are currently the only therapeutic options available to acute myocarditis patients, a significant proportion of whom develop severe sequelae, including cardiomyopathy.
Eligo's proprietary in vivo gene editing technology has the potential to precisely modify genes from resident bacteria encoding disease-driving peptide mimics, rendering these peptides non- immunogenic and thereby eliminating an important disease-aggravating factor. This approach can uniquely address key unmet needs in microbiome-related diseases by removing bacterial triggers of disease while maintaining commensal bacteria that are essential to our health.
The alliance between Eligo Bioscience and Kantonsspital St. Gallen will accelerate the development of novel therapies for inflammatory cardiac diseases by combining Kantonsspital St. Gallen's deep disease and patient insights and access to key patient samples, data and animal models, with Eligo's unique gene editing platform. Eligo's platform technology is powered to specifically deliver base-editing enzymes only to those resident bacteria that harbor peptide mimics using proprietary delivery particles. Eligo Bioscience owns the first patents covering in situ base editing of the microbiome as well as a broad patent portfolio to support its platform technology, including the use of CRISPR to kill bacteria.
"With this strategic collaboration with Kantonsspital St. Gallen, Eligo further consolidates its leadership in the field of microbiome gene editing and applies its unique platform to address the underlying cause of inflammatory cardiac diseases, for which to date only symptomatic treatments are available," said Dr. Xavier Duportet, Chief Executive Officer of Eligo Bioscience. "We are delighted to partner with leaders in the field of bacterial mimicry to advance first-in-class and valuable therapeutic approaches."
"This alliance with Eligo Bioscience is an important milestone for the research at our hospital as it will lead to the therapeutic application of our foundational discoveries in patients with high unmet need," said Prof. Dr. Burkhard Ludewig, Head of the Institute of Immunobiology and the Medical Research Center at Kantonsspital St. Gallen.
About Kantonsspital St. Gallen
The Kantonsspital St. Gallen is one of the largest hospitals in Switzerland and serves as the major tertiary referral center for Eastern Switzerland. More than 6,000 employees at the Kantonsspital St. Gallen strive to deliver high-level care and treatment according to evidence-based standards. The first-class medical services are complemented and supported by strong basic, translational and clinical research to provide patients with access to validated interventions and novel treatments.
About Eligo
Eligo Bioscience is the world leader in microbiome gene editing therapy and is advancing a highly differentiated pipeline of precision medicines to address unmet medical needs in inflammation, autoimmunity and oncology caused by the expression of specific deleterious bacterial genes by our microbiome.
Eligo was founded by scientists from The Rockefeller University, where CRISPR-based antimicrobials were invented, and by scientists from MIT. Eligo was named a Technology Pioneer by the World Economic Forum in 2017. Eligo has received venture capital funding from Khosla Ventures and Seventure Partners, and non-dilutive funding from GlaxoSmithKline, the European Commission, CARB-X, and Bpifrance.
Contact: Xavier Duportet, xavier.duportet@eligo-bioscience.com
Logo - https://mma.prnewswire.com/media/1533529/Eligo_Bioscience_SA_Logo.jpg
View original content:
SOURCE Eligo Bioscience
|
https://www.whsv.com/prnewswire/2022/09/13/eligo-bioscience-kantonsspital-st-gallen-announce-their-strategic-alliance-address-inflammatory-cardiac-diseases-through-vivo-gene-editing/
| 2022-09-13T11:33:05Z
|
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Sept. 13, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the appointment of Philip Kantoff, M.D., to its Board of Directors. Dr. Kantoff brings invaluable insight and experience to ESSA as a renowned medical oncologist and leader in the clinical development of new prostate cancer treatments.
"Phil's breadth and quality of accomplishments are unmatched, and we are honored to welcome him to ESSA's Board of Directors," stated Richard M. Glickman, L.L.D. (Hon), Chairman of ESSA's Board of Directors. "We are eager to leverage Phil's admirable expertise in prostate cancer clinical research, as we work to further ESSA's pipeline of first-in-class anitens targeting the N-terminal domain of the androgen receptor."
"ESSA's development program is focused on uniquely interfering with androgen-driven prostate cancer through targeting of the N-terminal domain of the androgen receptor. I look forward to advising and working with ESSA's Board of Directors and management team during this pivotal time," said Philip Kantoff, M.D.
Dr. Kantoff currently serves as the Chief Executive Officer and Co-founder of Convergent Therapeutics, where he spearheads the development of precision radiopharmaceuticals for prostate cancer treatment. Previously, Dr. Kantoff served as Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), managing more than 450 physicians and physician-scientists, while caring for patients, running a funded laboratory and developing improved cancer therapies. Prior to MSK, he was Professor of Medicine at Harvard Medical School and the Jerome and Nancy Kohlberg Chair at Harvard Medical School, Director of the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute and Division Head of Solid Tumor Oncology, serving as principal investigator in significant trials developing new therapeutic targets for patients with advanced prostate cancer. During this time, Dr. Kantoff conducted laboratory research focused on the genetic epidemiology of prostate cancer, mechanisms of resistance, the role of noncoding RNAs in prostate cancer, and the discovery of biomarkers as potential prognostic tools and/or therapeutic targets. Dr. Kantoff earned both his undergraduate and medical degrees from Brown University and is board certified in internal medicine and medical oncology. He has written more than 500 articles and books and is the recipient of numerous awards celebrating his research and clinical skills.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
This release contains certain information which, as presented, constitutes "forward-looking information" within the meaning of the Private Securities Litigation Reform Act of 1995 and/or applicable Canadian securities laws. Forward-looking information involves statements that relate to future events and often addresses expected future business and financial performance, containing words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions and includes, but is not limited to, the Company's plans to leverage Mr. Kantoff's expertise, plans to further ESSA's pipeline and the Company's development program.
Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of ESSA to control or predict, and which may cause ESSA's actual results, performance or achievements to be materially different from those expressed or implied thereby. Such statements reflect ESSA's current views with respect to future events, are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by ESSA as of the date of such statements, are inherently subject to significant medical, scientific, business, economic, competitive, political and social uncertainties and contingencies. In making forward looking statements, ESSA may make various material assumptions, including but not limited to (i) the accuracy of ESSA's financial projections; (ii) obtaining positive results of clinical trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market and economic conditions.
Forward-looking information is developed based on assumptions about such risks, uncertainties and other factors set out herein and in ESSA's Quarterly Report on Form 10-Q dated August 4, 2022 under the heading "Risk Factors", a copy of which is available on ESSA's profile on EDGAR at www.sec.gov and on the SEDAR website at www.sedar.com, and as otherwise disclosed from time to time on ESSA's EDGAR and SEDAR profiles. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made and ESSA undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as may be required by applicable United States and Canadian securities laws. Readers are cautioned against attributing undue certainty to forward-looking statements.
View original content:
SOURCE ESSA Pharma Inc
|
https://www.whsv.com/prnewswire/2022/09/13/essa-pharma-appoints-philip-kantoff-its-board-directors/
| 2022-09-13T11:33:12Z
|
New Report Reveals Vision Loss a Concern for Aging Americans Surveyed, But Majority Are Unaware Age-related Macular Degeneration Is a Leading Cause of Blindness
VAUGHAN, Ontario, Sept. 13, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today released a report of survey results from the company's first annual Visionary Report, which was designed to identify new key insights into the value Americans place on their eyesight, as well as the 'blind spots' that may exist in the understanding and awareness of Age-related Macular Degeneration (AMD), a leading cause of vision loss for those over age 501 and the leading cause of blindness for the 65+ population2.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/8949451-bausch-lomb-sponsored-visionary-report-amd/
Most notably in the report, 81% of U.S. adults surveyed would be willing to give up something else that is important - going on vacation, a million dollars, the internet, listening to music, the ability to remember people's names or another one of their senses - if it meant never losing their eyesight. Despite this clear prioritization of the ability to see, only 37% of U.S. adults 50+ surveyed know that AMD is a very real threat as a leading cause of vision loss for Americans.
"Today in the United States, an estimated 16 million Americans suffer from AMD, and this figure is expected to grow as the number of those age 65 and older continues to rise,"3-4 said Joe Gordon, president, Global Consumer, Surgical and Vision Care, Bausch + Lomb. "Bausch + Lomb is committed to addressing the eye health needs of patients, and we believe it's important to gain a better understanding of how Americans understand this condition and its potentially debilitating impact on their vision. Our hope is that this report will raise awareness, help to fill those education gaps and foster important dialogue between eye care professionals and their patients."
Key findings from the 2022 Visionary Report include:
Eyesight is a crystal clear priority across generations.
- 62% of Americans 50+ are worried about losing their eyesight as they age.
- 81% of Americans would be willing to give up one of the following if it meant never losing their eyesight: going on vacation again, a million dollars, the internet, listening to music, the ability to remember people's names or another one of their senses.
Despite this, AMD – a leading cause of vision loss – isn't in focus.
- Only 44% of Americans are concerned about developing AMD as they get older.
- Alzheimer's disease and dementia impact 11% of seniors 65+ and 82% of Americans 65+ are very/somewhat familiar with it. By contrast, AMD impacts 30% of the 65+ population and only 56% of those aged 65+ are aware of it.5
True understanding of AMD remains blurry.
- 61% of Americans aren't aware that a dilated eye exam is needed to diagnose AMD.
- 58% of Americans 50+ aren't sure if the progression of AMD is inevitable.
- Less than half of Americans are aware that vitamins/supplements may reduce the risk of progression of AMD in some patients.
Americans have a desire to see what they've been missing, learn more and take action.
- 75% of Americans who see an ophthalmologist/optometrist and have heard of AMD have never discussed it with their provider.
- 77% of this group would be interested in discussing AMD, along with its warning signs and risk factors, with their eye doctor.
"The data included in the Bausch + Lomb Visionary Report is impactful as a practicing physician as it demonstrates that many of those who are vulnerable to AMD are both unaware of the risk and are unfortunately lacking a full understanding of AMD and how it can affect their vision," said Rishi Singh, staff physician, Cleveland Clinic Florida, and president, Cleveland Clinic Martin North and South Hospitals. "It's clear that the majority of Americans who have been to the eye doctor are interested in discussing the condition, warning signs and risk factors, and these are insights my colleagues and I can use to help patients feel confident and in control of their eye health."
To read the 2022 Visionary Report, visit https://www.sightmatters.com/visionary-report.
About the Methodology Behind the Visionary Report
The Visionary Report was conducted online within the United States by The Harris Poll on behalf of Bausch + Lomb from April 14-18, 2022 among 2,073 respondents, 18 years of age and older. The sampling precision of Harris Online Polls is measured by using a Bayesian credible interval. For this study, the sample data is accurate to within +2.8 percentage points using a 95% confidence level.
About AMD
Age-related Macular Degeneration (AMD) is a progressive eye condition that impacts central vision and is a leading cause of blindness in adults aged 50 and older. The eye disease impacts central vision and occurs when the macula – the part of the eye that controls sharp straight-ahead vision – is damaged over time, causing people to have difficulty seeing faces, reading, driving or doing close-up work like cooking.3 Early-stage AMD often does not present any symptoms or changes in vision, as symptoms usually appear gradually over time. This progressive condition can impact one or both eyes.3
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.
Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb's filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on Bausch + Lomb, including but not limited to its project development timelines, launches and costs (which may increase). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
References
- Source: Prevent Blindness: Age-Related Macular Degeneration Fact Sheet: https://preventblindness.org/wp-content/uploads/2021/01/PBAMD_Fact-Sheet21.pdf.
- Centers For Disease Control and Prevention Website. Retrieved from https://www.cdc.gov/visionhealth/resources/features/macular-degeneration.html#:~:text=AMD%20is%20a%20major%20cause,vision%20needed%20to%20see%20clearly. Accessed June 8, 2022.
- National Eye Institute Website. Retrieved from https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration. Accessed June 8, 2022.
- U.S. Census Bureau, Population Projections. Retrieved from https://www.census.gov/newsroom/press-releases/2018/cb18-41-population-projections.html. Accessed June 8, 2022.
- Centers for Medicare and Medicaid Services, Chronic Conditions Prevalence State/County Table: All Fee-For-Service Beneficiaries.
© 2022 Bausch & Lomb Incorporated or its affiliates.
PV2.0092.USA.22
View original content:
SOURCE Bausch + Lomb
|
https://www.whsv.com/prnewswire/2022/09/13/first-annual-bausch-lomb-sponsored-visionary-report-spotlights-nations-blind-spots-age-related-macular-degeneration-leading-cause-vision-loss-people-50/
| 2022-09-13T11:33:18Z
|
VANCOUVER, BC, Sept. 13, 2022 /PRNewswire/ - First Mining Gold Corp. ("First Mining" or the "Company") (TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) is pleased to announce that Big Ridge Gold Corp. ("Big Ridge") (TSXV: BRAU) has completed the Stage 1 earn-in requirements (the "Stage 1 Earn-In") with respect to the Hope Brook Gold Project ("Hope Brook") as set out in the earn-in agreement (the "Agreement") that Big Ridge signed with First Mining on April 5, 2021. As required under the Agreement, Big Ridge has (i) incurred $10 million in qualifying exploration expenditures at Hope Brook, (ii) issued 15,000,000 common shares of Big Ridge ("Big Ridge Shares") to First Mining, and (iii) granted to First Mining a 1.5% net smelter returns ("NSR") royalty on Hope Brook, of which 0.5% can be bought back by Big Ridge for $2 million.
With the Stage 1 Earn-In now complete, Big Ridge has earned a 51% ownership interest in Hope Brook and has until June 8, 2026 to acquire an additional 29% direct interest in Hope Brook (the "Stage 2 Earn-In") by: (i) incurring a further $10 million in exploration expenditures (the "Additional Expenditures"); and (ii) issuing additional Big Ridge Shares to First Mining in the amount that is the lesser of (a) 10,000,000 Big Ridge Shares; or (ii) the number of Big Ridge Shares which, when combined with the number of Big Ridge Shares owned by First Mining at the time of issuance, would result in First Mining owning 19.9% of the issued and outstanding Big Ridge Shares outstanding. Upon completion of the Stage 2 Earn-In, First Mining will hold a 20% interest in Hope Brook which will be free carried until the completion of a Feasibility Study by Big Ridge.
"First Mining is delighted that Big Ridge has completed its $10 million worth of Stage 1 expenditures on the Hope Brook project in such an expeditious timeframe", stated Dan Wilton, CEO of First Mining. "Our partnership with Big Ridge has surfaced significant value for First Mining's shareholders and continues to highlight the potential value for the Hope Brook deposit. Our team remains encouraged and eagerly awaits results from Big Ridge's ongoing Phase 1 drill program."
"The successful completion of the Stage 1 earn-in at Hope Brook marks a significant milestone in the development of this exciting project" commented Mike Bandrowski, CEO of Big Ridge. "The promising results from our Phase 1 drill program have motivated the Big Ridge team to continue to advance the Hope Brook Project and highlight that it is a much larger, high-grade deposit in a Tier-1 location."
To date, Big Ridge has completed 61 diamond drill holes and released results from 33 of those holes. The Phase 1 drill program at Hope Brook has focused on connecting the Main Zone and the 240 Zone near surface and at depth, respectively, and testing the down dip extensions to both the Main and 240 Zones. Results from the Phase 1 drill program will be included in the updated mineral resource estimate that Big Ridge expects to issue in H1 2023.
The Hope Brook Gold Project is an advanced stage, high-grade gold project that produced 752,162 ounces of gold from 1987 – 1997. Hope Brook hosts an indicated gold resource totalling 5,500,000 tonnes grading 4.77 grams per tonne gold for 844,000 ounces and inferred resources totalling 836,000 tonnes grading 4.11 grams per tonne gold for 110,000 ounces based on a 3.0 gram per tonne cut-off grade and a long-term gold price of US$1,200, according to a technical report for Big Ridge Gold Corp., prepared by authors Michael Cullen, P. Geo., and Matthew Harrington, P. Geo., of Mercator Geological Services Limited and Jeffrey Burke, P. Geo., and titled "NI 43-101 Technical Report for the Hope Brook Gold Project, Newfoundland And Labrador, Canada", May 6, 2021.
The Hope Brook gold deposit is a high-sulfidation epithermal gold deposit hosted in the Proterozoic aged Whittle Hill Sandstone and is intruded by a Late Proterozoic quartz-feldspar porphyry sill-dyke complex of the Roti Intrusive Suite. The deposit is located adjacent to and within an extensive advanced argillic alteration envelope which includes pyrophyllite, kaolinite, andalusite, and alunite. The principal gold mineralization occurs in a buff-coloured massive, vuggy silicic alteration with an associated, less developed grey silicic alteration with pyrite, chalcopyrite and lesser bornite. Gold mineralization is also found with pyrite in units of advanced argillic alteration adjacent to or near silicic alteration horizons. The altered and mineralized zone is cut by mafic dykes whose contacts are often mineralized. All of the altered and mineralized sequences and the intruded dykes have been folded.
Hope Brook is located 85 kilometres east of Port aux Basques, Newfoundland. The project has well maintained infrastructure on site, including an operational 28-person camp, an 1,100-meter airstrip, ice-free docking facility and importantly, connection to the provincial electrical power grid via an on-site substation.
Significant exploration potential remains on the ~26,000-hectare concession providing a great opportunity to expand the mine area as well as surface showings throughout the concessions.
Big Ridge Gold Corp. is an exploration and development company managed by a disciplined and experienced team of officers and directors. The Company is committed to the development of advanced stage mining projects using industry best practices combined with strong social license from the local communities. Big Ridge owns a 100% interest in the highly prospective Oxford Gold Project located in Manitoba and the Destiny Gold Project in Quebec. Big Ridge is the operator of the Hope Brook Gold Project located in Newfoundland and Labrador.
Hazel Mullin, P.Geo., Director, Data Management and Technical Services of First Mining, is a "Qualified Person" for the purposes of National Instrument 43-101 Standards of Disclosure for Mineral Projects ("NI 43-101"), and she has reviewed and approved the scientific and technical disclosure contained in this news release.
First Mining is a gold developer advancing a portfolio of gold projects in Canada, with our most advanced project being the Springpole Gold Project in northwestern Ontario, which is one of the largest undeveloped gold projects in Canada, and where we have commenced a Feasibility Study and permitting activities are on-going with a draft Environmental Impact Statement ("EIS") for the project published in June 2022. First Mining also owns the Cameron, Duparquet, Duquesne and Pitt gold projects, all advanced-stage gold projects in Ontario (in the case of Cameron) and Québec. Our portfolio of gold project interests also includes the Pickle Crow gold project (being advanced in partnership with Auteco Minerals Ltd.), the Hope Brook gold project (being advanced in partnership with Big Ridge Gold Corp.), an equity interest in Treasury Metals Inc., and a portfolio of 21 gold royalties.
First Mining was established in 2015 by Mr. Keith Neumeyer, founding President and CEO of First Majestic Silver Corp.
ON BEHALF OF FIRST MINING GOLD CORP.
Daniel W. Wilton
Chief Executive Officer and Director
This news release includes certain "forward-looking information" and "forward-looking statements" (collectively "forward-looking statements") within the meaning of applicable Canadian and United States securities legislation including the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date of this news release. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "plans", "projects", "intends", "estimates", "envisages", "potential", "possible", "strategy", "goals", "opportunities", "objectives", or variations thereof or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions.
Forward-looking statements in this news release relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events and include, but are not limited to, statements with respect to: (i) completion and timing of the Stage 2 Earn-In; (ii) the timing for results of Big Ridge's Phase 1 exploration drill program at Hope Brook; (iii) timing for the release by Big Ridge of an updated mineral resource estimate for Big Ridge; (iv) the Company's plans with respect to advancing its portfolio of gold projects; and (v) Feasibility and permitting activities related to the Springpole Gold Project. All forward-looking statements are based on First Mining's or its consultants' current beliefs as well as various assumptions made by them and information currently available to them. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Such factors include, without limitation the Company's business, operations and financial condition potentially being materially adversely affected by the outbreak of epidemics, pandemics or other health crises, such as COVID-19, and by reactions by government and private actors to such outbreaks; risks to employee health and safety as a result of the outbreak of epidemics, pandemics or other health crises, such as COVID-19, that may result in a slowdown or temporary suspension of operations at some or all of the Company's mineral properties as well as its head office; fluctuations in the spot and forward price of gold, silver, base metals or certain other commodities; fluctuations in the currency markets (such as the Canadian dollar versus the U.S. dollar); changes in national and local government, legislation, taxation, controls, regulations and political or economic developments; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected formations, pressures, cave-ins and flooding); the presence of laws and regulations that may impose restrictions on mining; employee relations; relationships with and claims by local communities, indigenous populations and other stakeholders; availability and increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development; title to properties.; and the additional risks described in the Company's Annual Information Form for the year ended December 31, 2021 filed with the Canadian securities regulatory authorities under the Company's SEDAR profile at www.sedar.com, and in the Company's Annual Report on Form 40-F filed with the SEC on EDGAR.
First Mining cautions that the foregoing list of factors that may affect future results is not exhaustive. When relying on our forward-looking statements to make decisions with respect to First Mining, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. First Mining does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by the Company or on our behalf, except as required by law.
The Company is a "foreign private issuer" as defined in Rule 3b-4 under the United States Securities Exchange Act of 1934, as amended, and is eligible to rely upon the Canada-U.S. Multi-Jurisdictional Disclosure System, and is therefore permitted to prepare the technical information contained herein in accordance with the requirements of the securities laws in effect in Canada, which differ from the requirements of the securities laws currently in effect in the United States. Accordingly, information concerning mineral deposits set forth herein may not be comparable with information made public by companies that report in accordance with U.S. standards.
Technical disclosure contained in this news release has not been prepared in accordance with the requirements of United States securities laws and uses terms that comply with reporting standards in Canada with certain estimates prepared in accordance with NI 43-101.
NI 43-101 is a rule developed by the Canadian Securities Administrators that establishes standards for all public disclosure an issuer makes of scientific and technical information concerning the issuer's material mineral projects.
View original content to download multimedia:
SOURCE First Mining Gold Corp.
|
https://www.whsv.com/prnewswire/2022/09/13/first-minings-joint-venture-partner-big-ridge-gold-completes-stage-1-earn-in-hope-brook-gold-project-ontario-canada/
| 2022-09-13T11:33:25Z
|
AMSTERDAM, Sept. 13, 2022 /PRNewswire/ -- Flytxt B.V. today announced that its Flytxt CLTV AI for CX solution is now available on SAP® Store and is part of SAP's industry cloud portfolio for the telecommunication industry.
Flytxt CLTV AI leverages integration capabilities of SAP Business Technology Platform (SAP BTP) and integrates with SAP Customer Data Platform to deliver actionable customer and product intelligence to improve customer experience workflows and decisions, resulting in better business outcomes.
"Capitalizing on customer lifetime value (CLTV) is rapidly becoming a key factor for subscription business success; however, maximizing CLTV has been difficult despite having access to vast amounts of customer data and computing resources," said Dr. Vinod Vasudevan, CEO of Flytxt. "Simultaneously, subscription businesses are increasingly turning toward outcome-based business models to secure recurring revenue streams. The Flytxt solution helps businesses in the SAP ecosystem maximize CLTV through our well-trained and market-proven AI."
Subscription businesses using SAP Customer Data Platform can make use of this add-on solution from Flytxt to have additional customer intelligence in the form of predictive insights, recommendations, and next best actions.
"The Flytxt CLTV AI for CX solution complements our portfolio and enables actionable customer and product intelligence for our customers," said Carl Kehres, Head of Telecommunication Industry Business Unit at SAP. "We look forward to collaborating with Flytxt to bring the value of our partnership to customers who want to drive cost-effective and sustainable growth in their industry."
The Flytxt CLTV AI for CX solution:
- Leverages Flytxt's AI/ML models trained with trillions of curated data points to derive accurate and deeper insights on historical and predicted usage behavior of customers
- Prescribes recommendations and next best actions at scale for users of SAP Customer Data Platform to help optimize the value of every customer interaction across touch points and journeys
- Performs no-code analytics; saves time in performing manual analysis and custom AI/ML model development and training
- Supports APIs that can access customer, product, and campaign data from SAP Customer Data Platform and other CX applications and then feeds actionable intelligence back into these systems
To help enable companies to become intelligent enterprises, SAP is expanding its vertical solutions with an ecosystem of industry cloud solutions. The solutions leverage SAP BTP, with advanced technologies, and are interoperable with SAP's intelligent suite. Flytxt is working with SAP to create offerings that meet specific, telecommunications industry requirements to provide customers with tools to help achieve positive business outcomes. Learn more at SAP Store.
Flytxt is a partner in the SAP® PartnerEdge® program. Businesses that use SAP technologies from telecommunication, media, financial services, utilities, and travel sectors can subscribe to Flytxt's CLTV AI to gain additional intelligence for maximizing customer and product lifetime value.
About Flytxt B.V.
Flytxt is the trusted technology partner of 80+ digital enterprises across more than 50 countries, as well as of top CX platform vendors for CLTV maximization. Its award-winning, CLTV maximization AI has been designed and trained using real-world insights and patterns from more than a billion consumers and trillions of data points. The firm has a corporate office in Dubai, global development centres in India, and presence in Mexico, Netherlands, Colombia, Czech Republic, Spain, and Kenya.
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices.
For more information, press only:
Ami Atha
PrforFlytxt@bospar.com
Video: https://www.youtube.com/watch?v=LAKPADHUx8w
Logo: https://mma.prnewswire.com/media/1748972/Flytxt_Logo.jpg
View original content to download multimedia:
SOURCE Flytxt
|
https://www.whsv.com/prnewswire/2022/09/13/flytxt-cltv-ai-cx-now-available-sap-store-part-saps-industry-cloud-portfolio/
| 2022-09-13T11:33:31Z
|
New partnership provides Fortune 5000 and DoD customers with complete asset and
deployment management solution for indoor and outdoor private networks
MONTCLAIR, N.J., Sept. 13, 2022 /PRNewswire/ -- Future Technologies Venture, LLC, (Future Technologies), a lead system integrator focused on Industry 4.0 and Mission Critical solutions, and Sitetracker, the leading deployment operations management software for critical infrastructure providers, today announced a partnership that will enable Future Technologies' private network customers (Private 4G/5G, Fiber, IoT, Fixed Wireless, Edge Computing) to have the insights, efficiencies, and competitive advantages of Sitetracker included in their Digital Asset Management as a Service solution.
"Our customers are Fortune 50 to Fortune 5000 and the US Department of Defense customers deploying private networks for mission critical and Industry 4.0 applications, so our solutions need to be cutting-edge, reliable, and secure," said Peter Cappiello, CEO, Future Technologies. "With Sitetracker, we have a more robust and complete Private Network Digital Asset Management solution, giving customers even better data, planning, and insights into their productions."
Future Technologies' Digital Asset Management solution is an extension of Future Technologies project-based services offering the company have been delivering the past 22 years. In these customer engagements, Future Technologies provides end-to-end solutions through Use Case definition & solution, Site Audits, Network Design, RF Design, Tower Mapping, Structural Analysis, Construction Drawings, Regulatory Review, Environmental Services, Zoning & Permitting, Deployment and Maintenance. Through this partnership with Sitetracker, Future Technologies has curated the Sitetracker platform to be a single pane of glass for their private network clients to efficiently manage their digital transformation of their Network (Wired & Wireless), Edge Computing, Vertical Assets (Towers, Poles, Rooftops) and IoT devices (Sensors, Access Control, Cameras).
This Digital Asset Management solution is already being implemented for a Large Fortune 150 Energy Customer for a digital oil field private network deployment (Fiber, CBRS, Fixed Wireless, IoT), as well as a US Department of Defense customer for Private Cellular Network (4G/5G) production deployment. Future Technologies and Sitetracker anticipate quickly expanding this digital asset management solution to their over 180 existing private network clients across vertical markets including Oil & Gas, Chemical, Manufacturing, Logistics, Rail, Utility, and the Department of Defense. According to research from IDC, worldwide private LTE/5G wireless infrastructure revenues will reach $8.3 billion by 2026, and the market is expected to achieve a five-year compound annual growth rate (CAGR) of 35.7% over the 2022-2026 forecast period.
"Future Technologies' focuses on solving client problems with an emphasis on use case development for each customer and provides them a tailored, intelligent approach to private networks to activate these solutions, and now with Sitetracker, each customer's use case solutions can be further dissected, strategized, managed, and deployed," said Giuseppe Incitti, CEO, Sitetracker. "By our two companies partnering, customers get a best-of-breed managed service that will offer them unparalleled value across their entire production cycle. We look forward to a long and beneficial relationship with Future Technologies and their customers."
Future Technologies Venture, LLC, is a Lead System Integrator (LSI) specializing in the assessment, planning, design, implementation, and support of innovative communications solutions for vertical markets – DoD, utility, oil & gas, manufacturing and transportation. Future Technologies maintains a strong concentration on emerging standards such as 5G, 4G, Private LTE, WIFI, SCADA and automation technologies. Future Technologies is headquartered in Atlanta, Ga. www.futuretechllc.com
Sitetracker powers the rapid deployment of tomorrow's infrastructure. The global leader in deployment operations management software, Sitetracker helps innovative companies like British Telecom, KPN, Segra, and ChargePoint manage millions of sites and assets representing over $150 billion in portfolio holdings. By giving telecommunications, utility, smart cities, and energy teams a cloud-based solution that works easily and effectively, Sitetracker is accelerating the path to digital equity and a more sustainable future. Deploy what's next. For more information, please visit https://www.sitetracker.com/.
View original content:
SOURCE Sitetracker
|
https://www.whsv.com/prnewswire/2022/09/13/future-technologies-partners-with-sitetracker-offer-digital-asset-management-service-private-networks/
| 2022-09-13T11:33:37Z
|
Givex and Counter Solutions can be found at CD 737 at ExCel in London from September 14 to 15.
TORONTO, Sept. 13, 2022 /PRNewswire/ - Givex Information Technology Group Ltd. ("Givex") (TSX: GIVX) announced today it will exhibit at the definitive restaurant, pub and bar event Casual Dining at ExCeL in London September 14-15 with recently-acquired UK-based Counter Solutions.
Casual Dining marks the first trade show that Givex and Counter Solutions will present together after the acquisition was completed in August. At CD 737, Givex will be showcasing its leading point-of-sale system, GivexPOS along with its Kitchen Display System (KDS), Stock System and loyalty and gift card products, while Counter Solutions will demonstrate its kiosk and WAY2PAY unattended retail functionality.
"We are thrilled at how quickly and thoughtfully the Counter Solutions and Givex teams collaborated in a few short weeks to prepare to display our new collective capabilities," said Jurgen Ketel, Managing Director of Givex EMEA. "Our products perfectly complement each other, and we are able to show both new and existing clients how seamlessly our products work together to create efficiencies that are simply not found through other providers."
Counter Solutions' WAY2PAY platform offers micro market & smart-refrigeration technology which allows customers to purchase products from controlled access chillers using their payment card, Apple Pay and Google Pay.
"In addition to our products being aligned and allowing us to offer new and exciting products to our respective client bases, one of the primary reasons we chose to partner with Givex is because of the depth of its team," said Richard Bernans, Managing Director of Counter Solutions. "Both teams worked hard to ensure that we were ready to present together at Casual Dining, and we are excited to be able to showcase new and innovative solutions at the show for our clients across the globe."
Givex (TSX: GIVX) (OTCQX: GIVXF) is a global fintech company providing merchants with customer engagement, point of sale and payment solutions, all in a single platform. We are integrated with 1000+ technology partners, creating a fully end-to-end solution that delivers powerful customer insights. Our platform is used by some of the world's largest brands, comprising approximately 116,000 locations across more than 100 countries. Learn more at givex.com.
View original content to download multimedia:
SOURCE Givex
|
https://www.whsv.com/prnewswire/2022/09/13/global-fintech-company-givex-recently-acquired-counter-solutions-exhibit-together-londons-casual-dining-trade-show/
| 2022-09-13T11:33:39Z
|
VANCOUVER, BC, Sept. 13, 2022 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to announce additional assay results from its recently completed five hole 3,485 metre (m) drilling program on the La Garrucha target, located less than one kilometre to the east of existing mineral resources on the Company's 100% owned La Mina Project ("La Mina"), located in the Middle Cauca Porphyry Belt, Antioquia, Colombia.
- The 2022 drilling program has discovered extensions of previously identified gold-copper porphyry mineralization at the La Garrucha target, which is within the La Mina Project.
- Assay results returned to date from the 2022 drilling program have almost doubled the size of the La Garrucha gold-copper porphyry mineral system to at least 400 m strike and 775 m below surface, with the system remaining open to the southeast and to depth.
- LME1108 includes a 'Main Zone' intercept of:
431.23 m at 0.55 grams per tonne (g/t) gold (Au) and 0.12 percent (%) copper (Cu), or alternatively expressed as 0.73 g/t gold equivalent (AuEq), from 181.27 m downhole.
- La Garrucha lies approximately one kilometre east of existing estimated mineral resources within the La Cantera and Middle Zone deposits.
- Pending receipt of all drill assays the La Garrucha gold-copper porphyry mineral system will undergo geological modelling and will be included in an updated mineral resource estimate for the La Mina Project expected to be initiated in the fourth quarter of 2022, with the intention to initiate an updated La Mina Preliminary Economic Assessment ("PEA") in 2023.
Alastair Still, CEO of GoldMining, commented, "Our team has competed our first exploration drilling program in Colombia safely and on budget, and we are very pleased with the initial drill results to date, targeting the expansion of the La Garrucha discovery at the La Mina Project. Results from LME1108 will help define the size of the mineralized system, which extends for hundreds of metres and remains open for further expansion. While we still have assay results pending from the final hole drilled in the program, we currently plan to initiate an update to the mineral resource estimate in the fourth quarter of 2022, consistent with our focused approach to unlocking value from our portfolio of gold and gold-copper projects located throughout the Americas."
Tim Smith, VP Exploration of GoldMining, commented, "The re-entry of LME1108 has extended gold-copper porphyry mineralization over 300 metres deeper than all previous drilling completed at La Garrucha and represents the deepest drilling completed thus far for the entire La Mina Project. This continuity of mineralization to depth provides a new vector for the ongoing exploration of the broader La Mina mineral system. We expect that the synthesis of geological, geochemical and geophysical data amassed from the historic and recent drilling will allow the GoldMining team to identify and prioritize additional targets for future exploration campaigns."
From late March through to mid-August 2022 GoldMining completed a diamond core drilling program, comprising five drill holes for 3,485 m at its La Garrucha target within the La Mina Project (see Figures 1 & 2). On June 23, 2022, the Company announced interim results from the first two holes of the drilling program, including the initial entry of LME1108 which returned 345.54 m at 0.57 g/t Au and 0.12% Cu (0.74 g/t AuEq), from 254.95 m depth. As of the previous reporting date, LME1108 ended in mineralization and up-hole assays had not yet been returned. The Company has subsequently completed a re-entry extension of LME1108 to a total depth of 915.49 m and is now pleased to present comprehensive results for LME1108 which extends mineralization up-hole via additional assay results received, and from the deeper down-hole extension via re-entry drilling.
LME1108 Total Mineralized Porphyry Envelope (extended up- and down-hole via additional core sampling and drill hole re-entry respectively):
In addition to re-entry of LME1108, a new fence of drilling located a further 100 metres along strike targeted the edge of the magnetic high associated with the La Garrucha target to test the extents of porphyry mineralization. Drill holes LME1109 and LME1110 intersected broad low-grade porphyry mineralization and both holes ended in low-grade mineralization. Although the underlying magnetic 'high' is waning to the southeast, the edges of the host porphyry intrusion have not yet been defined and therefore the mineral system remains open along strike to the southeast. The drill logs and multi-element assay results will be analyzed against a three-dimensional inversion model of the magnetic response to determine whether the system could be extended further to the southeast by drilling.
Comprehensive assay intercepts for LME1107 and LME1108, and partial assay results from holes LME1109 and LME1110, can be found in Table 1.
The 2022 La Garrucha drilling targeted strike and depth extensions of the previously intersected gold-copper mineralized porphyry intrusive system, last drilled in 2011 by Bellhaven Copper & Gold Inc. ("Bellhaven") prior to its acquisition by GoldMining. Selected intercepts from the previous drilling are listed below and a comprehensive summary of historic La Garrucha intercepts is also provided in Table 1.
A fifth and final drill hole of the 2022 program, LME1111, was drilled to provide improved confidence of the continuity of the porphyry mineral system between the previous Bellhaven drilling and the recently completed GoldMining drilling (see Figure 2). Core logging and sampling of LME1111 is currently being completed, with assays to be reported as they become available.
La Garrucha gold and copper mineralization is coincident with potassic alteration in the core of the porphyry intrusive complex. Potassic alteration is characterized by secondary potassium feldspar and biotite, disseminated and vein magnetite, quartz stockwork veining and both vein-hosted and disseminated sulphides that include pyrite, chalcopyrite and lesser bornite.
With the 2022 step out drilling the La Garrucha porphyry mineral system now extends over 400 m strike and 300 m width. To depth, the re-entry extension of LME1008 has extended mineralization from a previously intersected maximum depth of 450 m below surface, to approximately 775 m below surface where the porphyry mineral system remains open to depth (see Figure 3).
Geological interpretation of the La Garrucha drilling program will extend to encompass re-logging of the previous Bellhaven core, to place copper and gold mineralization in spatial and temporal context with the hosting La Garrucha porphyry intrusive complex and also to compare against the other La Mina porphyry deposits at La Cantera and Middle Zone. Geological three-dimensional modelling and subsequent geostatistical modelling will be completed during Q4 2022 with the intention to initiate an updated mineral resource estimate by year-end including the La Garrucha mineralization, with current plans to update the La Mina PEA in 2023.
Additional information regarding the La Mina Project, including existing resource estimates and historic work at the project, is set out in the technical report titled "NI 43-101 Technical Report and Preliminary Economic Assessment, La Mina Project, Antioquia, Republic of Colombia" with an effective date of January 12, 2022 (the "Existing La Mina Technical Report"), which is available on the Company's website at www.goldmining.com.
Table 1 – La Garrucha gold assay intercepts from 2022 drilling program received as of 13th September 2022 and drill intercepts for historic Bellhaven drilling.
Table 2 –La Garrucha drillhole collar location coordinates.
Paulo Pereira, P. Geo., President of GoldMining, has reviewed and approved the technical information contained in this news release. Mr. Pereira is a Qualified Person as defined in National Instrument 43-101.
For this program of drill core sampling, samples were taken from the NQ/HQ core by sawing the drill core in half, with one-half sent to ALS Colombia LTDA in Medellín for assaying and the other half retained for future reference. Sample lengths downhole range from a minimum of 0.50 m to a maximum of 2.10 m. ALS Colombia LTDA is a certified commercial laboratory located in Medellín, Antioquia, Colombia and is independent of GoldMining. GoldMining has implemented a stringent quality assurance and quality-control (QA/QC) program for the sampling and analysis of drill core which includes insertion of duplicates, mineralized standards and blank samples for each batch of 100 samples. The gold analyses were completed by ALS Au-AA23 method (fire-assay with an atomic absorption finish on 30 grams of material). Repeats were also carried out by fire-assay. Copper analyses were completed by ALS ME-ICP61 method (four acid digest with ICP analysis).
GoldMining Inc. is a public mineral exploration company focused on the acquisition and development of gold assets in the Americas. Through its disciplined acquisition strategy, GoldMining now controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, U.S.A., Brazil, Colombia, and Peru. The Company also owns more than 20 million shares of Gold Royalty Corp. (NYSE American: GROY).
This document contains certain 'forward-looking information' and 'forward-looking statements' within the meaning of applicable Canadian and U.S. securities laws ("forward-looking statements") that reflect the current views and/or expectations, including statements regarding the ' future work programs and planned activities and studies at the Company's La Mina Project and expectations regarding the La Mina Project. Forward-looking statements are based on the then-current expectations, beliefs, assumptions, estimates and forecasts about the business and the markets in which GoldMining operates. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including: delays to plans caused by restrictions and other future impacts of COVID-19 or any other inability of the Company to meet expected timelines for planned project activities; results of exploration programs may not confirm expectations; the inherent risks involved in the exploration and development of mineral properties, fluctuating metal prices, unanticipated costs and expenses, risks related to government and environmental regulation, social, permitting and licensing matters, and uncertainties relating to the availability and costs of financing needed in the future. These risks, as well as others, including those set forth in GoldMiningꞌs Annual Information Form for the year ended November 30, 2021, and other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (the "SEC"), could cause actual results and events to vary significantly. Accordingly, readers should not place undue reliance on forward-looking statements and information. There can be no assurance that forward-looking information, or the material factors or assumptions used to develop such forward-looking information, will prove to be accurate. The Company does not undertake any obligations to release publicly any revisions for updating any voluntary forward-looking statements, except as required by applicable securities law.
The disclosure in this news release and referred to herein was prepared in accordance with NI 43-101 which differs significantly from the requirements of the SEC. The terms "proven mineral reserve", "probable mineral reserve" and "mineral reserves" used in this news release are in reference to the mining terms defined in the Canadian Institute of Mining, Metallurgy and Petroleum Standards (the "CIM Definition Standards"), which definitions have been adopted by NI 43-101. Accordingly, information contained in this news release providing descriptions of our mineral deposits in accordance with NI 43-101 may not be comparable to similar information made public by other U.S. companies subject to the United States federal securities laws and the rules and regulations thereunder.
Investors are cautioned not to assume that any part or all of mineral resources will ever be converted into reserves. Pursuant to CIM Definition Standards, "Inferred mineral resources" are that part of a mineral resource for which quantity and grade or quality are estimated on the basis of limited geological evidence and sampling. Such geological evidence is sufficient to imply but not verify geological and grade or quality continuity. An inferred mineral resource has a lower level of confidence than that applying to an indicated mineral resource and must not be converted to a mineral reserve. However, it is reasonably expected that the majority of inferred mineral resources could be upgraded to indicated mineral resources with continued exploration. Under Canadian rules, estimates of inferred mineral resources may not form the basis of feasibility or pre-feasibility studies, except in rare cases. Investors are cautioned not to assume that all or any part of an inferred mineral resource is economically or legally mineable. Disclosure of "contained ounces" in a resource is permitted disclosure under Canadian regulations; however, the SEC normally only permits issuers to report mineralization that does not constitute "reserves" by SEC standards as in place tonnage and grade without reference to unit measures.
Canadian standards, including the CIM Definition Standards and NI 43-101, differ significantly from standards in the SEC Industry Guide 7. Effective February 25, 2019, the SEC adopted new mining disclosure rules under subpart 1300 of Regulation S-K of the United States Securities Act of 1933, as amended (the "SEC Modernization Rules"), with compliance required for the first fiscal year beginning on or after January 1, 2021. The SEC Modernization Rules replace the historical property disclosure requirements included in SEC Industry Guide 7. As a result of the adoption of the SEC Modernization Rules, the SEC now recognizes estimates of "Measured Mineral Resources", "Indicated Mineral Resources" and "Inferred Mineral Resources". In addition, the SEC has amended its definitions of "Proven Mineral Reserves" and "Probable Mineral Reserves" to be substantially similar to corresponding definitions under the CIM Definition Standards. During the period leading up to the compliance date of the SEC Modernization Rules, information regarding mineral resources or reserves contained or referenced in this news release may not be comparable to similar information made public by companies that report according to U.S. standards. While the SEC Modernization Rules are purported to be "substantially similar" to the CIM Definition Standards, readers are cautioned that there are differences between the SEC Modernization Rules and the CIM Definitions Standards. Accordingly, there is no assurance any mineral reserves or mineral resources that the Company may report as "proven mineral reserves", "probable mineral reserves", "measured mineral resources", "indicated mineral resources" and "inferred mineral resources" under NI 43-101 would be the same had the Company prepared the reserve or resource estimates under the standards adopted under the SEC Modernization Rules.
View original content to download multimedia:
SOURCE GoldMining Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/goldmining-extends-mineralization-its-la-garrucha-target-la-mina-project-colombia-drill-results-include-43123-m-073-gt-aueq/
| 2022-09-13T11:33:46Z
|
Brandt joins as the firm's first CHRO after nearly 20 years in the financial services industry
CONSHOHOCKEN, Pa., Sept. 13, 2022 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ: HLNE) today announced that it has hired Kristin Brandt to the newly-created role of Chief Human Resources Officer, based in the firm's Conshohocken, Penn. headquarters and reporting into CEO Mario Giannini.
Brandt is a longtime Human Resources professional with 25 years of experience, nearly 20 of which were within the financial services and banking industry. She comes to Hamilton Lane from Lazard, where she spent seven years and most recently served as the Head of HR for the Americas Investment Banking division. Prior to Lazard, she spent 12 years at Bank of America Merrill Lynch in a variety of leadership roles, primarily within the Global Corporate and Investment Banking division. Brandt spent much of her early career within the consulting industry, after earning a BA from Tufts University and an MBA from Columbia University.
Mario Giannini commented: "Kristin has extensive experience in building world-class Human Resources operations within large and growing financial firms, and we will look to her to help us continue to scale our own function, construct the roadmap for our future and bring an even greater focus on finding, fostering and supporting the part of our business that truly sets us apart – our employees."
Brandt joins Hamilton Lane at a time of high growth for the firm, which has expanded its employee base by 42% since March 2020, to more than 540 employees across 21 offices globally today. The firm has expanded its commingled product platform and SMA businesses, and has also seen significant growth in its Evergreen business, launched just over three years ago and which is designed to provide private markets access with a single allocation, monthly or quarterly liquidity, low investment minimums and immediate exposure. Among her areas of focus will be continuing to invest in the functions that support employee growth and development – recruitment, retention, mentorship and training.
"I can already see that this is a firm that cares deeply about its people – and knows that its continued success will be due in no small part to excellent, committed, passionate and engaged employees. I am thrilled to be stepping into this role at a time of significant global growth, and look forward to supporting our people and teams around the world," Brandt said.
Hamilton Lane has an award-winning culture, as one of only five firms consecutively named to Pensions & Investments' Best Places to Work in Money Management list in the 10 years since the ranking was established.
About Hamilton Lane
Hamilton Lane (NASDAQ: HLNE) is a leading private markets investment management firm providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for 30 years, the firm currently employs more than 540 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has more than $832 billion in assets under management and supervision, composed of $108 billion in discretionary assets and more than $724 billion in non-discretionary assets, as of June 30, 2022. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit www.hamiltonlane.com or follow Hamilton Lane on LinkedIn: https://www.linkedin.com/company/hamilton-lane/.
Media Contact
Kate McGann
kmcgann@hamiltonlane.com
+1 240 888 4078
Investor Contact
John Oh
joh@hamiltonlane.com
+1 610 617 6026
View original content:
SOURCE Hamilton Lane
|
https://www.whsv.com/prnewswire/2022/09/13/hamilton-lane-names-kristin-brandt-chief-human-resources-officer/
| 2022-09-13T11:33:52Z
|
The nation's largest COVID-19 Research Database and advanced data-analysis platform to power the early identification of patients at risk of developing chronic kidney disease
FORT LAUDERDALE, Fla. and SAN FRANCISCO, Sept. 13, 2022 /PRNewswire/ -- HHS Technology Group, LLC™ (HTG); Datavant, the leader in helping organizations securely connect health data; and Mathematica announced today they are collaborating to offer public and private sector access to invaluable resources to fight the invisible epidemic of chronic kidney disease (CKD) and long-term COVID-19.
"CKD is a common, serious, costly, and often preventable disease," said Linda Smith-Wheelock, president and CEO of the National Kidney Foundation of Michigan. "More than 1 million Michigan adults, or one in seven, have the disease. Unfortunately, many people don't know they have CKD, as there are few symptoms in its early stages. Michigan Medicaid spends over $1 billion yearly on CKD, and available data shows that at least 40% of all COVID-19-related deaths are tied to kidney disease."
This partnership will increase the knowledge, awareness, and understanding of preventable kidney disease, promote the adoption of evidence-based strategies to reduce CKD, and identify financially sustainable approaches for CKD prevention, detection, and management. Individuals with kidney disease are at a significantly higher risk of experiencing poor outcomes from COVID-19, making this research vital.
"Chronic kidney disease is preventable through early identification, which makes it all the more agonizing that so many Americans continue to experience this silent killer," said Brett Furst, President of HHS Technology Group. "As a result of this initiative, state Medicaid agencies now have the data analytic tools to move quickly on chronic kidney disease prevention and reduce preventable disease, deaths, and hospitalizations."
HTG, Datavant, and Mathematica have designed a real-time data-analysis platform that captures, aggregates, matches, and evaluates data across various sources, including Medicare, Medicaid, hospitals, labs, physician offices, and commercial payers. With actionable insights from this rich data, medical providers can identify and intervene with patients at risk of developing CKD and long COVID earlier than conventional means.
Industry stakeholders will now be able to access the nation's largest COVID-19 Research Database to measure the effectiveness of these programs and develop strategies to address health disparities in the vulnerable populations at elevated risk for CKD and COVID-19. The Research Database is an initiative led by numerous prominent companies with a mission to accelerate real-world pandemic research to understand the disease and inform evidence-based healthcare policy. As of May 2022, the COVID-19 Research Database contained more than 85 billion HIPAA-compliant, patient-level records and has powered over 70 publications and presentations addressing the direct and indirect effects of the COVID-19 pandemic on population health.
"The effects of long COVID can create devastating repercussions for patients who are already experiencing chronic conditions, such as CKD, diabetes, and hypertension," said Travis May, Founder and President of Datavant. "The COVID-19 Research Database is a tremendous asset enabling novel public-health insights by delivering real-world data to stakeholders throughout the healthcare continuum."
Discover your Data (DyD), HTG's robust analytics platform, powers the Research Database leveraging advanced technologies, including machine learning and Artificial Intelligence. These technologies, combined with sophisticated data analytics, deliver insights and deep understanding, allowing data exploration in real-time to accelerate and accurately solve some of healthcare's most complex questions. The team is utilizing AWS with its cloud-first approach to solving these problems, allowing them to rapidly develop a robust, secure, scalable, and efficient system to perform this vital work.
"With real-time analytics that deliver insights for early detection of high-risk patients, medical providers are empowered to deliver timely diagnosis and treatments for better health outcomes," said Christopher Trenholm, SVP and General Manager of the Health Unit at Mathematica. "We are proud to partner with HTG and Datavant in this important initiative to take action and support solutions that fight this deadly disease."
HHS Technology Group is a software and solutions company serving the needs of commercial enterprises and government agencies. HHS Technology Group delivers modular software solutions, custom development, and integration services for the modernization and operation of systems supporting a wide spectrum of business and government needs. For more information about HHS Technology Group, visit www.hhstechgroup.com.
Mathematica applies expertise at the intersection of data, methods, policy, and practice to improve well-being around the world. We collaborate closely with public- and private-sector partners to translate big questions into deep insights that improve programs, refine strategies, and enhance understanding. Learn about our work at Mathematica.org.
Datavant's mission is to connect the world's health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of patient health records across datasets. Learn more about Datavant at www.datavant.com.
Media Contacts:
Janet Mordecai
Amendola Communications (for HHS Technology Group)
jmordecai@acmarketingpr.com
Larine Hamied
Marketing, Datavant
larine@datavant.com
Amy Berridge
Senior Manager, Communications
aberridge@mathematica-mpr.com
View original content to download multimedia:
SOURCE HHS Technology Group
|
https://www.whsv.com/prnewswire/2022/09/13/hhs-technology-group-datavant-mathematica-partner-combat-chronic-kidney-disease/
| 2022-09-13T11:33:58Z
|
New Assay Results Include 44.4 g/t Au over 6.4 m, 19.6 g/t Au over 10.4m & 10.7 g/t Au over 14.5 m
RENO, Nev., Sept. 13, 2022 /PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE: IAUX) ("i-80", or the "Company") is pleased to announce results from an additional 19 holes drilled in the ongoing 2022 surface drill program testing the high-grade South Pacific Zone at the Company's Granite Creek Property ("Granite Creek" or "the Property") located in Humboldt County, Nevada.
The South Pacific Zone ("SPZ") is a new zone of high-grade gold mineralization located immediately north of the underground mine workings at Granite Creek (Figure 1). Drilling continues to delineate and expand mineralization in the SPZ with new results indicating significant expansion potential including hole iGS22‑24 that returned 10.7 g/t gold (Au) over 14.5 metres (m) and is a 40 m northern step-out from iGS22-04 (11.2 g/t Au over 7.3 m). Additionally, hole iGS22-16 was drilled in the southern portion of the SPZ, with three impressive intervals within 100 m of existing underground workings, including 15.5 g/t Au over 2.7 m, 19.6 g/t Au over 10.4 m and 10.2 g/t Au over 4.9 m. The SPZ remains open for expansion along strike to the north and at depth (see Figures 1, 2 & 3).
Highlight results from 2022 drilling in the South Pacific Zone (and adjacent horizons):
- 12.1 g/t Au over 7.0 m (0.35 oz/ton Au over 23.0 feet) in hole iGS22-07
- 19.6 g/t Au over 10.4 m (0.57 oz/ton Au over 34.0 feet) in hole iGS22-16
- 44.4 g/t Au over 6.4 m (1.30 oz/ton Au over 21.0 feet) in hole iGS22-18
- 10.7 g/t Au over 14.5 m (0.31 oz/ton Au over 47.7 feet) in hole iGS22-24
- 15.3 g/t Au over 7.1 m (0.45 oz/ton Au over 23.4 feet) in hole iGS22-25
The SPZ is the priority target of the ongoing surface drill program at Granite Creek and is anticipated to be included in a resource update following the 2022 program. Multiple holes were drilled to better define the upper and southern limits of the SPZ and returned modest results, as was anticipated based on historic drilling. Additional drilling in 2022 has been completed along strike and at depth, with assays pending, and has continued to intersect mineralization within the target horizon, suggesting further upside. Table 1 provides a summary of new results from the SPZ. So far in 2022, more than thirty (30) holes have been drilled in the SPZ.
"The continuity of high-grade mineralization within the South Pacific Zone appears to be excellent over a strike length of more than 600 metres and dip length of 250 metres", stated Tyler Hill, Senior Geologist of i‑80. "The zone remains open for expansion with the goal for it to be a significant source of production for Granite Creek in the coming years. Owing to our substantial success, we have prioritized the extension of the decline in order to accelerate the development of underground workings towards the SPZ."
High-grade mineralization at Granite Creek occurs in a near-identical geological setting as that at the multi‑million‑ounce Turquoise Ridge Mine located immediately to the north (Figure 4); proximal to a major regional fault (the Getchell or Range Front fault) on the eastern edge of the large Osgood Mountains intrusive complex. The Granite Creek deposit remains open at depth and along strike from the existing underground workings.
"Ongoing drilling in the South Pacific Zone continues to confirm one of the highest-grade gold discoveries made in recent years, not only in Nevada but anywhere in the world", stated Ewan Downie, Chief Executive Officer of i-80. "Given its proximity to our existing underground workings, the SPZ can be developed quite rapidly and represents a potential game-changer in our ultimate production profile."
Table 1 – Summary of New Assay Results from 2022 Surface Drilling in SPZ
The Granite Creek Property is strategically located proximal to Nevada Gold Mines' Turquoise Ridge and Twin Creeks mines at the north end of the Battle Mountain-Eureka Trend, at its intersection with the Getchell gold belt in Nevada.
All samples were submitted to ALS Minerals (ALS) of Sparks, NV, which is an ISO 9001 and 17025 certified and accredited laboratory, independent of the Company. Samples submitted through ALS are run through standard prep methods and analyzed using Au-AA23 (Au; 30g fire assay) and ME-ICP41 (35 element suite; 0.5g Aqua Regia/ICP-AES). ALS also undertakes their own internal coarse and pulp duplicate analysis to ensure proper sample preparation and equipment calibration. i-80 Gold Corp's QA/QC program includes regular insertion of CRM standards, duplicates, and blanks into the sample stream with a stringent review of all results.
Tim George, PE, Mine Operations Manager, reviewed the technical and scientific information contained in this press release and is a Qualified Person within the meaning of NI 43-101.
i-80 Gold Corp. is a well-financed, Nevada-focused, mining company with a goal of achieving mid-tier gold producer status through the development of multiple deposits within the Company's advanced-stage property portfolio with processing at i-80's centralized milling facility that includes an autoclave.
Certain statements in this release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws, including but not limited to, the expansion or mineral resources at Granite Creek and the potential of the Granite Creek project. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company, its projects, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", "scheduled", "forecast", "predict" and other similar terminology, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. These statements reflect the Company's current expectations regarding future events, performance and results and speak only as of the date of this release.
Forward-looking statements and information involve significant risks and uncertainties, should not be read as guarantees of future performance or results and will not necessarily be accurate indicators of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements or information, including, but not limited to: material adverse changes, unexpected changes in laws, rules or regulations, or their enforcement by applicable authorities; the failure of parties to contracts with the company to perform as agreed; social or labour unrest; changes in commodity prices; and the failure of exploration programs or studies to deliver anticipated results or results that would justify and support continued exploration, studies, development or operations.
View original content to download multimedia:
SOURCE i-80 Gold Corp
|
https://www.whsv.com/prnewswire/2022/09/13/i-80-gold-drilling-expands-south-pacific-zone-high-grade-granite-creek/
| 2022-09-13T11:33:59Z
|
PARIS, Sept. 13, 2022 /PRNewswire/ -- An independent study designed and overseen by Environmental Standards, Inc. and conducted by Pace Analytical Services LLC found that no PFAS were identified or found to leach into the contents of IPACKCHEM's proprietary Advanced In-Mold Fluorinated (IMF) containers.
"This study confirms that IPACKCHEM's Advanced IMF barrier process creates packaging that is safe, secure and sustainable, and is a solution to PFAS leaching from fluorinated containers. We believe our technology and process can help deliver the benefits of fluorinated HDPE packaging while safeguarding public health and protecting the environment," said JP Morvan, chief executive officer of IPACKCHEM.
In March of 2021, EPA found that certain HDPE containers posed the risk of leaching PFAS into the contents of the containers. EPA's study confirmed that it detected eight different PFAS from the fluorinated HDPE containers, with levels ranging from 20-50 parts per billion.
Since then, EPA has noted that fluorination processes that use fluorine gas without the presence of oxygen can reduce the risk of PFAS formation. In addition, the FDA has authorized the use of barrier technology containers for food use only when the fluorination of the containers is done via manufacturing processes that use nitrogen.
IPACKCHEM's proprietary Advanced IMF process uses a dilute mixture of Fluorine in Nitrogen that reacts with only the inner surface of the container to create a barrier to chemical migration, ensuring product integrity and purity.
The Pace Advanced IMF Container Study Findings
The independent study, a summary of which was released today, was conducted by scientists at Pace Analytical Services with the testing designed and overseen by Environmental Standards, a specialized chemistry consultancy with significant experience in these types of testing.
- The study was conducted using a highly robust process with multiple samples, an aggressive solvent and longitudinal testing over varied timeframes.
- The study evaluated whether any of 19 target PFAS compounds1 were found in a methanol solvent after one to three months exposure, for the different types of containers that were commercially available outside the United States.
- None of the target PFAS was detected in the samples from the IPACKCHEM Advanced IMF containers at or above the Limit of Quantification (LOQ).
The study was conducted through a contract with Steptoe & Johnson and funded by IPACKCHEM.
"We believed it was important to subject our Advanced IMF industrial containers to scientific testing to determine if they performed safely and consistent with our highest standards. We are gratified by the results of that testing, which can give users confidence that they can use our containers safely," Morvan said.
IPACKCHEM
IPACKCHEM was founded three decades ago with the mission to improve the handling of specialty chemicals from both an environmental and safety standpoint. It has since grown to become a global leader in high performance plastic packaging and now serves customers from production locations in four continents.
At its inception, IPACKCHEM introduced innovative rigid plastic packaging products with barrier properties to ensure the safe transportation, storage and handling of chemicals used in crop protection, animal health, flavors & fragrances, pharmaceuticals and laboratory applications.
IPACKCHEM's rigid barrier plastic containers meet stringent procedural quality controls and are certified by the United Nations for transport of hazardous goods.
IPACKCHEM's proprietary packaging solution with Advanced IMF barrier technology is 100 percent recyclable and can also be manufactured using a high percentage of post-consumer recycled content (up to 50%).
1 The Study was designed to test for 19 PFAS compounds, a group that includes the 8 PFAS compounds that were detected in the US EPA studies.
View original content to download multimedia:
SOURCE IPACKCHEM
|
https://www.whsv.com/prnewswire/2022/09/13/independent-scientific-study-demonstrates-pfas-is-not-identified-or-leached-ipackchem-advanced-in-mold-fluorinated-containers/
| 2022-09-13T11:34:06Z
|
Inaugural Award from the Indianapolis Prize honors conservationists early in their careers
INDIANAPOLIS, Sept. 13, 2022 /PRNewswire/ -- Officials from the Indianapolis Prize, the world's leading award for animal conservation, today named ten Finalists for the newly created Emerging Conservationist Award. The Winner will be awarded $50,000 to advance their work to protect species.
The Emerging Conservationist Award recognizes professional wildlife conservationists, biologists and scientists under 40 years of age working to make strides in saving animal species from extinction. The inaugural Emerging Conservationist Award Winner will be announced in April 2023 and will be recognized at the 2023 Indianapolis Prize Gala presented by Cummins Inc. in downtown Indianapolis on Sept. 30, 2023.
"The Emerging Conservationist Award supports the next generation of conservationists who are actively making a positive difference for the future of biodiversity," said Dr. Rob Shumaker, President & CEO of the Indianapolis Zoological Society, Inc. "These Finalists, along with all of the Prize honorees, share a deep commitment to protecting nature and inspiring people to care for our world."
The Indianapolis Prize recognizes the world's leading conservationists whose work provides future generations with replicable and actionable conservation practices. The Finalists of the Emerging Conservationists represent the people we can rely on to save species around the world.
The Finalists of the 2023 Emerging Conservationist Award include:
Alejandro Arteaga (Tropical Herping, Ecuador) – Alejandro Arteaga is a biologist, conservationist and wildlife photographer. Arteaga co-founded Tropical Herping, a tour agency that offers nature photography trips and tours throughout the tropics. His research is focused on tropical amphibians and reptiles. He has discovered and described 20 new species to science and raised funds to save 106 hectares of Chocó rainforest in Ecuador.
Sergio A. Balaguera-Reina, Ph.D. (University of Florida – Fort Lauderdale Research and Education Center, USA) – Dr. Sergio Balaguera-Reina is a conservation biologist focused on understanding the roles that crocodile species play in aquatic and coastal systems. Dr. Balaguera-Reina also develops conservation plans that provide support for other species as well as the habitats and landscapes that they inhabit.
Fanny M. Cornejo (Rainforest Partnership, USA; Yunkawasi, Peru) – Fanny Cornejo is a primatologist, anthropologist and the director of Yunkawasi, an organization that works with Amazonian and Andean communities for the conservation of threatened species through sustainable economic development and protected area management approach. Fanny is also executive director of the Rainforest Partnership in Peru, Yunkawasi's strategic partner for conservation and sustainable development activities in Peru.
Akbar John, Ph.D. (Institute of Oceanography and Maritime Studies, INOCEM; International Islamic University Malaysia, IIUM, Malaysia) – Dr. Akbar John is an Associate Professor and conservation scientist focused on advancing the science and conservation of horseshoe crabs in Southeast Asia. Dr. John is responsible for establishing a facility to track global horseshoe crab biology, which serves as a referral source for future research on horseshoe crabs.
Corinne J. Kendall, Ph.D. (North Carolina Zoo, USA) – Dr. Corinne Kendall launched the first effort to protect vultures in the Southern Highlands of Tanzania. Dr. Kendall is the founder of the Association of Zoos and Aquariums' African Vulture Saving Animals from Extinction program, which has developed a tool for discovering poaching and poisoning activities in real-time, based on the movements of vultures fitted with satellite tracking tags.
Arthur Bienvenu Muneza, Ph.D. (Giraffe Conservation Foundation, Africa) – Dr. Arthur Muneza is a wildlife ecologist investigating a variety of factors affecting the survival and reproduction of giraffe populations across East Africa by calculating population, mapping disease ecology, assessing sources of mortality and evaluating predatory interactions with lions.
Megan Murgatroyd, Ph.D. (HawkWatch International, USA) – Dr. Megan Murgatroyd is a conservation biologist focused on understanding and conserving the world's most understudied and threatened raptors globally. Dr. Murgatroyd investigates the impacts of land-use change on Verreaux's Eagles and implements GPS tracking to understand and predict wind turbine collision risk for Verreaux's Eagles.
Nguyen Van Thai (Save Vietnam's Wildlife, Vietnam) – Nguyen Thai is the founder of Save Vietnam's Wildlife, which works to halt the extinction and champion the recovery of threatened species in Vietnam such as the critically endangered pangolin. He established Vietnam's first anti-poaching units, which have destroyed 9,701 animal traps, dismantled 775 illegal camps, confiscated 78 guns, and arrested 558 people for poaching, leading to a significant decline in illegal activities in PúMát National Park.
Olivier Nsengimana (Rwanda Wildlife Conservation Association, Rwanda) – Olivier Nsengimana is responsible for designing and implementing a conservation project to save the endangered grey-crowned crane. He established a database of illegally kept cranes in Rwanda, which led to 233 cranes being freed and 160 of those individuals being reintroduced to the wild. A licensed veterinarian, Nsengimana is the founder and director of the Rwanda Wildlife Conservation Association, an organization working to expand research and conservation connected to endangered or threatened species in Rwanda.
Stephanie Vaz Nogueira Campos (Federal University of Rio de Janeiro, Brazil) – Stephanie Vaz is an entomologist dedicated to firefly conservation. She is responsible for describing dozens of firefly species and providing tools and resources to facilitate firefly identification in the Neotropics. She discovered past conservation components were not protecting firefly populations from light pollution.
The Emerging Conservationist Award – made possible through a grant from the Kobé Foundation – was created to identify and support conservationists under 40 years of age with the talent to make a significant impact on saving an animal species or group of species. The Emerging Conservationist Finalists are selected through a two-stage selection process, where a Review Committee evaluates and then narrows the application pool to 10 Finalists who are then sent to the Selection Committee to choose a Winner. The Inaugural Emerging Conservationist Award Winner will be announced in April 2023 and will then be recognized at the Indianapolis Prize Gala presented by Cummins Inc. in downtown Indianapolis on Sept. 30, 2023.
For additional media assets related to the 2023 Emerging Conservationist Finalists, click here.
To learn more about the Emerging Conservationist Award, visit IndianapolisPrize.org/EmergingConservationist/
ABOUT THE EMERGING CONSERVATIONIST AWARD
The Indianapolis Prize Emerging Conservationist Award – made possible through a grant from the Kobé Foundation – is a biennial award that supports conservationists under 40 years of age with the talent and drive to make a significant impact on saving an animal species or group of species.
ABOUT THE INDIANAPOLIS PRIZE
The Indianapolis Prize is a signature conservation initiative of the Indianapolis Zoological Society, Inc. The Indianapolis Prize recognizes and rewards conservationists who have achieved major victories in advancing the sustainability of an animal species or group of species. Winners receive an unrestricted $250,000 award. Remaining Finalists each receive $50,000. Since 2006, the Indianapolis Prize has administered more than $5 million in cash awards.
View original content:
SOURCE Indianapolis Prize
|
https://www.whsv.com/prnewswire/2022/09/13/indianapolis-prize-announces-ten-finalists-new-award-recognizing-emerging-conservationists/
| 2022-09-13T11:34:12Z
|
- Ericsson to host a briefing on recent Vonage acquisition and development of Global Network Platform
- Conference call including Q&A scheduled at 6:00 PM CEST, September 26
STOCKHOLM, Sept. 13, 2022 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) invites stakeholders to a briefing on September 26, 6:00 PM CEST on the recent acquisition of Vonage and the development of Global Network Platform.
Ericsson's President and CEO Börje Ekholm will present and take questions together with Rory Read, SVP and Head of Business Area Global Communications Platform, Savinay Berry, Head of Product & Engineering for Vonage and Jan Karlsson, Head of Global Network Platform.
CONFERENCE CALL FOR ANALYSTS, INVESTORS AND JOURNALISTS
A conference call for financial analysts, investors and journalists will begin at 6:00 PM CEST Stockholm (5:00 PM BST London, 12:00 PM EDT New York).
Conference call: Join here
To ask a question: Access dial-in information here
The conference call will be available on-demand on Ericsson's website after the event.
FOLLOW US:
Subscribe to Ericsson press releases here
Subscribe to Ericsson blog posts here
https://twitter.com/ericsson
https://www.facebook.com/ericsson
https://www.linkedin.com/company/ericsson
MORE INFORMATION AT:
Ericsson Newsroom
media.relations@ericsson.com (+46 10 719 69 92)
investor.relations@ericsson.com (+46 10 719 00 00)
ABOUT ERICSSON:
Ericsson enables communications service providers and enterprises to capture the full value of connectivity. The company's portfolio spans the following business areas: Networks, Cloud Software and Services, Enterprise Wireless Solutions, Global Communications Platform, and Technologies and New Businesses. It is designed to help our customers go digital, increase efficiency and find new revenue streams. Ericsson's innovation investments have delivered the benefits of mobility and mobile broadband to billions of people globally. Ericsson stock is listed on Nasdaq Stockholm and on Nasdaq New York. www.ericsson.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Ericsson
|
https://www.whsv.com/prnewswire/2022/09/13/invitation-briefing-vonage-global-network-platform/
| 2022-09-13T11:34:19Z
|
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- CeriFi, a Leeds Equity Partners portfolio company, today announced the acquisition of Solomon Exam Prep ("Solomon" or the "Company"), a leading provider of securities licensing exam preparation and review materials for FINRA, NASAA, MSRB and NFA licensing exams. Solomon represents the twelfth acquisition for CeriFi, a leading provider of premium financial education, training and certification solutions to the financial services industry. Terms of the transaction were not disclosed.
"Karen and Jeremy have built a truly impressive portfolio of securities exam preparation courses and materials that enable students and professionals to pass their exams and earn their licenses. We are thrilled that they will be joining the CeriFi team to expand and improve CeriFi's suite of securities licensing solutions," said Matthew Given, CEO of CeriFi.
CeriFi's product portfolio includes education, training and certification in accounting, financial crime, financial planning, financial risk management, insurance, securities licensing and tax. CeriFi also offers financial curriculum and courseware to universities.
Jeremy Solomon, President and Co-Founder of Solomon Exam Prep, said, "We are delighted to be joining forces with CeriFi, the clear leader in financial services training and certification. Our team is energized by the unique opportunity ahead to better serve financial institutions and professionals by driving the best learning outcomes."
"The acquisition of Solomon further expands the depth and breadth of CeriFi's securities licensing content and product suite and uniquely positions CeriFi to meet the ever-changing needs of our financial services customers. We look forward to working with Karen and Jeremy Solomon and to the continued success of Solomon as part of CeriFi," said Eric Geveda, Managing Director at Leeds Equity Partners.
Polsinelli served as legal counsel to Leeds Equity Partners. Michael Best & Friedrich served as legal counsel to Solomon.
CeriFi is a diversified education, training and certification provider serving professionals across the financial services market. To date, CeriFi has acquired twelve highly complementary companies, including Dalton Education, Money Education, Keir Financial Education, Pass Perfect, the CFP assets of LoneStar Financial Education, the Association of Certified Financial Crime Specialists, Bionic Turtle, CPMI, Fast Forward Academy, Spidell Publishing, MarkMeldrum.com and Solomon Exam Prep.
For additional information on CeriFi, see http://www.cerifi.com/.
Solomon Exam Prep has helped thousands of financial professionals pass their FINRA, NASAA, MSRB and NFA securities licensing exams including the SIE and the Series 3, 6, 7, 14, 22, 24, 26, 27, 28, 50, 51, 52, 53, 54, 63, 65, 66, 79, 82 and 99. Solomon also offers Continuing Education for Investment Adviser Representatives. Solomon Exam Prep is led by founders Karen and Jeremy Solomon, who have maintained a lifelong commitment to advancing learning and education. Solomon Exam Prep draws from a pool of seasoned educators, practitioners and communicators who are experienced in both investment education and the process of adult learning.
For additional information on Solomon, see https://solomonexamprep.com/ .
Leeds Equity Partners is a New York-based private equity fund dedicated exclusively to partnering with management teams in the education, training and information services industries (the "Knowledge Industries"). The firm was founded in 1993 and has managed over $4.5 billion of capital across a broad spectrum of companies within the Knowledge Industries. Leeds Equity seeks to leverage its sector-focused expertise and market insights to create long-term value for its partner companies.
For additional information on Leeds Equity Partners, see http://www.leedsequity.com/.
For More Information:
Jeffrey T. Leeds
Tel. 212-835-2000
Fax: 212-835-2020
www.leedsequity.com
View original content:
SOURCE LEEDS EQUITY PARTNERS
|
https://www.whsv.com/prnewswire/2022/09/13/leeds-equity-backed-cerifi-further-expands-into-securities-exam-preparation-with-acquisition-solomon-exam-prep/
| 2022-09-13T11:34:20Z
|
LAFAYETTE, La., Sept. 13, 2022 /PRNewswire/ -- LHC Group (NASDAQ: LHCG) and University of Maryland Medical System (UMMS) today announced the signing of a definitive agreement to form a new joint venture partnership to provide enhanced in-home healthcare services throughout a large portion of the state of Maryland.
The partnership's combined assets will include multiple locations serving 20 Maryland counties, the city of Baltimore, and the greater metropolitan area.
It is anticipated that the agreement will be finalized in the fourth quarter of 2022, subject to customary closing conditions, at which time LHC Group will purchase majority ownership and assume management responsibility. LHC Group expects incremental annualized revenue from this joint venture of approximately $4.8 million and that it will not materially affect its 2022 diluted earnings per share.
"Joining forces in Maryland with such an accomplished and respected health institution like UMMS is a great opportunity," said Keith Myers, LHC Group chairman and CEO. "Together, we will expand the availability of vital healthcare services in the place patients want it most – the comfort of their own home. With our combined experience and infrastructure, we will be able to offer more families and patients the high-quality, efficient, and effective in-home healthcare they deserve."
LHC Group is a leading national provider of in-home healthcare services and the joint venture partner of choice for over 400 hospitals across the United States.
"Our partnership with LHC Group is an important step forward in our journey to continue improving access to post-acute care for our patients, which is an increasingly essential element in the continuum of care that we provide at UMMS," said Mohan Suntha, MD, MBA, the System's President and Chief Executive Officer.
UMMS is a private, university-based regional health system focused on serving the healthcare needs of Maryland. UMMS' flagship academic campus, the University of Maryland Medical Center in Baltimore, is recognized regionally and nationally for excellence in specialized care.
As the demand for in-home healthcare continues to increase, hospital and home health partnerships focus on delivering patient-centered care in the comfort of the patient's home or place of residence. They are an increasingly key component in helping patients manage their conditions, avoid unnecessary hospital readmissions, and achieve the best possible health outcomes in the most cost-efficient manner.
About LHC Group, Inc.
LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around the nation, offering quality, value-based healthcare to patients primarily within the comfort and privacy of their home or place of residence. The company's 29,000 employees deliver home health, hospice, home- and community-based services, and facility-based care in 37 states and the District of Columbia – reaching 68 percent of the U.S. population aged 65 and older. Through Imperium Health, the company's ACO management and enablement company, LHC Group helps partners improve both savings and patient outcomes with a value-based approach. As the preferred joint venture partner for more than 400 leading U.S. hospitals and health systems, LHC Group works in cooperation with providers to customize each partnership and reach more patients and families with an effective and efficient model of care.
About the University of Maryland Medical System
The University of Maryland Medical System (UMMS) is an academic private health system, focused on delivering compassionate, high-quality care and putting discovery and innovation into practice at the bedside. Partnering with the University of Maryland School of Medicine and University of Maryland, Baltimore who educate the state's future health care professionals, UMMS is an integrated network of care, delivering 25 percent of all hospital care in urban, suburban and rural communities across the state of Maryland. UMMS puts academic medicine within reach through primary and specialty care delivered at 11 hospitals, including the flagship University of Maryland Medical Center, the System's anchor institution in downtown Baltimore, as well as through a network of University of Maryland Urgent Care centers and more than 150 other locations in 13 counties. For more information, visit www.umms.org.
Forward-looking Statements
Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions, and are based on assumptions and assessments made by LHC Group's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and LHC Group undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in LHC Group's most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled "Risk Factors", as well LHC Group's current reports on Form 8-K, filed with the Securities and Exchange Commission.
View original content to download multimedia:
SOURCE LHC Group, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/lhc-group-university-maryland-medical-system-announce-home-health-partnership/
| 2022-09-13T11:34:26Z
|
Webcast will feature Brad Konkol, Head of Slacker Radio and Kit Gray, President of PodcastOne
LOS ANGELES, Sept. 13, 2022 /PRNewswire/ -- LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment and technology platform, announced today details of its webcast to introduce the senior management of its audio division wholly-owned subsidiaries.
Conference Call and Webcast
WHEN: Tuesday, September 13, 2022
TIME: 2:00 PM ET / 11:00 AM PT
DIAL-IN (Toll Free): 844-200-6205
DIAL IN NUMBER (Local): 646-904-5544
ACCESS CODE: 118153
REPLAY NUMBER: 866-813-9403 / ACCESS CODE: 283704
WEBCAST – Both the live webcast and a replay can be accessed on the Investor Relations section of LiveOne's website at Events | LiveOne.
The webcast can also be accessed at: https://events.q4inc.com/attendee/993392851
- Recently surpassed 2.5 million total members, including 800,000 free members on an ad-supported model**
- Over 1.7 million monthly paying members versus 1.48 million at March 31, 2022**
- 2 million paid members expected by March 2023**
- Recently launched Android Automotive App to reach next generation connected vehicles
- PodcastOne posted record revenue of $8.7 million in Q1 Fiscal Year 2023
- PodcastOne recently closed $8.1 million financing at a post-money valuation of $68 million
- PodcastOne spin-out and dividend of a portion of its common equity to 15K+ LiveOne shareholders is expected to be completed by the end of Fiscal Year 2023
- PodcastOne Ranked #8 on Podtrac's List of Top U.S. Podcast Publishers with record unique monthly audience exceeding 7.3 million, more than 2.1 billion downloads annually, and 325 podcasts
About LiveOne, Inc.
Headquartered in Los Angeles, California, LiveOne, Inc. (NASDAQ: LVO) (the "Company") is an award-winning, creator-first, music, entertainment and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events. The Company was awarded Best Live Moment by Digiday for its "Social Gloves" PPV Event, and has been a finalist for 8 more awards, including Best Live Event, Best Virtual Event, Best Overall Social Media Excellence, and Best Original Programming from Cynopsis and Digiday. As of September 8, 2022, the Company has accrued a paid and free ad-supported membership base of 2.5 million**, streamed over 2,900 artists, has a library of 30 million songs, 600 curated radio stations, over 300 podcasts/vodcasts, hundreds of pay-per-views, personalized merchandise, released music-related NFTs, and created a valuable connection between fans, brands, and bands. The Company's wholly-owned subsidiaries include Slacker Radio, React Presents, Gramophone Media, Palm Beach Records, Custom Personalization Solutions, LiveXLive, PPVOne and PodcastOne, which generates more than 2.48 billion downloads per year and 300+ episodes distributed per week across its stable of top-rated podcasts. LiveOne is available on iOS, Android, Roku, Apple TV, Amazon Fire, and through OTT, STIRR, and XUMO. For more information, visit www.liveone.com and follow us on Facebook, Instagram, TikTok, and Twitter at @liveone.
Forward-Looking Statements
All statements other than statements of historical facts contained in this press release are "forward-looking statements," which may often, but not always, be identified by the use of such words as "may," "might," "will," "will likely result," "would," "should," "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "continue," "target" or the negative of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including: the Company's reliance on one key customer for a substantial percentage of its revenue; the Company's ability to consummate any proposed financing, acquisition, spin-out, distribution or transaction, including the proposed spin-out of PodcastOne or its pay-per-view business, the timing of the closing of such proposed event, including the risks that a condition to closing would not be satisfied within the expected timeframe or at all, or that the closing of any proposed financing, acquisition, spin-out, distribution or transaction will not occur or whether any such event will enhance shareholder value; PodcastOne's ability to list on a national exchange; the Company's ability to continue as a going concern; the Company's ability to attract, maintain and increase the number of its users and paid members; the Company identifying, acquiring, securing and developing content; the Company's intent to repurchase shares of its common stock from time to time under its announced stock repurchase program and the timing, price, and quantity of repurchases, if any, under the program; the Company's ability to maintain compliance with certain financial and other covenants; the Company successfully implementing its growth strategy, including relating to its technology platforms and applications; management's relationships with industry stakeholders; the effects of the global Covid-19 pandemic; uncertain and unfavorable outcomes in legal proceedings; changes in economic conditions; competition; risks and uncertainties applicable to the businesses of the Company's subsidiaries; and other risks, uncertainties and factors including, but not limited to, those described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, filed with the U.S. Securities and Exchange Commission (the "SEC") on June 29, 2022, Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022, filed with the SEC on August 15, 2022, and in the Company's other filings and submissions with the SEC. These forward-looking statements speak only as of the date hereof, and the Company disclaims any obligations to update these statements, except as may be required by law. The Company intends that all forward-looking statements be subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.
** Included in the total number of paid members for the reported periods are certain members which are the subject of a contractual dispute. LiveOne is currently not recognizing revenue related to these members.
LiveOne IR Contact :
(310) 601-2505
ir@liveone.com
Press Contact :
LiveOne
aileen@liveone.com
917.842.9653
View original content:
SOURCE LiveOne, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/liveone-hold-conference-call-amp-webcast-introduce-management-liveones-audio-division-wholly-owned-subsidiaries-tuesday-september-13th-200-pm-et-1100-am-pt/
| 2022-09-13T11:34:32Z
|
INDIANAPOLIS, Sept. 13, 2022 /PRNewswire/ -- Michelle Asha Cooper, Ph.D., deputy under secretary at the U.S. Department of Education, will join Lumina Foundation on Oct. 3 as vice president for public policy and executive director of Lumina's Washington, D.C., office.
Cooper will lead the development and implementation of state and federal policy initiatives that advance the foundation's efforts to support today's students at community colleges and four-year colleges and universities. Cooper brings a wealth of experience, a deep devotion to students, and an acute understanding of policymaking at all levels. She will use these attributes to advance Lumina's strategic plan and elevate its commitment to ending systemic racism in higher learning.
Cooper is among the nation's most influential voices in championing access and success for all students in education. She knows firsthand the transformative power of education and shares Lumina's conviction for advancing racial and economic equity and making opportunities for learning beyond high school available to all. Cooper brings more than 20 years of experience and boundless optimism to this role as a recognized advocate for equity and social justice, experienced practitioner, demonstrated leader, and a true collaborator.
"Michelle is a dynamic, proven leader committed to addressing the myriad of issues facing American higher education, including racial injustice and economic inequality," said Jamie Merisotis, Lumina's president and CEO. "I am eager for her to join us and to learn from her experiences."
Cooper has served in the Biden administration as deputy under secretary, acting assistant secretary for postsecondary education, and deputy assistant secretary for higher education programs. Cooper led higher education's pandemic recovery efforts in these roles by managing $76 billion in pandemic aid for students and institutions. She supported the Education Department's efforts to mitigate the financial harm of the pandemic by helping student loan borrowers at the highest risk of falling behind in their payments or loan default through targeted debt relief.
Cooper launched the Raise the B.A.R.: Bold + Action + Results campaign that celebrates reforms that drive social and economic mobility among U.S. students. She also was responsible for a $3 billion grant portfolio supporting college and university programs, expanding global awareness, and building their capacity. These institutions included community colleges, Historically Black Colleges and Universities, Tribal Colleges and Universities, Hispanic-Serving Institutions, and other Minority-Serving Institutions.
Before joining the administration, Cooper served as president and chief executive officer at the Institute for Higher Education Policy (IHEP) for more than 12 years. She also held leadership positions with the Advisory Committee on Student Financial Assistance, the American Association of Colleges & Universities (AAC&U), The Council of Independent Colleges, and King's College.
Cooper is a native of Charleston, S.C., and lives in Washington, D.C., with her family. She earned a bachelor's degree from the College of Charleston, a master's from Cornell University, and her doctorate from the University of Maryland, College Park.
Lumina Foundation is an independent, private foundation in Indianapolis that is committed to making opportunities for learning beyond high school available to all. We envision a system that is easy to navigate, delivers fair results, and meets the nation's need for talent through a broad range of credentials. Our goal is to prepare people for informed citizenship and for success in a global economy.
Media Contact:
Tracy Chen
Director of Media Strategy, Lumina Foundation
tchen@luminafoundation.org
317-670-0521
View original content to download multimedia:
SOURCE Lumina Foundation
|
https://www.whsv.com/prnewswire/2022/09/13/longtime-champion-racial-equity-education-join-lumina-foundation/
| 2022-09-13T11:34:38Z
|
Kate Johnson Appointed President and CEO, Joins Board of Directors;
Jeff Storey to Retire
DENVER, Sept. 13, 2022 /PRNewswire/ -- Lumen Technologies (NYSE: LUMN) today announced Kate Johnson has been appointed President, Chief Executive Officer and a member of the company's Board of Directors with the transition date expected to be November 7, 2022. Johnson succeeds Jeff Storey, who has announced his retirement after a distinguished 40-year career within the telecommunication and technology industries, including Lumen and its predecessors. Storey will remain with the company through December 31, 2022, to ensure a smooth transition.
Johnson is a technology executive with an extraordinary track record of success. She specializes in leading digital and business transformations to drive growth, having held key leadership roles across a variety of Fortune 100 companies including Oracle, General Electric and Microsoft. Most recently, Johnson led Microsoft U.S., the company's largest business with a remit for all of the company's sales, services, marketing and operations. During her four-year tenure in this role, she led the division through a substantive cultural transformation while nearly doubling enterprise revenues.
"Kate's appointment and the strategic transition announced today are the culmination of a succession plan that Jeff and the board have been engaged in for the past several years," said T. Michael Glenn, Chairman of Lumen's Board of Directors. "We are confident she is the right leader to take the reins at this important moment in Lumen's history. Kate is an inspiring and motivational leader who is known for identifying and creating growth. She is the ideal CEO for Lumen."
Johnson stated, "I am proud to take on the CEO role and eager to advance the strategy Jeff and the team have created. Lumen has made significant progress strengthening its balance sheet, expanding its fiber footprint and enhancing its portfolio of digital capabilities. I'm looking forward to leading this great company through its next chapter and helping customers leverage the Lumen platform to power amazing digital world experiences."
Glenn continued, "On behalf of the board, I thank Jeff for his leadership and commitment to Lumen during his time with the company. Thanks to his contributions, Lumen is leveraging the areas of our business that we believe are best poised for growth. The imprint Jeff leaves on Lumen is noteworthy – giving our customers better, faster and more secure connectivity. He led with care and empathy during challenging times including the pandemic, ensuring employees stayed safe and customers connected. He leaves Lumen with a strong foundation in place."
"It has been a privilege to serve as Lumen's CEO," said Storey. "Throughout my time with the company, I have been incredibly impressed by our team's commitment to Lumen and to our core purpose of furthering human progress through technology. I am proud of all that we have achieved together as we have driven forward on Lumen's transformation journey. However, when I took this amazing job, I always spoke openly with the board about my future timeline for retirement. I am confident that the organization has the strategy in place to deliver on its priority of achieving profitable revenue growth. I am very excited to welcome Kate to Lumen. I believe her experience, leadership and enthusiasm are exactly what we need as we drive the company forward."
Lumen is guided by our belief that humanity is at its best when technology advances the way we live and work. With approximately 450,000 route fiber miles and serving customers in more than 60 countries, we deliver the fastest, most secure platform for applications and data to help businesses, government and communities deliver amazing experiences. Learn more about the Lumen network, edge cloud, security, communication and collaboration solutions and our purpose to further human progress through technology at news.lumen.com/home, LinkedIn: /lumentechnologies, Twitter: @lumentechco, Facebook: /lumentechnologies, Instagram: @lumentechnologies and YouTube: /lumentechnologies. Lumen and Lumen Technologies are registered trademarks in the United States.
Except for the historical and factual information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, many of which are beyond our control, including the finalization of transition planning. Actual events and results may differ materially from those anticipated, estimated or projected if one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect. These forward looking statements speak only as of the date of this press release. We undertake no obligation and expressly disclaims any such obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
View original content to download multimedia:
SOURCE Lumen Technologies
|
https://www.whsv.com/prnewswire/2022/09/13/lumen-announces-ceo-transition/
| 2022-09-13T11:34:40Z
|
HOPKINTON, Mass. and EDINBURGH, UK, Sept. 13, 2022 /PRNewswire/ -- Lykan Bioscience and RoslinCT, a leader in Contract Development and Manufacturing for cell therapies, announced the formation of its inaugural Scientific Advisory Board (SAB). The newly created SAB is comprised of cell and gene therapy pioneers with extensive domain experience. The SAB will be working closely with members of the Lykan Bioscience and RoslinCT management and scientific teams, providing valuable insight into a range of topics across the development and manufacturing of advanced therapies.
Scientific Advisory Board Members:
Michael Chambers, Cofounder of Aldevron, a provider of nucleic acids and proteins to the genomic medicine community, served as its chief executive officer for more than 20 years before serving as Executive Chairman of the Board until 2021 when Aldevron was acquired by Danaher Corporation. Michael is a proven visionary in the cell and gene therapy space and brings his extensive experience and network to the SAB.
Heidi Hagen, MBA, Chief Technology Officer of Sonoma Biotherapeutics, a privately held company leading the development of adoptive Treg cell therapies for autoimmune and inflammatory diseases. Heidi brings extensive experience in operations management and commercialization of innovative technologies from her 30 years in the biotechnology industry which includes 20 years in the cell and gene therapy industry.
Margit Jeschke, Ph.D., Margit was leading the global Analytical Stewardship & CMC Product Sciences section within Novartis Cell & Gene Technical Development & Manufacturing before she started working as independent consultant in January 2022. Margit brings extensive expertise on the analytical development strategy for cell & gene therapy and for biologics products.
Michael Kalos, Ph.D., Founder and Managing Director at Next Pillar Consulting, an LLC focused on providing consulting and advising services in the biopharmaceutical and venture space. Michael is an internationally recognized expert in cell therapy and brings over 25 years of cell therapy experience in both biopharma and academia. While at UPenn, Michael's laboratory developed the initial analytical assays and tests broadly employed in the cell therapy space today.
"The creation of a Scientific Advisory Board is a testament to our commitment to innovation on behalf of our partners," said Patrick Lucy, President & CEO of Lykan Bioscience. "We are honored that such esteemed industry experts have agreed to join the team as we continue to hone and execute the business strategy in such a promising and dynamic segment of the biotechnology industry."
Peter Coleman, CEO of RoslinCT commented: "Innovation is the driving force in our growth strategy and a key element in improving and reshaping healthcare. I am delighted that these key opinion leaders are able to support RoslinCT and Lykan. Their combined and considerable expertise will be invaluable as we continue to build on our momentum."
About Lykan Bioscience
Lykan Bioscience is an innovative contract development and manufacturing services organization (CDMO) focused on cell-based therapies. With decades of biopharmaceutical industry experience, Lykan offers a full range of development and manufacturing services. The state-of-the-art, purpose-built facility offering eight independent manufacturing suites is uniquely designed to fully integrate cGMP principles and advanced software solutions to enable real-time testing and release of product. Six additional cGMP processing suites will be commissioned by the end of 2022 to support US/EU clinical and commercial manufacturing. Located in Hopkinton, Massachusetts, 25 miles southwest of downtown Boston and in the proximity of four international airports, Lykan Bioscience is ideally situated to deliver life-saving cell therapy treatments to patients on behalf of their partners. Visit www.lykanbio.com
About RoslinCT
RoslinCT is a leading UK Cell Therapy Contract Development and Manufacturing Organisation (CDMO) focused on providing services for companies developing cell-based therapeutic products. Originally founded in 2006 as a spin-out from the Roslin Institute, we built on the broad range of scientific expertise available in the field of cell biology. Based at the Edinburgh BioQuarter, we operate fully licensed GMP manufacturing facilities and have a proven track record in the delivery of cell-based products. For further information, please visit www.roslinct.com.
Media Contact:
Lykan Bioscience
Director of Marketing
RoslinCT
Marketing Manager
Katerina Tsita
View original content to download multimedia:
SOURCE Lykan Bioscience; RoslinCT
|
https://www.whsv.com/prnewswire/2022/09/13/lykan-bioscience-roslinct-announce-establishment-scientific-advisory-board/
| 2022-09-13T11:34:46Z
|
21-point (37%) mean improvement in SNOT-22 total score at six weeks during the uncontrolled Part 1 stage of the 24-week BEACON trial
First patient dosed in the randomized, Part 2 stage of the BEACON trial
The LYR-220 program in post-surgical patients is in addition to LYR-210 which is in phase III for surgically naïve CRS patients.
WATERTOWN, Mass., Sept. 13, 2022 /PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the Company or Lyra), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced that the first patients have been treated in Part 2, the randomized stage, of the Phase 2 BEACON clinical trial of LYR-220 in adult patients with chronic rhinosinusitis (CRS) who have had a prior sinus surgery. LYR-220 has been specifically designed to deliver six months of continuous anti-inflammatory medication in a controlled and consistent fashion to the sinonasal passages for the millions of CRS patients that continue to require treatment despite prior surgical treatment.
The Phase 2 BEACON trial is a sham-controlled, parallel-group study to evaluate safety, tolerability, and pharmacokinetics of LYR-220 (7500µg MF) matrix, over a 24-week period, in symptomatic adult CRS patients who have had a prior bilateral sinus surgery. Part 1 of the BEACON trial was uncontrolled and designed primarily to assess the feasibility and tolerability of two matrix designs. In the randomized Part 2 stage, one design of LYR-220 will be compared to control in approximately 40 patients.
In the Part 1 stage, six patients received the LYR-220 matrix implant, demonstrating the feasibility and tolerability of LYR-220 placement bilaterally in this patient population. All six patients were treated for at least six weeks and no serious or unexpected product related adverse events have been reported. Although efficacy evaluation is not the objective during the uncontrolled Part 1 stage of the trial, there was a mean improvement of 21 points (37%) from the baseline in the 22-item Sino-nasal Outcome Test (SNOT-22) total score at 6 weeks. This is greater than twice the minimal clinically important difference of 8.9 points.
The first patient was dosed in Part 2, which is the randomized, controlled portion of the BEACON trial, evaluating the safety and efficacy of LYR-220. The Company anticipates completing enrollment for the full Phase 2 BEACON trial around year-end.
"From Part 1 of the trial, we have seen that both designs of LYR-220 can be successfully placed and have now determined the one matrix design to take forward to Part 2 of the trial. In addition, we are encouraged by the preliminary efficacy improvements that we observed in SNOT-22 scores even at six weeks," said Richard Nieman, M.D., Chief Medical Officer of Lyra Therapeutics.
"We are excited to move forward to the randomized, Part 2 stage of the BEACON trial with LYR-220, adding to our continued progress with the Phase 3 ENLIGHTEN program for LYR-210 in surgically naïve CRS patients," said Maria Palasis, Ph.D., President and Chief Executive Officer of Lyra Therapeutics. "We believe that Lyra is well positioned to potentially be the first to offer solutions for the full spectrum of CRS patients treated by ENT physicians, and we look forward to continued progress on our path to treating patients."
CRS is a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities and is the fifth most common condition in people under 65. Cardinal symptoms include nasal obstruction and congestion, facial pain and pressure, nasal discharge, and olfactory loss. The prevalence of CRS in the U.S. is estimated to be 14 million, with 8 million treated annually using medical management including topical steroid sprays and oral steroids. Roughly half of those treated fail and seek alternative medical intervention. While ENT physicians perform approximately 400,000 surgeries annually for CRS, 65% of patients have recurrent symptoms and 100% require ongoing medical management. Additionally, many patients are surgery unwilling as the current procedures are invasive, not curative, and often require long recovery times.
LYR-220 is an investigational product candidate that utilizes Lyra's proprietary XTreo™ platform to enable six months of local, intra-nasal, anti-inflammatory therapy from a single treatment for CRS in patients with post-surgical anatomy, a population which represents roughly forty percent of the four million CRS patients who fail medical management annually. LYR-220 is designed as a non-invasive alternative to repeat sinus surgery for CRS patients who have an enlarged nasal cavity due to sinus surgery but continue to require treatment to manage CRS symptoms. LYR-220 is a bioresorbable polymeric matrix designed to be administered in a brief, non-invasive, in-office procedure and is intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages.
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, local delivery of medications to diseased tissues not accessible with conventional therapeutic approaches. Lyra's XTreo™ platform is comprised of a biocompatible mesh scaffold, an engineered elastomeric matrix and a versatile polymer-drug complex. The Company's current pipeline of therapeutics target tissues deep in the ear, nose and throat passages and are designed to deliver continuous drug therapy for up to six months following a single non-invasive, in-office administration. Lyra has two product candidates in late-stage development for CRS, a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities: LYR-210, for surgically naïve patients, is being evaluated in the ENLIGHTEN Phase 3 clinical program, and LYR-220, for patients who have recurrent symptoms despite surgery, is being evaluated in the BEACON Phase 2 clinical trial. These two product candidates are designed to treat the estimated four million CRS patients in the U.S. that fail medical management each year. For more information, please visit lyratherapeutics.com and follow us on LinkedIn and Twitter.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the enrollment and success of the Phase 2 BEACON trial; the timing for topline results from the Phase 2 BEACON trial; the Company's continued progress with the Phase 3 ENLIGHTEN program for LYR-210; the safety and efficacy of LYR-220; the Company's position as a leader in the development of solutions for CRS patients treated by ENT physicians; and the anticipated success of leveraging the XTreo™ platform. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the fact that the Company has incurred significant losses since inception and expects to incur additional losses for the foreseeable future; the Company's need for additional funding, which may not be available; the Company's limited operating history; the fact that the Company has no approved products; the fact that the Company's product candidates are in various stages of development; or the fact that the Company may not be successful in its efforts to identify and successfully commercialize its product candidates; the fact that clinical trials required for the Company's product candidates are expensive and time-consuming, and their outcome is uncertain; the fact that the FDA may not conclude that certain of the Company's product candidates satisfy the requirements for the Section 505(b)(2) regulatory approval pathway; the Company's inability to obtain required regulatory approvals; effects of recently enacted and future legislation; the possibility of system failures or security breaches; effects of significant competition; the fact that the successful commercialization of the Company's product candidates will depend in part on the extent to which governmental authorities and health insurers establish coverage, adequate reimbursement levels and pricing policies; failure to achieve market acceptance; product liability lawsuits; the fact that the Company relies on third parties for the manufacture of materials for its research programs, pre-clinical studies and clinical trials; the Company's reliance on third parties to conduct its preclinical studies and clinical trials; the Company's inability to succeed in establishing and maintaining collaborative relationships; the Company's reliance on certain suppliers critical to its production; failure to obtain and maintain or adequately protect the Company's intellectual property rights; failure to retain key personnel or to recruit qualified personnel; difficulties in managing the Company's growth; effects of natural disasters, terrorism and wars (including the developing conflict between Ukraine and Russia); the fact that the global pandemic caused by COVID-19 could adversely impact the Company's business and operations, including the Company's clinical trials; the fact that the price of the Company's common stock may be volatile and fluctuate substantially; significant costs and required management time as a result of operating as a public Company and any securities class action litigation. These and other important factors discussed under the caption "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) on August 9, 2022 and its other filings with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While the Company may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, even if subsequent events cause its views to change.
Contact:
Kathryn Morris
The Yates Network LLC
914-204-6412
kathryn@theyatesnetwork.com
View original content to download multimedia:
SOURCE Lyra Therapeutics, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/lyra-therapeutics-advances-phase-2-beacon-clinical-trial-lyr-220-post-surgical-chronic-rhinosinusitis-patients-randomized-stage-study/
| 2022-09-13T11:34:52Z
|
"Doc Watkins & Friends, Salute to Troops"
SAN ANTONIO, Sept. 13, 2022 /PRNewswire/ -- In what is being dubbed a throwback to the legacy of the nostalgic military-appreciation variety show, a group of investors being led by Marcos Resendez, a fourth generation veteran, presents "Doc Watkins & Friends, Salute to Troops" Friday, November 11 at 7 pm in San Antonio, TX (Military City, USA) at the new Tech Port Center & Arena. Complimentary tickets are being made available to 1,000 troops with the inaugural event benefitting the USO San Antonio. The USO has a rich history of leveraging entertainment in support of its services and programs critical to the ever-increasing needs of our soldiers and their families.
In the spirit of the classic variety show, guest performances will include a memorable mix of comedic and musical talent, from marquee to up-and-coming. Joining as the host and headliner will be San Antonio's, Doc Watkins, an Oregon native by way of Austin, TX, who holds a PhD in music, is himself a classically trained pianist and resident host of San Antonio's favorite live jazz spot, JazzTX. "I'm honored and thrilled to help bring this grand tradition back, right here in my hometown of San Antonio," Watkins said. "This event is just the beginning of what we hope to be a years-long tradition of honoring our servicemen and women through a timeless evening of great entertainment." Watkins will be performing with a full orchestra that includes active and retired service members.
The event will be executive produced by primetime Emmy Award-winning writer and comedian, Hugh Fink, formerly of Saturday Night Live. "Being given the unique opportunity to produce a spectacular contemporary version of a classic variety show in support of the Troops is an honor, and I'm truly excited to bring my Hollywood experience to San Antonio — a great American city that I fell in love with the very first time I experienced the Riverwalk, The Alamo and Puffy Tacos," Fink said.
Having opened in May 2022 on the grounds of former Kelly Air Force Base, Tech Port Center & Arena is one of the most technologically advanced entertainment venues in the world, boasting a 3,000 seat arena, the largest array of musical tesla coils, a LAN gaming center, tech incubator, interactive science and technology museum and more.
"This event allows us to shine a spotlight on the ongoing effort of San Antonio to foster an environment of opportunity and innovation in one of its most important communities, while also respecting the men and women whose ensures our path remains clear to accomplish that mission," said Resendez.
In line with the theme of honoring the military the investment group has pledged all net proceeds of the production to be donated to USO San Antonio and in future years will broaden the influence and support to additional beneficiaries serving similar support missions.
Salute To Troops Media Contact:
Geller Communications
717-903-3716
media@salutetotroops.com
www.salutetotroops.com
View original content:
SOURCE Salute to Troops
|
https://www.whsv.com/prnewswire/2022/09/13/military-city-host-1000-troops-throwback-variety-show/
| 2022-09-13T11:34:59Z
|
Brand Celebrates its Famous Queso with "Queso Incognito," Liquid Gold Queso Card and Free Queso Day
ATLANTA, Sept. 13, 2022 /PRNewswire/ -- For many, queso is more than just a fun snack—it's an obsession. And queso-obsessed consumers are in luck! Moe's Southwest Grill® is giving cheese lovers a new way to enjoy their beloved queso anytime, anywhere. The quick-service restaurant known for their bold and flavorful Southwestern fare is unveiling the limited-edition "Queso Incognito," a portable speaker-shaped container that keeps their liquid gold undetectable—so they don't have to share. Sneak your queso into restaurants, movie theaters, or even family dinner (sorry, Mom!). Moe Rewards members can enter to win one of three limited-edition Queso Incognito and accompanying Liquid Gold Queso Card, unlocking a flood of queso for the remainder of 20221.
"Our three-cheese queso—fondly referred to as 'liquid gold' by our fans—is a Moe's staple, and we think something this iconic deserves to be celebrated," said Tory Bartlett, Chief Brand Officer at Moe's Southwest Grill. "This year, we've gone bigger than ever before to give our most loyal queso enthusiasts a chance to enjoy their favorite treat, wherever and whenever. We're excited to kick off the queso festivities and to give our customers more of what they're craving."
On September 20, Moe Rewards members can enter to win the limited-edition Queso Incognito and the exclusive Liquid Gold – The Queso Card by scanning their Moe Rewards app in-store or by signing into their Moe Rewards account for online orders, or by commenting on the giveaway social post on Moe's Instagram or Facebook.1
Grand Prize Winners of the Queso Incognito Giveaway will receive the exclusive portable "speaker" and a Queso Gold card which gives them an abundance of queso for the rest of the year2. For context, that's more than THREE kegs of beer!
Moe Rewards members who aim for Liquid Gold can also fulfill their queso obsession through the September 20th giveaway with a chance to win free queso for a year.3 Six hundred lucky winners will receive the new, bigger side of queso once a week for a full year.
Sign up for Moe's free Moe Rewards program by downloading the app available on the App store and Google Play. New members will instantly receive a free side of queso upon sign up.
Moe's will offer a free side of queso - no purchase necessary - to all customers who visit one of 650+ participating restaurants nationwide on September 20—National Queso Day. Online purchasers must purchase at least one entree per person thru Moe Rewards to redeem the offer online or in the Moe Rewards app.4
For more information about the Queso Incognito giveaway and Free Queso Day, visit Moes.com.
###
Welcome to Moe's!® Founded in 2000 and based in Atlanta, GA, Moe's Southwest Grill is a fast-casual restaurant franchise that serves high quality and fresh southwestern food. Moe's has an extensive variety of menu items to please the entire family – from burritos to specialty items like quesadillas, nachos and stacks. Whether you visit one of the 650+ franchised locations across 38 states or have us cater your next event, free chips and salsa come with every order. Check us out online at www.moes.com to find a store near you, and then connect with us on Instagram, Twitter and Facebook.
Contact: press@moes.com
View original content to download multimedia:
SOURCE Moe's Southwest Grill
|
https://www.whsv.com/prnewswire/2022/09/13/moes-southwest-grill-queso-obsessed-fans-can-enter-win-gadget-sneak-their-liquid-gold-into-anywhere/
| 2022-09-13T11:35:00Z
|
Wide-Spread Clinical Evidence using the MolecuLight Wound Imaging Platform Demonstrates its Significant Global Adoption and Proven Utility in Wound Care
TORONTO and SYDNEY, Sept. 13, 2022 /PRNewswire/ - MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that its MolecuLight wound imaging platform is featured in 8 presentations and posters at Wounds Australia 2022. The national conference is being hosted from September 14 - 17, 2022 in Sydney, Australia.
"Wounds Australia 2022 brings together leading clinicians, researchers and industry to share best practices in wound care to improve wound care practices and patient outcomes", says Terry Swanson, NP, Vice Chair of the International Wound Infection Institute, Co-Chair of Wounds Australia 2022 conference and international expert in wound management and wound infection. "This includes showcasing new imaging technologies for helping to improve the cleaning and debridement of wounds, such as the MolecuLight novel point-of-care imaging devices, which highlight the presence and location of elevated bacterial burden in wounds. These diagnostic technologies are becoming key tools in informing wound care decision-making at the point-of-care and we are we're thrilled to have their clinical results shared at multiple talks and posters this coming week".
The clinical posters and presentation featuring the MolecuLight i:X from Wounds Australia 2022 are as follows:
(a) Clinical Posters include:
- Uncovering the high prevalence of bacterial burden in surgical site wounds with point-of-care fluorescence imaging
Kylie Sandy-Hodgetts, Charles A. Andersen, Omar Al-Jalodi, Laura Serena, Christina Teimouri, Thomas E. Serena
⇓ Download poster - An Image is Worth 10,000 Microbes: How Fluorescence Imaging Augments IWGDF Criteria for Detection of Bacterial Burden in Diabetic Foot Ulcers
Thomas E. Serena, David Armstrong
⇓ Download poster - Underappreciated bacterial burden in pressure injuries throughout: clinical trial and real-world evidence
Charles A. Andersen, Katherine McLeod, Rowena Steffan, Thomas E. Serena
⇓ Download poster - Reliance on Clinical Signs and Symptom Assessment Leads to Misuse of Antimicrobials: Post hoc Analysis of 350 Chronic Wounds
Thomas E. Serena, Lisa Gould, Karen Ousey, and Robert S. Kirsner
⇓ Download poster
(b) Clinical Presentations include:
- Acute and Surgical Wounds - Setting the Scene: Dr. Thomas Serena
- Diagnostics, Theragnostics and Innovations for Chronic Wounds: Dr Thomas Serena
- Setting the Scene: Diagnostic/ Theragnostic: Dr Thomas Serena
- Uncovering Covert Pathogenic Bacterial Burden in Surgical Site Wounds with Point-of-Care Fluorescence Imaging: Prof. Kylie Sandy-Hodgetts
In additional to the clinical posters and presentations at Wounds Australia 2022, the MolecuLight i:X® and DX™ imaging devices will be available for demonstration in the MolecuLight booth #2 in the Exhibit Hall at the International Convention Centre (ICC) in Sydney, Australia.
The MolecuLight i:X® and DX™ are the only imaging devices for the real-time detection of elevated bacterial burden in wounds that are FDA cleared and CE and Health Canada Approved. With unmatched clinical evidence including over 60 peer-reviewed publications and 1,500 patients, they are used by leading wound care facilities globally.
MolecuLight Inc. is a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight's suite of commercial devices, which include the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, are point-of-care handheld imaging devices for the real-time detection and localization of bacterial load in wounds and digital wound measurement. MolecuLight procedures performed in the United States benefit from an available reimbursement pathway which include two CPT® codes for physician work to perform "fluorescence imaging for bacterial presence, location, and load" and facility payment for Hospital Outpatient Department (HOPD) and Ambulatory Surgical Center (ASC) settings through an Ambulatory Payment Classification (APC) assignment. The company is also commercializing its unique fluorescence imaging platform technology for other global markets with relevant unmet needs in food safety, consumer cosmetics and other key industrial markets.
View original content to download multimedia:
SOURCE MolecuLight
|
https://www.whsv.com/prnewswire/2022/09/13/moleculight-featured-8-presentations-posters-wounds-australia-2022-conference/
| 2022-09-13T11:35:06Z
|
Keynote speakers AbbVie, AstraZeneca, Boehringer Ingelheim, CSL Behring, and GSK headline one of the industry's largest events for driving collaboration and innovation
PLEASANTON, Calif., Sept. 13, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that visionaries from AbbVie, AstraZeneca, Boehringer Ingelheim, CSL Behring, and GSK will be keynote speakers at the 2022 Veeva R&D and Quality Summit on Oct.19 and 20 in Boston. Speakers will showcase how innovations and advancements in clinical, quality, regulatory, and safety enable greater efficiency and speed across the product lifecycle.
With more than 2,000 industry professionals and over 100 sessions, Veeva R&D and Quality Summit is one of life sciences' largest and most impactful events. Attendees will learn strategies to establish a clinical data foundation for patient-centric digital trials, transform quality management across the value chain, optimize regulatory operations, and deliver new levels of productivity in safety. Featured keynotes and sessions include:
- AbbVie sharing its vision for transforming safety to improve patient outcomes.
- AstraZeneca highlighting how modern quality management enables tangible value creation.
- Boehringer Ingelheim on enabling digital execution in clinical trials to bring treatments to patients faster.
- Global Blood Therapeutics explaining ways to turn the trial master file (TMF) into a strategic advantage for fast, accurate clinical trials.
- GSK showing how they built a unified development ecosystem across clinical, quality, and regulatory for speed and agility.
- Forge Biologics discussing how digital quality management helps to accelerate processes and build trust with partners.
- Moderna on the benefits of establishing an end-to-end regulatory system for increased agility and visibility.
"Life sciences has made significant progress in streamlining processes and making information sharing easier," said Jim Reilly, vice president, Veeva Development Cloud strategy. "Veeva R&D and Quality Summit will bring the industry back together in person to connect with peers, share learnings, and discuss strategies that can move the industry forward."
The event is open exclusively to life sciences industry professionals. Register and stay up to date on the agenda and program details at veeva.com/Summit.
Register for Veeva R&D and Quality Summit: veeva.com/Summit/register
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:
SOURCE Veeva Systems
|
https://www.whsv.com/prnewswire/2022/09/13/more-than-2000-biopharma-leaders-come-together-veeva-rampd-quality-summit-advance-drug-development/
| 2022-09-13T11:35:13Z
|
HOUSTON, Sept. 13, 2022 /PRNewswire/ -- Motiva Enterprises LLC ("Motiva") announced today the expiration of the previously announced cash tender offer (the "Offer") for any and all of its outstanding 6.85% senior notes due January 15, 2040 (CUSIP Nos. 61980AAD5 (144A) and U61999AC9 (Reg. S)) (the "Notes"). The Offer was made on the terms and subject to the conditions set forth in the Offer to Purchase, dated September 6, 2022 (the "Offer to Purchase"), and the related Notice of Guaranteed Delivery attached to the Offer to Purchase (the "Notice of Guaranteed Delivery"). The Offer to Purchase and the Notice of Guaranteed Delivery are referred to herein collectively as the "Offer Documents."
As of the expiration of the Offer at 5:00 p.m., New York City time, on September 12, 2022 (the "Expiration Date"), $326,733,000, or 32.67%, of the $1,000,000,000 aggregate principal amount of the Notes had been validly tendered and delivered (and not validly withdrawn), and an additional $100,000 aggregate principal amount of the Notes had been submitted pursuant to the guaranteed delivery procedures described in the Offer Documents and remain subject to the delivery of the underlying Notes. Payment for the Notes tendered through The Depository Trust Company's Automated Tender Offer Program will be made on September 14, 2022 (the "Settlement Date"), and payment for the Notes tendered pursuant to the guaranteed delivery procedures is expected to be made on September 16, 2022.
As previously announced, the "Tender Offer Consideration" is $1,012.56 for each $1,000 principal amount of the Notes, plus accrued and unpaid interest to, but not including, the Settlement Date, payable on the Settlement Date. For the avoidance of doubt, accrued interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including Notes tendered pursuant to the guaranteed delivery procedures described in the Offer Documents.
J.P. Morgan Securities LLC acted as the dealer manager for the Offer.
This press release does not constitute an offer to buy or a solicitation of an offer to sell any Notes. The Offer is being made solely pursuant to the Offer Documents. The Offer is not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Offer to be made by a licensed broker or dealer, the Offer will be deemed to be made on behalf of Motiva by J.P. Morgan Securities LLC or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.
About Motiva
Headquartered in Houston, Texas, Motiva refines, distributes, and markets petroleum products throughout the Americas. The company's Port Arthur Manufacturing Complex is comprised of North America's largest refinery (with a crude capacity of 630,000 barrels a day), the country's largest base oil plant, and an adjacent chemical plant. Under exclusive, long-term brand licenses with Shell and Phillips 66 (for the 76® brand), Motiva's marketing operations support more than 5,000 retail gasoline stations. Motiva, a Delaware limited liability company, is wholly owned by Aramco.
Forward-Looking Statements
Certain statements herein or in the Offer Documents are "forward-looking statements," which are generally identifiable by words such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "likely," "may," "plan," "position," "possible," "potential," "probable," "project," "should," "strategy," "will," or similar language. Forward-looking statements reflect Motiva's views based on historical results, current information and assumptions related to future developments. Except as may be required by law, Motiva undertakes no obligation to update any forward-looking statements made herein or in the Offer Documents. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those projected or implied by the forward-looking statements. Please refer to the "Forward-Looking Statements" and "Risk Factors" sections in the Offer to Purchase for a description of these and other risks and uncertainties that could cause actual results to differ materially from those projected or implied by the forward-looking statements.
Investor Relations Contact:
Joan Wu, Treasurer
e-mail: motiva-debt@motiva.com, or
Reginald Hart, Treasury Manager (713) 427-3202
e-mail: motiva-debt@motiva.com
View original content:
SOURCE Motiva Enterprises LLC
|
https://www.whsv.com/prnewswire/2022/09/13/motiva-announces-expiration-results-cash-tender-offer-any-all-its-685-senior-notes-due-january-15-2040/
| 2022-09-13T11:35:20Z
|
LOS ANGELES and ARLINGTON, Va. , Sept. 13, 2022 /PRNewswire/ -- The Motion Picture Licensing Corporation (MPLC) and the National Council on Aging (NCOA) have renewed a partnership to support audiovisual copyright compliance in senior centers that are affiliates of NCOA's National Institute of Senior Centers (NISC).
The partnership establishes a framework by which MPLC and NCOA will work together to provide NISC affiliate members with a special member rate for its Umbrella License® to NISC affiliate members for showing movies and TV shows. It will also advise members of the risks of failing to comply with copyright laws. Ideas and information will be shared via an MPLC educational strategy that will include partnering with NCOA on outreach to senior centers.
"Senior centers are vital and vibrant gathering places in the community. Showing movies at these locations is a wonderful way to strengthen connections among older adults and across generations. We're thrilled that MPLC is able to offer a discount to NISC affiliate members," said Dianne Stone, NCOA's Associate Director of Network Development and Engagement.
Since its founding in 1986, MPLC has taken an educational approach to the licensing of television, movies, and other audiovisual content, forging partnerships with industry associations in a variety of verticals to educate businesses about copyright compliance.
"We are excited to be working with NCOA's National Institute of Senior Centers," said Dave Davis, Chief Commercial Officer at MPLC. "They are passionate about the quality of life for America's senior citizens. We are pleased that through our license senior citizens are able to legally engage in public, shared movie and TV viewing experiences at senior centers across America."
According to the US Copyright Act, Title 17 of the United States Code, copyrighted movies, television, and other audiovisual content originally intended for personal, private use, require a public performance license when exhibited in public. Showing audiovisual content in auto dealerships and other public spaces via broadcast, cable, or satellite television; DVDs, downloads, or streaming services requires a public performance license.
About the National Council on Aging: NCOA is the national voice for every person's right to age well. We believe that how we age should not be determined by gender, color, sexuality, income, or ZIP code. Working with thousands of national and local partners, we provide resources, tools, best practices, and advocacy to ensure every person can age with health and financial security. Founded in 1950, we are the oldest national organization focused on older adults. NCOA's National Institute of Senior Centers (NISC) supports senior centers nationwide with best practices and innovations in programming, as well as networking and training opportunities.
About MPLC: MPLC is the global leader in non-theatrical licensing, supporting legal public performances of film, television, and other audiovisual content in more than 40 countries around the world. Under the Umbrella License®, a blanket license for public performance, MPLC represents rights holders ranging from major Hollywood studios to independent producers. MPLC licensees include government, corporations, and non-profit organizations. Hundreds of thousands of locations around the world publicly perform content legally with the Umbrella License.
View original content to download multimedia:
SOURCE MPLC
|
https://www.whsv.com/prnewswire/2022/09/13/mplc-national-council-aging-partner-offer-discounted-licenses-showing-movies-tv-shows-senior-centers/
| 2022-09-13T11:35:26Z
|
Six-month data from Phase 2 STARLIGHT trial expected in H1 2023
DALLAS, Sept. 13, 2022 /PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced full enrollment of its Phase 2 clinical trial of MCO-010, an ambient-light activatable Multi-Characteristic Opsin (MCO) optogenetic monotherapy to restore vision in blind patients, for Stargardt disease. Six-month data from the Phase 2 STARLIGHT trial are expected in H1 2023.
"We are excited by the therapeutic potential of MCO-010, supported by robust data from previous preclinical and clinical studies," said Sulagna Bhattacharya, CEO of Nanoscope. "Completing the quick two-month enrollment of this Phase 2 trial, which will evaluate the safety and effects of a single intravitreal injection of MCO-010, brings us another major step forward in developing this novel therapy with broad therapeutic application."
The Phase 2 STARLIGHT open-label trial (NCT05417126) enrolled six subjects with advanced vision loss due to a clinical or genetic diagnosis of Stargardt disease. In this study, all subjects received the same single intravitreal dose of 1.2E11gc/eye of MCO-010 as used in the Company's Phase 2b retinitis pigmentosa (RP) study.
Nanoscope's optogenetic therapy uses a proprietary AAV2 vector to deliver MCO genes into retinal cells to enable vision in different color environments. The therapy is administered as a single intravitreal injection for in-office delivery without the need for any other devices or interventions. MCO-010 has received orphan drug designations for RP and Stargardt disease from the FDA and is concurrently being evaluated in Nanoscope's Phase 2b RESTORE trial in patients with RP, with trial results also expected in H1 2023.
Nanoscope Therapeutics is developing gene-agnostic, sight restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases, for which no cure exists. The company's lead asset, MCO-010, is presently in Phase 2b multicenter, randomized, double-masked, sham-controlled clinical trials in the U.S. for retinitis pigmentosa (NCT04945772) with top line data expected H1 2023. The company has also initiated a Phase 2 trial of MCO-010 therapy in Stargardt patients (NCT05417126). MCO-010 has received FDA orphan drug designations for RP and Stargardt. Preclinical assets include non-viral laser delivered MCO-020 gene therapy for geographic atrophy.
Investor Contact:
Argot Partners
212-600-1902
Nanoscope@argotpartners.com
View original content to download multimedia:
SOURCE Nanoscope Therapeutics
|
https://www.whsv.com/prnewswire/2022/09/13/nanoscope-therapeutics-announces-completion-enrollment-starlight-phase-2-clinical-trial-mco-010-optogenetic-gene-therapy-stargardt-disease/
| 2022-09-13T11:35:33Z
|
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Temu announced the grand opening of its global online shopping marketplace, featuring the widest selection of merchandise at hard-to-beat prices.
Temu was created with the goal of empowering consumers by giving them access to a broad range of carefully curated products at ultra-competitive prices. Launched in the US in September 2022, Temu is available at www.temu.com and for downloading as mobile apps.
Among the categories featured are fashion, beauty and health, home and garden, jewelry and accessories, electronics, shoes and bags, sports and outdoors, pet supplies, office products, and more.
Temu is able to offer competitive prices for the products thanks to our access to a global network of suppliers and fulfillment partners. We share these sourcing and fulfillment capabilities with our sister e-commerce company under Nasdaq-listed PDD (Nasdaq: PDD), which has worked with more than 11 million global merchants and handled 61 billion orders in 2021.
To celebrate our grand opening, Temu is offering sitewide discounts with no minimum purchase for this promotional period. It also offers free shipping on all items during the launch promotion.
Temu's extensive list of great-value merchandise means there is something for everyone. Don't miss out on this special promotion for Temu's launch and enjoy even more savings!
About Temu:
Temu is a global online marketplace featuring the widest selection of unique merchandise at hard-to-beat prices given its sourcing and fulfillment capabilities built over the years. Created with the goal of empowering consumers, Temu works closely with its global network of suppliers and fulfillment partners to curate a range of competitively priced products that meet wide-ranging needs.
View original content to download multimedia:
SOURCE Temu
|
https://www.whsv.com/prnewswire/2022/09/13/nasdaq-listed-pdd-sister-company-temu-launches-global-online-marketplace-us/
| 2022-09-13T11:35:40Z
|
- US clinics acquired from Novamind demonstrating continued growth
- Physical rebranding of clinics is underway
- Announcing new client financing options in Canada
VANCOUVER, BC, Sept. 13, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus", the "Company") (TSX: NUMI) (OTCQX: NUMIF) is pleased to provide an update on the integration of the Novamind acquisition, which completed on June 10, 2022.
The Company's US clinics have continued to perform well during fiscal Q4 (the three months ended August 31, 2022), with strong client appointment growth in recent months. During August, more than 6,200 client appointments were held across Canada and the US, representing 25% growth compared to July. In total, the Company's eight US wellness clinics – six in Utah and two in Arizona – completed more than 4,900 client appointments in August, representing an increase of 22% from July.
"We continue to be pleased with the performance of our recently acquired US clinics – and their continued success in building strong client relationships," said Payton Nyquvest, Founder and CEO, Numinus. "Impressively, 15% of the client appointments held in August at our US clinics were from new clients."
Numinus is proud to provide a wide range of mental health care services, including traditional therapy, counseling, Transcranial Magnetic Stimulation (TMS), Ketamine-assisted therapy, and – when approved through Canada's Special Access Programme – psychedelic-assisted therapy.
Numinus is currently focused on growing its Ketamine-assisted therapy ("KAT") offering across Canada. Ketamine Therapy sessions at Numinus' US clinics (including KAT, Spravato and Ketamine medicine) grew 35% in August, compared to July, to 1,520 appointments. Demand for TMS services also continues to grow. During August, the Company completed 725 TMS appointments – a 23% increase relative to the prior month.
Cedar Clinical Research, the clinical trial management division of Numinus that was acquired through Novamind, also continues to achieve positive operational growth. During Numinus' fiscal fourth quarter, the division recruited 178 clinical trial participants for 16 third-party clinical studies, representing an 19% increase in clinical trial participation compared to the fiscal third quarter.
Numinus will release its fiscal fourth quarter and annual 2022 financial results on November 29, 2022.
Numinus' new brand has already been successfully applied to all of the Company's digital assets. By the end of 2022, Numinus intends to launch a new comprehensive client website, providing information and booking tools for all of the Company's wellness clinics. The rebranding of Numinus' physical wellness clinics is also now underway. Signage and office designs across all 13 wellness clinics are expected to be updated before the end of 2022 to reflect the new unified Numinus brand.
Numinus is pleased to announce that it is launching a new financing option for clinic patients in Canada. The Company expects this new option will increase the accessibility of its traditional therapy and Ketamine-assisted therapy to a wider client population.
"We understand that some people in need of therapy face financial hurdles in accessing treatments, so we're proud to provide another option for clients to consider," said Jason Lapensee, SVP, Operations.
Offered through iFinance, a third-party financing partner, Numinus' new financing option will allow Canadian clients to apply for financing with interest rates based on the applicant's credit history. Once approved, Numinus will provide the requested therapy services and collect full payment from iFinance following the completion of the treatment plan.
Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Neither Numinus Wellness Inc., nor any of its subsidiaries is a professional corporation licensed to practice health services. In jurisdictions where health services may only be provided by a corporation if that corporation holds a valid permit to do so, Numinus and its subsidiaries operate in a management services function to affiliated professional corporations, who provide health services to patients. Numinus and its subsidiaries do provide health services directly to patients in those jurisdictions where authorized to do so.
This news release includes certain "forward‐looking information" and "forward‐looking statements" (collectively "forward‐looking statements") within the meaning of applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. All statements in this news release that address events or developments that the Company expects to occur in the future are forward‐looking statements. There is no assurance that Numinus will achieve a US listing. Forward‐looking statements are statements that are not historical facts and are often identified by words such as "expect", "plan", "anticipate", "project", "target", "potential", "schedule", "forecast", "budget", "estimate", "intend" or "believe" and similar expressions or their negative connotations, or that events or conditions "will", "would", "may", "could", "should" or "might" occur, and include information regarding expectations around the rebranding, and expectation for other economic, business and/or competitive factors.
Forward‐looking statements necessarily involve assumptions, risks and uncertainties, certain of which are beyond the Company's control. These forward‐looking statements are qualified in their entirety by cautionary statements and risk factor disclosure contained in filings made by the Company with the Canadian securities regulators, including the Company's financial statements, related MD&A and Annual Information Form for the financial year ended August 31, 2021 and its interim financial statements and related MD&A for the three and nine months ended May 31, 2022, all filed with the securities regulatory authorities in all provinces and territories of Canada and available under the Company's profile at www.sedar.com. The risk factors are not exhaustive of the factors that may affect the Company's forward‐looking statements. The Company's forward‐looking statements are based on the applicable assumptions and factors management considers reasonable as of the date hereof, based on the information available to management of the Company at such time. The Company does not assume any obligation to update forward‐looking statements if circumstances or management's beliefs, expectations or opinions should change other than as required by applicable securities laws. There can be no assurance that forward‐looking statements will prove to be accurate, and actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward‐looking statements. Accordingly, undue reliance should not be placed on forward‐looking statements.
View original content:
SOURCE Numinus Wellness Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/numinus-provides-update-acquisition-integration-announces-new-client-financing-options/
| 2022-09-13T11:35:46Z
|
TORONTO, Sept. 13, 2022 /PRNewswire/ - O3 Mining Inc. (TSXV: OIII) (OTCQX: OIIIF) ("O3 Mining" or the "Corporation) is pleased to announce it has received initial results from its 10,500 metre drilling campaign on the Hygrade Fold area, within Marban Engineering in Val-d'Or, Quebec, Canada.
- 5.7 g/t Au over 7.6 metres in hole O3MA-22-341, including 30.9 g/t Au over 1.2 metres, within highly biotized ultramafic intrusion, with mineralization related to quartz veining containing visible gold
- 20.5 g/t Au over 2.2 metres in hole O3MA-22-351, including 73.5 g/t Au over 0.6 metres, within a sheared komatiitite, related to a felsic dike, with quartz veining and visible gold
O3 Mining's President and Chief Executive Officer, Mr. Jose Vizquerra commented, "We are very excited with the initial results from our exploration work at the Hygrade Fold area in the northwestern portion of Marban Engineering, as part of our brownfield exploration program. This underexplored, large land package offers significant exploration potential upside, with several historic showings, and promise for a new discovery. With our recent positive pre-feasibility study results (C$463M NPV (5%), unlevered IRR of 23.2% and over 160Koz gold per year), showing a robust standalone project, we look forward to the feasibility-level study ahead, and exploration work to grow the inferred mineral resource."
O3 Mining initiated a brownfield exploration program from late June to early September, drilling 10,500 metres within the Hygrade Fold area. This area encompasses two former mines, the Malartic Hygrade mine and the Orion #8 mine, which produced 40,000 oz Au over their mine life (historical production summarized in Table 2). The Hygrade Fold area also includes the Malartic H deposit, which is composed of several stacked zones hosted in basalt and felsic dikes, which has never been mined.
The compilation of historical drilling in this area revealed a previously underexplored sector with high-grade historic intercepts within wide basaltic units similar to the basalt hosting the Marban deposit. Assay results for 6,500 samples are still pending within the Hygrade Fold area. The summer drilling campaign confirmed the presence of a mineralized structure within the basaltic units and the Corporation plans to follow up drilling for the 2023 winter campaign on best intercepts as results are being received. The winter campaign will also aim to better define and expand known mineralization at Malartic H, Malartic Hygrade and Orion #8.
Table 1: Drill Hole Intercepts (only intercepts above 5 g/t Au * m are reported)
Table 2: Historical production within the Hygrade Fold area
Figure 2: Hygrade Fold Area Surface Map
The scientific and technical content of this news release has been reviewed, prepared, and approved by Mr. Sébastien Vigneau. (OGQ #993), Principal Geologist, who is a "qualified person" as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101").
O3 Mining Inc., an Osisko Group company, is a gold explorer and mine developer on the road to produce from its highly prospective gold camps in Québec, Canada. O3 Mining benefits from the support, previous mine-building success, and expertise of the Osisko team as it grows towards being a gold producer with several multi-million-ounce deposits in Québec.
O3 Mining is well-capitalized and owns a 100% interest in all its properties (66,000 hectares) in Québec. O3 Mining trades on the TSX Venture Exchange (TSXV: OIII) and OTC Markets (OTCQX: OIIIF). The Corporation is focused on delivering superior returns to its shareholders and long-term benefits to its stakeholders. Further information can be found on our website at https://o3mining.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
View original content to download multimedia:
SOURCE O3 Mining Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/o3-mining-intersects-205-gt-au-over-22-metres-including-735-gt-au-over-06-metres-hygrade-fold-marban-engineering/
| 2022-09-13T11:35:53Z
|
In a history-making move, OpenNode to test Bitcoin payment infrastructure in Bahrain via the Central Bank of Bahrain's Regulatory Sandbox
LOS ANGELES, Sept. 13, 2022 /PRNewswire/ -- As the first of many announcements to come from the region, OpenNode intends to test a bitcoin payment processing and payouts solution via the Central Bank of Bahrain ("CBB's") Regulatory Sandbox. Bitcoin payments had been non-existent in the island nation until now, which highlights the growing interest in Bitcoin throughout the Middle East. OpenNode intends to provide the infrastructure to help the country grow its economy and will showcase why Bitcoin is synonymous with better business.
Bahrain is widely regarded as having developed the first post-oil economy in the GCC by investing in tourism and banking. In 2017, the CBB launched the Regulatory Sandbox to develop the country's FinTech ecosystem and enhanced it in 2021 to transition towards a more diverse digital economy. The CBB authorized OpenNode to participate in the new Regulatory Sandbox Framework that allows FinTech firms to test their ideas and solutions in the Kingdom.
By introducing the infrastructure for bitcoin-based transactions, OpenNode intends to bring payment innovation to Bahrain in what promises to be the start of something big.
"This is a watershed moment for the people of Bahrain, the Middle East and the Bitcoin economy as a whole. OpenNode's leading Bitcoin infrastructure solution continues to pave the way for countries, governments and reputable financial institutions to adopt the Bitcoin standard and transact on the lightning network," says Afnan Rahman, CEO and Co-Founder at OpenNode.
OpenNode, the world's leading "Bitcoin-as-a-payment-network" infrastructure company, is currently active in more than 160 countries around the world.
Commenting on this announcement, Dalal Buhejji, Executive Director - Investment Development for Financial Services at the Bahrain Economic Development Board said, "We are proud to have worked with the Central Bank towards establishing a strong financial services ecosystem within the Kingdom of Bahrain. As a country, we have always been ahead of the curve in adopting Fintech solutions thanks to our regulator's flexibility and forward thinking.
Financial services is an important sector within our economy, and fintech platforms such as the one soon to be tested by OpenNode are essential to ensure we continue to innovate while simultaneously adhering to best regulatory measures."
For media inquiries, please contact Tim Stuart at (818) 699-8193 or tim(at)opennode(dot)com.
Learn more at www.opennode.com
OpenNode is the leading "Bitcoin-as-a-payment-network" infrastructure company, servicing companies in more than 160 countries through innovative Bitcoin Lightning Network-powered products. OpenNode removes complexity and risk by providing superior technology solutions, including simple no-code, turn-key hosted checkouts, e-commerce plug-ins and APIs for customized integrations. Compatible with every Bitcoin wallet, OpenNode is transforming money and payments for every business, everywhere. Founded in 2017 and backed by influential global investors, OpenNode is on a mission to empower and connect the world with Bitcoin.
View original content:
SOURCE OpenNode
|
https://www.whsv.com/prnewswire/2022/09/13/opennode-test-bitcoin-payments-bahrain/
| 2022-09-13T11:36:00Z
|
- Opera's crypto-centric browser (Win, Mac, Android, iOS) evolves the user experience to be truly Web3-ready ahead of the Ethereum Merge
- It's adding seamless support for major third party wallets including Metamask and others
- The industry-first Web3 wallet selector allows users to seamlessly choose which wallet they want to interact with a given dApp - without having to manage conflicting extensions, go deep into settings or deal with annoying pop ups
- The browser partners with DappRadar for better dApps access
OSLO, Norway, Sept. 13, 2022 /PRNewswire/ -- Opera (NASDAQ: OPRA), the company behind the world's first multi-platform Web3 browser, today announces one of the most significant updates since its genesis that will make the lives of crypto users much easier: The Opera Crypto Browser now supports MetaMask and other leading wallets. To match this development, the browser is also shipping the innovative "Wallet Selector," an industry-first multi-wallet management tool. This feature allows users to seamlessly pick which one of their wallets they want to interact with a particular dApp or website. They can now choose between their wallets directly in the browser address bar, without needing to go into settings or having to deal with competing extensions. Beyond Opera Crypto Browser's native wallet, the wallets supported in the Wallet Selector include Metamask and hundreds more, as long as they are available as Opera or Chrome extensions (yes, these work in Opera too).
Browser wallet extensions are essential tools for exploring Web3. They allow users to explore and interact with various decentralized apps (dApps) and services. However, not all wallet extensions are created equal. Many only support specific networks, and some offer different features such as in-app swaps and staking. To explore multiple networks, crypto users tend to need several browser wallets which creates an unnecessary barrier to adoption and impairs the user experience. Opera is changing this with today's update and the innovative Wallet Selector feature in the browser address bar.
Opera's new Wallet Selector – which automates the precarious process of switching between crypto wallets while swapping tokens or transacting with dApps – is a gamechanger for the broader Web3 ecosystem. "We created the Wallet Selector based on the feedback we got from our users. It saves them a lot of pain as they no longer have to constantly go into settings or to navigate between competing wallet extensions," said Tomasz Stawarz, Engineering Director at Opera.
Opera's industry-first Web3 Wallet Selector solves this issue by aggregating compatible wallet extensions and automating the connection process. The selector remembers users' preferences for different websites, allowing them to connect to dApps effortlessly. This update brings Web3 one step closer to the experience we know from Web2 ahead of the Ethereum Merge.
"The upcoming Merge is the most important technological update in the history of crypto that will move Ethereum from proof-of-work to proof-of-stake, thus making it more scalable, secure, sustainable, and ready to be used by the mainstream user. Opera is the only browser truly ready for this shift and the only one offering web users all the tools they need to give Web3 a try in a safe environment," said Susie Batt, Crypto Ecosystem Lead at Opera.
On top of the ease of use of multiple wallets, Opera Crypto Browser also provides security enhancements that protects its users from hacks and phishing. The phishing detection feature blocks the users from entering blacklisted phishing sites. The browser's secure clipboard protects users from scary clipboard hacks, making sure the wallet address or account number they copied is the same one they are pasting.
To make the Web3 experience more accessible and fun, the Opera Crypto Browser now resolves human-readable wallet handles for YAT, FIO Crypto Handles e.g Jane@opera and ENS domains like iamtesting.eth. These features allow users to make cryptocurrency transactions using simple-to-memorize domain and wallet addresses consisting of words or even strings of emojis as well as Handshake domain resolution.
The Opera Crypto Browser has also partnered with DappRadar to provide its users with access to more than 11,000 dApps. The platform also gives them unique insight into valuable metrics. All of the dApps are accessible as easily as any website on web2, from the browser address bar. The users identify themselves using one of their wallets, picked via the Wallet Selector.
The upgrade also overhauls the Crypto Corner feature, including a new Hot Tweets section including the latest trending tweets around crypto. Additionally, the popular BNB Chain Decentralized Finance (DeFi) app, PancakeSwap, has been integrated with the Crypto Browser and is available in the browser's native crypto wallet. This allows users to trade tokens directly from within the wallet without the hassle of connecting to an external dApp first.
Opera is also updating the mobile version of its Crypto Browser with a new navigation and added private mode.
The updated Crypto Browser by Opera from Norway comes amid a downturn in the global crypto market, yet institutional interest in cryptocurrencies continues to thrive. A recent independent analysis by Messari revealed that almost twice as much ($35B) investment capital flowed into crypto projects in 2022 than in 2021 ($19B).
Susie Batt, Crypto Ecosystem Lead at Opera, said: "The development of the world's first Crypto Browser is a realization of our aims to provide the tools that enable open access to Web3. Not only have we provided a gateway into Web3, but we've also simplified many everyday processes native to the crypto space that may previously have confused the average web user. The Opera Crypto Browser is currently the best, most comprehensive portal into Web3 for new and experienced users alike."
The Opera Crypto Browser is Opera's all-encompassing browser product offering a window into the world of cryptocurrency, blockchain, and Web3. The Crypto Browser now delivers access to multiple blockchain networks including Ethereum, Bitcoin, BNB, Polygon, and others, as well as tens of thousands of dApps and protocols built on top of them. The browser also includes a built-in crypto wallet, as well as a series of privacy-enhancing features including a secure clipboard, a built-in browser VPN and ad blocker. It also gives users direct access to key platforms and messengers, including Twitter, Telegram and Discord directly in the sidebar, which means they don't have to reach for separate apps. The development of the Crypto Browser signals Opera's intent to offer internet users a simplified, one-stop window for interacting with the blockchains and protocols that make up the Web3 space.
To download the Opera Crypto Browser, click here.
The Wallet Selector is available in the desktop version of the Opera Crypto Browser and currently supports standard EVM web3 interface-based wallets (EIP-1193).
Join Opera's Crypto communities at:
Opera Crypto Twitter
Opera Crypto Discord
Opera Crypto Telegram
Opera is a global web innovator with an engaged and growing base of hundreds of millions of monthly active users who seek a better internet experience. Building on over 25 years of innovation that started with browser products, Opera is now leveraging its brand and highly engaged user base in order to expand its business into new segments. Today, Opera offers users around the world a range of products and services that include PC and mobile browsers, the newsreader Opera News, and apps dedicated to gaming, crypto, e-commerce and classifieds. In 2018, Opera introduced the first browser with a built-in crypto wallet and Web3 support. Opera is headquartered in Oslo, Norway and listed on the NASDAQ stock exchange (OPRA). In January 2022, Opera released the first version of its Crypto Browser, a dedicated web browser tweaked to crypto-enthusiasts and the crypto-curious.
View original content to download multimedia:
SOURCE Opera Limited
|
https://www.whsv.com/prnewswire/2022/09/13/opera-crypto-browser-integrates-metamask-other-wallets-unveils-industry-first-web3-wallet-selector-ahead-merge/
| 2022-09-13T11:36:06Z
|
Periscope adds tourism account to growing client roster
MINNEAPOLIS, Sept. 13, 2022 /PRNewswire/ -- Periscope, an award-winning, full-service advertising agency, today announced a three-year engagement as the official creative agency of record for Meet Minneapolis, securing its first venture into the tourism space and further solidifying the agency's ties to the Twin Cities.
Periscope will lead the campaign and media strategy to attract more visitors to Minneapolis, touting the breadth of unique experiences and opportunities the city offers to visitors from across the nation as leisure travel bounces back. This win gives Periscope the unique opportunity to help revitalize tourism in its home city, and continues a growth trend with 10 clients added to the agency's roster in 2022.
"Our team has a wealth of tourism experience, and we are proud to add Meet Minneapolis as a client under the Periscope logo. We've been a part of the Minneapolis landscape for 60+ years, and we've earned the right to knock this work out of the park. We owe it to our city," said Liz Grabek, SVP, Consumer Strategy at Periscope.
This new partnership demonstrates Periscope's dedication to celebrating Minneapolis and to drive growth to local businesses that benefit the city.
"We have a unique opportunity to reintroduce Minneapolis to regional visitors that have heard a lot about us, but not a lot from us," stated Courtney Ries, Senior Vice President of Destination Branding and Strategy for Meet Minneapolis. "Periscope's keen understanding and excitement for this opportunity — coupled with their unbridled passion for the city — makes them a great partner for this work."
The full scope includes Strategy, Creative Concepting and Campaign Execution, as well as PR and Influencer Marketing managed in partnership with Minneapolis-based PR and influencer marketing agency Friend of a Friend. Work is expected to begin rolling out early in 2023.
ABOUT PERISCOPE
Periscope, a Quad company, is an award-winning agency that provides a full spectrum of integrated marketing services for a wide range of acclaimed brands. As a part of Quad, Periscope represents a key creative discipline that enables Quad to provide a full through-the-line offering and help brands reimagine their marketing experience to be more streamlined, impactful, flexible and frictionless. Learn more at www.periscope.com.
ABOUT MEET MINNEAPOLIS
Meet Minneapolis is a private, not-for-profit, member-based association. It actively promotes and sells the Minneapolis area as a destination for conventions and meetings, works to maximize the visitor experience and markets the city as a desirable tourist destination to maximize the economic and social benefit to the greater Minneapolis area. Meet Minneapolis is accredited by the Destination Marketing Accreditation Program (DMAP) of Destinations International.
View original content to download multimedia:
SOURCE Periscope; Meet Minneapolis
|
https://www.whsv.com/prnewswire/2022/09/13/periscope-appointed-agency-record-meet-minneapolis/
| 2022-09-13T11:36:13Z
|
PORTLAND, Ore., Sept. 13, 2022 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, today announced the appointment of Dr. John Liu to the Company's Board of Directors, effective September 9, 2022.
Dr. Liu currently serves as a director on the boards of Digital China Holdings Limited, a Hong Kong-based provider of information technology (IT) products and systems solutions, and dormakaba Holding AG, a global leader in the security and access control market. Dr Liu also held prior roles as the China chief executive officer of Afiniti, the global chief executive officer of VOSS, and as the chief operating officer of Wanda Internet Technology Group. Additionally, he previously served as a non-executive director on the board of ARM Holdings Plc. Earlier in his career, Dr. Liu held numerous senior executive positions at globally recognized communications and networking companies, including the corporate vice president and president of Greater China at Google Inc. and the China chief executive officer of SK Telecom Co., Ltd. He holds a bachelor's degree in Mathematics from Beijing Normal University, obtained a Ph.D. in Telecommunications Network Management from Technical University of Denmark and is a graduate of Harvard Business School's Senior Executive Program.
"We are very pleased to welcome Dr. Liu as a new independent director on Pixelworks' Board," stated Daniel Heneghan, Chairman of the Board. "He possesses extensive senior-level leadership experience at global technology companies, including a deep understanding of business development and strategic tactics required to drive successful operations in Asia. I look forward to working with Dr. Liu and his future contributions to the Board, as the Company continues to pursue its focused growth strategy centered around mobile visual processing solutions in Asia and the proliferation of Pixelworks' TrueCut Motion platform in North America."
Following the appointment of Dr. Liu as an independent Director, Pixelworks' Board of Directors is comprised of seven members.
About Pixelworks
Pixelworks provides industry-leading content creation, video delivery and display processing solutions and technology that enable highly authentic viewing experiences with superior visual quality, across all screens – from cinema to smartphone and beyond. The Company has a 20-year history of delivering image processing innovation to leading providers of consumer electronics, professional displays, and video streaming services. For more information, please visit the company's web site at www.pixelworks.com.
Pixelworks and the Pixelworks logo are registered trademarks of Pixelworks, Inc.
View original content to download multimedia:
SOURCE Pixelworks, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/pixelworks-appoints-dr-john-liu-board-directors/
| 2022-09-13T11:36:19Z
|
BELOIT, Wis., Sept. 13, 2022 /PRNewswire/ -- Regal Rexnord Corporation (NYSE: RRX) is hosting its 2022 Investor Day today at The New York Stock Exchange beginning at 8:00AM ET. The event will be webcast live on the Company's investor relations website at investors.regalrexnord.com.
CEO Louis Pinkham, CFO Rob Rehard, and other members of the executive leadership team will discuss the Company's strategic growth objectives, including plans to accelerate profitable organic sales growth, continue to expand adjusted gross margins and adjusted EBITDA margins, grow free cash flow, and drive significant potential value creation through various capital deployment initiatives.
In conjunction with today's event, the Company is reaffirming its annual 2022 guidance, including organic revenue growth at a high single digit rate, to approximately $5.2 billion, GAAP earnings per share in a range of $7.01 to $7.61, and adjusted earnings per share* in a range of $10.20 to $10.80.
The Company is also introducing the following financial targets for the 2023 to 2025 period:
- Organic net sales growth at a CAGR of 4% to 6%
- Adjusted EBITDA margin expansion of ~300 basis points
- Adjusted earnings per share growth at a low double digit CAGR
- Annual free cash flow conversion of at least 100%
The Company also announced today plans to achieve carbon emission neutrality on scopes 1 and 2 by 2032, and targets net zero across scopes 1, 2 and 3 by 2050.
Commenting on the new Net Zero goals, CEO Louis Pinkham said: "We are proud to be setting more aggressive environmental impact goals, which are aligned with our Regal Rexnord values. Our teams have been working diligently to improve the integrity of our environmental data, to develop the skills and tools needed to aggressively make our operations more environmentally friendly, and to establish relevant metrics, plus a governance structure, to ensure we progress towards our net zero goals."
Regal Rexnord Corporation is a global leader in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors and electronic controls, air moving products and specialty electrical components and systems, serving customers around the world. Through longstanding technology leadership and an intentional focus on producing more energy-efficient products and systems, Regal Rexnord helps create a better tomorrow – for its customers and for the planet.
Regal Rexnord is comprised of four segments: Motion Control Solutions, Climate Solutions, Commercial Systems and Industrial Systems. Regal Rexnord is headquartered in Beloit, Wisconsin and has manufacturing, sales, and service facilities worldwide. For more information, visit RegalRexnord.com.
* Non-GAAP Financial Measurement, See Appendix for Reconciliation
This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, which reflect Regal Rexnord's current estimates, expectations and projections about Regal Rexnord's future results, performance, prospects and opportunities. Forward-looking statements include statements that are not historical facts and can be identified by forward-looking words such as "anticipate," "believe," "confident," "estimate," "expect," "intend," "plan," "may," "will," "project," "forecast," "would," "could," "should," and similar expressions. These forward-looking statements are based upon information currently available to Regal Rexnord and are subject to a number of risks, uncertainties, and other factors that could cause actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. Important factors that could cause actual results to differ materially from the results referred to in the forward-looking statements Regal Rexnord makes in this release include: dependence on key suppliers and the potential effects of supply disruptions; fluctuations in commodity prices and raw material costs; any unforeseen changes to or the effects on liabilities, future capital expenditures, revenue, expenses, synergies, indebtedness, financial condition, losses and future prospects; the possibility that Regal Rexnord may be unable to achieve expected synergies and operating efficiencies in connection with the merger with the Rexnord Process & Motion Control business (the "Rexnord PMC business") and the acquisition of Arrowhead Systems, LLC ("Arrowhead") (together with the merger with the Rexnord PMC business, the "Transactions") within the expected time-frames or at all and to successfully integrate the Rexnord PMC business and Arrowhead; Regal Rexnord's ability to identify and execute on future M&A opportunities, including significant M&A transactions; the impact of any such M&A transactions on Regal Rexnord's results, operations and financial condition, including the impact from costs to execute and finance any such transactions; expected or targeted future financial and operating performance and results; operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers, clients or suppliers) being greater than expected following the Transactions; Regal Rexnord's ability to retain key executives and employees; the continued financial and operational impacts of and uncertainties relating to the COVID-19 pandemic on customers and suppliers and the geographies in which they operate; uncertainties regarding the ability to execute restructuring plans within expected costs and timing; challenges to the tax treatment that was elected with respect to the acquisition of the Rexnord PMC business and related transactions; requirements to abide by potentially significant restrictions with respect to the tax treatment of the Rexnord PMC business which could limit Regal Rexnord's ability to undertake certain corporate actions that otherwise could be advantageous; actions taken by competitors and their ability to effectively compete in the increasingly competitive global electric motor, drives and controls, power generation and power transmission industries; the ability to develop new products based on technological innovation, such as the Internet of Things, and marketplace acceptance of new and existing products, including products related to technology not yet adopted or utilized in geographic locations in which Regal Rexnord does business; dependence on significant customers; seasonal impact on sales of products into HVAC systems and other residential applications; risks associated with global manufacturing, including public health crises and political, societal or economic instability, including instability caused by the conflict between Russia and Ukraine; issues and costs arising from the integration of acquired companies and businesses and the timing and impact of purchase accounting adjustments; Regal Rexnord's overall debt levels and its ability to repay principal and interest on its outstanding debt; prolonged declines in one or more markets, such as heating, ventilation, air conditioning, refrigeration, power generation, oil and gas, unit material handling, water heating and aerospace; economic changes in global markets, such as reduced demand for products, currency exchange rates, inflation rates, interest rates, recession, government policies, including policy changes affecting taxation, trade, tariffs, immigration, customs, border actions and the like, and other external factors that Regal Rexnord cannot control; product liability, asbestos and other litigation, or claims by end users, government agencies or others that products or customers' applications failed to perform as anticipated, particularly in high volume applications or where such failures are alleged to be the cause of property or casualty claims; unanticipated liabilities of acquired businesses; unanticipated adverse effects or liabilities from business exits or divestitures; unanticipated costs or expenses that may be incurred related to product warranty issues; infringement of intellectual property by third parties, challenges to intellectual property, and claims of infringement on third party technologies; effects on earnings of any significant impairment of goodwill; losses from failures, breaches, attacks or disclosures involving information technology infrastructure and data; cyclical downturns affecting the global market for capital goods; and other risks and uncertainties including, but not limited, to those described in the section entitled "Risk Factors" in Regal Rexnord's Annual Report on Form 10-K on file with the SEC and from time to time in other filed reports including Regal Rexnord's Quarterly Reports on Form 10-Q. For a more detailed description of the risk factors associated with Regal Rexnord, please refer to Part I, Item 1A in the Regal Rexnord Annual Report on Form 10-K for the fiscal year ended January 1, 2022 on file with the SEC and subsequent SEC filings. Shareholders, potential investors, and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this release are made only as of the date of this release, and Regal Rexnord undertakes no obligation to update any forward-looking information contained in this release or with respect to the announcements described herein to reflect subsequent events or circumstances.
(Dollars in Millions, Except per Share Data)
We prepare financial statements in accordance with accounting principles generally accepted in the United States of America ("GAAP"). We also periodically disclose certain financial measures in our quarterly earnings releases, on investor conference calls, and in investor presentations and similar events that may be considered "non-GAAP" financial measures. This additional information is not meant to be considered in isolation or as a substitute for our results of operations prepared and presented in accordance with GAAP.
In this press release, we disclose adjusted earnings per share, and we reconcile this measure in the table below to the most directly comparable GAAP financial measure. We believe that this non-GAAP financial measure is useful for providing investors with additional information regarding our results of operations and for helping investors understand and compare our operating results across accounting periods and compared to our peers. Our management uses this measure to help us evaluate our business and forecast our future results. Accordingly, we believe disclosing and reconciling this measure helps investors evaluate our business in the same manner as management.
View original content:
SOURCE Regal Rexnord Corporation
|
https://www.whsv.com/prnewswire/2022/09/13/regal-rexnord-corporation-hosts-2022-investor-conference-reaffirms-2022-guidance-introduces-new-three-year-financial-targets-net-zero-goals/
| 2022-09-13T11:36:26Z
|
Trusted collaboration aims at financially empowering people and enterprises throughout the continent
OSLO, Norway and MEXICO CITY, Sept. 13, 2022 /PRNewswire/ -- Reltime AS, a disruptive global Web3 and Metaverse financial technology company, and Triskel Capital Ltd. have entered into a long-term strategic partnership to change the way people and businesses in Latin America financially interact and transact.
Together with Reltime as its next-generation strategic partner, Triskel aims at putting financial power and freedom squarely in the hands of the people—regardless of income, background, gender, race, ethnicity, banked, unbanked or underbanked status—as well as merchants and businesses.
Without any middlemen, they will be able to:
- Seamlessly create their own personal or merchant account using a mobile app, completely free of charge.
- Move and send money as well as pay and get paid, almost instantly (between 2-3 seconds to/from 150 countries), cheaper (at a fraction of the cost) and more securely.
- Lend, borrow (with or without collateral and interest) and earn money to/from their phone contacts or on Reltime's global marketplace.
- Create joint accounts with family and friends.
- Swap digital assets with anyone in the world.
- Do more with money—anytime, anyplace and anywhere.
- And much more…
"Triskel and Reltime are a perfect match," says Peter Michel Heilmann, CEO, Reltime. "Both our companies are at the forefront of an exciting new Web3 and Metaverse movement and revolution. Building a relationship of trust, hand in hand, Triskel and Reltime are introducing game-changing products, services and solutions that we hope will win the hearts and trust of millions of people and businesses throughout Latin America. This truly is a unique moment in time to partner up with Triskel in this exciting, dynamic and growing continent."
"We are exhilarated to be strategically collaborating with Reltime," says Illiane Caballero, CEO and co-founder, Triskel Capital. "This newly-formed partnership aims at revolutionising the way we in Latin America conduct our financial transactions. Together, we are going to offer unique, game-changing and hard-needed Web3 financial solutions to anyone—people, merchants, entrepreneurs and companies— in Latin America wishing to take back control of their finances and enjoy complete financial freedom."
Reltime and Triskel are keen on working closely with other Latin American partners on the ground in order to penetrate the various markets more rapidly. Furthermore, Triskel will be offering Reltime's FastTrack to Web3 to companies such as a telecommunications firms, trusted brands, financial service providers and other B2B2C partners, enabling them to build their own integrated, white-labelled, state-of-the-art Web3 financial ecosystem within three weeks.
In addition, last week Reltime announced that it is developing and will soon be launching its Decentralised Exchange (DEX), cutting out any middlemen and providing businesses, traders and producers anywhere in the world with freedom and attractive benefits through peer-to-peer (P2P) trading, swapping, pooling, winning and farming of digital assets, commodities, precious metals and foreign exchange world-wide. The Reltime DEX could, for example, be used as a truly easy-to-use platform for Latin American cocoa producers to trade their quality beans directly with buyers on the other side of the planet, without the interference of any intermediaries.
The global technology company from Norway is also developing the world's first all-in-one Web3 and Metaverse payment, identity and cold storage biometric card.
About Reltime
Headquartered in Oslo, Reltime is building a global movement to change the way people and businesses financially interact and transact. Protecting their identity and assets in a completely new way, Reltime has built the first global Web3 financial ecosystem atop its Layer 1, Proof of Authority blockchain. The disruptive global Web3 and Metaverse financial technology company with full Nordic trust, honesty and transparency is changing the game in the New World. Reltime offers cutting-edge, white-labelled B2B2C, Metaverse and Web3 solutions to telecommunications, financial service providers and other trusted partners from around the globe. With wholly-owned subsidiaries in Norway, Lithuania and El Salvador, Reltime has a global license to hold digital assets on behalf of customers and third parties.
Reltime's goal is by 2025 for 100 million people and enterprises to be financially free and do more with money by sending, receiving, withdrawing, depositing, borrowing, lending, earning, swapping, staking, trading, interacting and transacting on the Metaverses and in the real world, and to become the leading, preferred and trusted financial Metaverse partner for both people and businesses.
A 24-page presentation can be downloaded at https://reltime.com/pitch and white paper 5.0 at https://reltime.com/whitepaper.
#MoreThanMoney
About Triskel Capital Ltd.
Triskel Capital is a multidisciplinary partnership incorporated in 2020 by a highly-experienced and diversified group of professionals, who share a passion for finance, technology and disruption. Based in St. Vincent and the Grenadines, the offshore company services its clients through a multinational network, combining operational efficiency and attractive returns.
In just two years' time, Triskel Group has managed to position Triskel Trading (a brokerage firm), Beat Markets (a technology company specialised in creating Expert Advisors for institutional, wealth and retail clients) and, finally, our new financial platform in the financial sector, Triskel Capital, hand in hand with Reltime.
Web site: https://www.triskel-trading.com.
For any media or investor enquiries, please contact:
Cornelia S. van der Laak, International Relations Officer
Reltime AS
Tel.: +4740769988
cornelia@reltime.com
Peter Michel Heilmann, CEO
Reltime AS
pm@reltime.com
Web site: https://www.reltime.com/
Twitter: https://twitter.com/reltime_rtc
Telegram: https://t.me/reltimedefiecosystem
Facebook: https://www.facebook.com/reltimeecosystem
LinkedIn: https://www.linkedin.com/company/reltimedefi
BitMart: https://www.bitmart.com/trade/en?symbol=RTC_USDT
CoinTiger: https://nomics.com/exchanges/cointiger/markets/rtc_usdt
For more information on Triskel Group, please contact:
Abel Benitez, CVO & Co-Founder
Triskel Group and Beat Markets
Tel.: +52 55 8018 7606
abel@triskel-trading.com
Illiane Caballero, CEO & Co-Founder
Triskele Capital Ltd.
Tel.: +52 951 234 6395
ceo@triskel-trading.com
Triskel: https://www.triskel-trading.com/
LinkedIn: https://www.linkedin.com/company/triskel-capital
info@triskel-trading.com
Beat Markets: https://beat-markets.com/
Tel.: +34 656 30 39 75
info@beat-markets.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://news.cision.com/reltime-as/i/reltime-s-headquarters-in-oslo,c3088758 Reltime's headquarters in Oslo
https://news.cision.com/reltime-as/i/reltime-s-logo,c3088760 Reltime's logo
https://news.cision.com/reltime-as/i/triskel-group-s-logo,c3088757 Triskel Group's logo
View original content:
SOURCE Reltime AS
|
https://www.whsv.com/prnewswire/2022/09/13/reltime-triskel-capital-forge-strategic-financial-web3-metaverse-partnership-latin-america/
| 2022-09-13T11:36:33Z
|
- Earnings Call Scheduled for 8:00 a.m. ET on September 21, 2022 –
BEIJING, Sept. 13, 2022 /PRNewswire/ -- RLX Technology Inc. ("RLX" or the "Company") (NYSE: RLX), a leading branded e-vapor company in China, today announced that it will report its unaudited financial results for second quarter ended June 30, 2022, before the U.S. markets open on Wednesday, September 21, 2022.
The Company's management will host an earnings conference call at 8:00 A.M. U.S. Eastern Time on September 21, 2022 (8:00 P.M. Beijing/Hong Kong Time on September 21, 2022).
Dial-in details for the earnings conference call are as follows:
Participants should dial-in 10 minutes before the scheduled start time and ask to be connected to the call for "RLX Technology Inc." with the Participant Code as set forth above.
Additionally, a live and archived webcast of the conference call will be available on the Company's investor relations website at https://ir.relxtech.com.
A replay of the conference call will be accessible approximately two hours after the conclusion of the call until September 28, 2022, by dialing the following telephone numbers:
About RLX Technology Inc.
RLX Technology Inc. (NYSE: RLX) is a leading branded e-vapor company in China. The Company leverages its strong in-house technology and product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products. RLX Technology Inc. sells its products through an integrated offline distribution and "branded store plus" retail model tailored to China's e-vapor market.
For more information, please visit https://ir.relxtech.com
Contacts
In China:
RLX Technology Inc.
Head of Investor Relations
Sam Tsang
Email: ir@relxtech.com
The Piacente Group, Inc.
Jenny Cai
Tel: +86-10-6508-0677
Email: RLX@tpg-ir.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
Email: RLX@tpg-ir.com
View original content:
SOURCE RLX Technology Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/rlx-technology-report-second-quarter-2022-financial-results-september-21-2022/
| 2022-09-13T11:36:39Z
|
ROBOROCK drives growth through innovation
BEIJING, Sept. 13, 2022 /PRNewswire/ -- According to data recently released by Euromonitor, worldwide retail sales of robot vacuums exceeded 15 million units in 2021, representing a compound annual growth rate in excess of 20% over the past five years. In particular, the Asia-Pacific region accounted for some 44.2% of the total, making it the world's largest robot vacuum market. High-end robot vacuums, generally priced at over US$500, deliver far superior performance in terms of intelligence and cleaning efficiency when compared with standard models. Last year, high-end models made up over 30 per cent of the total sales of robot vacuums. Several high-end brands, including Roborock and iRobot, together occupied over 80% of the global market. Most notably, Roborock ranked first among robot vacuum manufacturers worldwide in terms of sales of high-end models for the 12 months from July 2021 to June 2022.
According to Chinese market data released by AVC for the second quarter of 2022, Roborock's G10S series had ranked first among robot vacuums in terms of both online sales and market share in the smart cleaning sector for three consecutive months. Roborock's interim report for 2022 showed that the company's sales of robot vacuums jumped 24.49% YoY during the first half of the year. The impressive performance was attributable to the firm's sustainable growth resulting from its ongoing innovation in technology.
In the first half of 2022, Roborock's R&D expenses grew 13.74% YoY to 226 million yuan (approx. US$31.6 million), accounting for 7.74% of the company's revenue. In addition, the firm has acquired 753 patents, with R&D staff making up 54.08% of the total headcount. With a continued increase in R&D investment, Roborock rapidly enhanced its competence in technology.
In March 2022, Roborock rolled out the G10S/S7 MAXV high-end robot vacuums series with the upgraded algorithm system RR mason 9.0, enabling millimeter-wave obstacle avoidance through high-precision navigation and route planning. The series also features the industry's first VibraRise® sonic vibration technology that scrubs floors up to 3,000 times per minute as well as disruptive integration of Auto Mop Washing, Auto Antibacterial, Auto Tank Refilling, Auto Dust Collection and Auto-Empty Dock, in addition to optional water and drying components. With these technologies, the series has significantly enhanced cleaning efficiency, delivering an optimized hands-free floor cleaning experience.
In 2021, Roborock took the lead in increasing exposure and gaining acceptance of robot vacuums among the general public by providing customers with innovative premium products that use cutting-edge technologies to create a cleaner household environment while delivering a hands-free cleaning experience. By doing so, the leading robot vacuum company has contributed to the growth of the sector.
Given the ongoing pursuit of a high-quality household environment for thousands of years, especially in a fast-paced world, there is a growing trend whereby consumers prefer to use robots to do the housework so that they can spend more time on the things that matter or with the people they love. In September 2022, Roborock tied up with China's top online shopping platform Tmall.com, to launch the Super Brand Day campaign in a move to raise the awareness of its popular, high-tech products to a wider range of consumer groups, with the aim of enhancing the quality of day-to-day life and well-being of consumers worldwide.
View original content to download multimedia:
SOURCE Roborock
|
https://www.whsv.com/prnewswire/2022/09/13/roborock-ranks-first-among-robot-vacuum-makers-globally-terms-sales-high-end-models/
| 2022-09-13T11:36:46Z
|
College students will gain tangible credentials across business subjects and earn as they learn
PHILADELPHIA, Sept. 13, 2022 /PRNewswire/ -- Saxbys, a Certified B Corporation and National Education Company, is expanding its reach by debuting Experiential Learning Badges to augment The Saxbys Experiential Learning Platform (E.L.P.), providing all student cafe leadership the opportunity to broaden their education and skills through tangible, professional credentials.
The Saxbys E.L.P. partners with 14 leading higher education institutions to offer full academic credit and wages to a Student Cafe Executive Officer (Student C.E.O.) who has full autonomy of their on-campus cafe for six months. With the launch of the Badge program, Saxbys is quadrupling the reach of its E.L.P. curriculum, serving not only Student C.E.O.s, but all part-time student cafe leadership.
Learners can engage with a range of business disciplines that are not tied to any specific major, giving them the chance to explore different interests and bolster their resume experience.
The Experiential Learning Badges will debut with three curricula: Supply Chain Management, Talent Acquisition, and Training & Development. Each teaches broad disciplines before offering hands-on experience within Saxbys' student-run cafes.
This program blends the rigor of the academic approach and the application of corporate training with an important twist. The entire program is designed for students balancing college with work – not only are the Badges free, Saxbys is paying team members who participate, giving them the unique opportunity to 'earn as they learn.'
"We made the intentional decision to pay our learners as a signifier of just how much we value and believe in their education," said Dr. Liz Langemak, Director of Academic Platforms at Saxbys. "This investment from Saxbys lowers the barriers to achieving knowledge across subjects, propelling our team members into impactful careers."
Becoming badged and certified offers pathways to promotions and raises at Saxbys, and grants learners meaningful credentials that they can add to their resumes and LinkedIn profiles.
"We know that our higher education partners and students alike are hungry for skills that differentiate them and set them up for success as they launch their careers," said Nick Bayer, Founder & CEO of Saxbys. "Our Experiential Learning Badges will allow students to supplement their education – at no cost – serving as an investment in their future that will pay dividends."
View original content to download multimedia:
SOURCE Saxbys
|
https://www.whsv.com/prnewswire/2022/09/13/saxbys-announces-experiential-learning-badges-empower-education-exploration/
| 2022-09-13T11:36:53Z
|
Spectra7 HDMI IC Embedded in Car Entertainment Active Cable Harness
SAN JOSE, Calif., Sept. 13, 2022 /PRNewswire/ -- (TSXV: SEV) (OTCQB: SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leading provider of high-performance analog semiconductor products for data centers, 5G infrastructure, virtual and augmented reality, and other connectivity markets, and Elka International (ELKA), today announced that they are now in production with JVCKENWOOD, a Tier 1 Japan based automotive supplier with an in-vehicle entertainment system active cable harness that includes an embedded HDMI IC from Spectra7.
Spectra7's HDMI redriver IC allows Elka to create a long, thin, low power and light weight interconnect solution for connecting rear seat displays to the entertainment center in the vehicle. By using Spectra7's IC, the cable gauge (AWG) and conductor weight is reduced nearly 10x compared to a passive cable solution. The solution supports HDMI resolutions up to 1080p at 60Hz.
"Spectra7 has created an innovative and compelling solution to address the challenge of routing high speed video over thin conductors throughout a vehicle," said Roy Ting, President at Elka. "We are seeing significant business with JVCKENWOOD and are now promoting the solution to others in the automotive market."
"We are extremely proud to be working with ELKA to broaden access to our ACC solutions for the automotive market," said Spectra7 CMO John Mitchell. "Elka is a well-known manufacturer high quality cable assemblies for the international market."
Established in 1974, Elka International Ltd. is one of the world's leading cable manufacturers specializing in audio, video, communication and electronic cable assembly and wire harnesses for automotive, medical and industrial equipment. In this highly competitive industry, ELKA has made its name through strong engineering support, customer-oriented services, and high performance products.
For more information, please visit http://www.elka.com/
Spectra7 Microsystems Inc. is a high-performance analog semiconductor company delivering unprecedented bandwidth, speed and resolution to enable disruptive industrial design for leading electronics manufacturers in data centers, virtual and augmented reality, and other connectivity markets. Spectra7 is based in San Jose, California with a design center in Cork, Ireland and technical support location in Dongguan, China. For more information, please visit www.spectra7.com.
Neither the TSX Venture Exchange nor its regulation services provided (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's Management's Discussion and Analysis for the year ended December 31, 2021. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.
For more information, please contact:
Matt Kreps/Jim Fanucchi
Darrow Associates
214-597-8200
ir@spectra7.com
Spectra7 Microsystems Inc.
Bonnie Tomei
Chief Financial Officer
669-212-1089
ir@spectra7.com
Spectra7 Microsystems Inc.
John Mitchell
Public Relations
650-269-3043
pr@spectra7.com
View original content to download multimedia:
SOURCE Spectra7 Microsystems Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/spectra7-elka-achieve-production-status-with-jvckenwood-automotive-application/
| 2022-09-13T11:36:59Z
|
FORT LAUDERDALE, Fla., Sept. 13, 2022 /PRNewswire/ -- In recognition of National Suicide Prevention Month, Sunshine Health is highlighting the critical steps it's taking to address a person's whole health, including its recently launched predictive risk model, Choose Tomorrow, used to identify at-risk individuals and offer evidence-based suicide prevention interventions. Sunshine Health also partners with leading national and local organizations to support community events focused on mental wellbeing and equips members and the communities they live in with behavioral health resources.
"Through our innovative, evidence-based approaches to care, such as the Choose Tomorrow program, and active involvement with our behavioral health community partners, Sunshine Health is committed to helping people experiencing a behavioral health crisis year-round, because one life lost is too many," said Nathan Landsbaum, Sunshine Health CEO. "Mental health is a key component of physical health."
Sunshine Health has embarked on a critical mission to reduce the risk of suicide for at-risk young adults through Choose Tomorrow, a suicide prevention program. Through a collaborative effort between Sunshine Health and Zero Suicide, the Choose Tomorrow framework is an effort to reduce the number of deaths by suicide to zero.
Through an innovative, predictive risk model, Child Welfare Specialty Plan members who may be at risk are identified before a crisis occurs. Sunshine Health equips trained staff to offer evidence-based interventions – vetted by suicide prevention experts – with demonstrated clinical efficacy. As this initiative moves forward, Sunshine Health aims to expand the program to make a more meaningful impact on the lives of at-risk members.
Volunteer Florida's Healthy Minds Teen Summit
In April, Sunshine Health sponsored a two-day conference with teen leaders at Volunteer Florida's Healthy Minds Teen Summit, where 75 Florida middle and high school students gathered in Orlando to talk about normalizing mental health. Breaking the stigma was the number one topic among teen leaders, who learned about strategies and resources to take back to their peers to help deal with everything from the stresses of everyday life to dealing with severe trauma. At the summit, they also heard inspiring stories around mental health from Olympic gymnast Dominque Dawes, former college basketball star turned business owner Iman MacFarland and basketball superstar Magic Johnson.
Partnering with the National Alliance on Mental Illness
Sunshine Health partners with the National Alliance on Mental Illness (NAMI) local chapters throughout the state to bring mental health awareness and resources to local communities, including hosting groups in Sunshine Health Welcome Rooms to promote access to mental health resources and fostering connections between attendees. Sunshine Health is also a featured sponsor at the upcoming 2022 NAMI Florida Annual Conference on Sept. 15-17 in Orlando.
Florida Behavioral Health Association Conference
Sunshine Health is a long-time sponsor of the annual Florida Behavioral Health Association (FBHA) Conference, which brings together mental health and substance abuse providers from across the state to share best practices and discuss advancements and innovations in behavioral healthcare.
Behavioral Health Crisis Resources Available on SunshineHealth.com
Sunshine Health offers behavioral health resources on its website including What to Do in Mental Health Crisis and After a Behavioral Health Crisis, where members and the general public can access information on behavioral health resources and learn what is available to them across the state.
Support of the 988 Suicide Crisis Lifeline
Sunshine Health supports the nationwide effort to inform its members and the public about the National 988 Suicide & Crisis Lifeline that is available to anyone, anytime. This three-digit number will connect anyone experiencing behavioral health-related distress to the existing National Suicide Prevention Line for care and support. Sunshine Health spread awareness on the main landing page of SunshineHealth.com, through dedicated communications to members and providers, and sharing social media posts on the health plan's social media channels.
Headquartered in Broward County and with offices across the state, Sunshine Health is among the largest healthcare plans in Florida. Offering coordinated care and a network of support for our members, Sunshine Health is transforming the health of the community, one person at a time. Sunshine Health is a wholly owned subsidiary of Centene Corporation, a diversified, multi-national healthcare enterprise. It offers government-sponsored managed care through Medicaid, Long Term Care, the Health Insurance Marketplace (Ambetter), and Medicare Advantage and Prescription Drug Plans (Wellcare). Its specialty plans include the Child Welfare Specialty Plan serving children in or adopted from the state's Child Welfare system; the Serious Mental Illness Specialty Plan for people living with serious mental illness; and the Children's Medical Services Health Plan, operated by Sunshine Health on behalf of the Florida Department of Health for children and adolescents with special healthcare needs. For more information, visit SunshineHealth.com or follow us on Facebook and Twitter @SunHealthFL.
View original content:
SOURCE Sunshine Health
|
https://www.whsv.com/prnewswire/2022/09/13/sunshine-health-highlights-behavioral-health-initiatives-programs-during-national-suicide-prevention-month/
| 2022-09-13T11:37:06Z
|
Adds New Icon to Visual Identity Underscoring Private Blockchain Technology Platform Focused on Risk Reduction, Confidentiality & Operational Efficiencies
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Symbiont, Inc. a technology pioneer solving complex global finance problems using enterprise blockchain solutions, announced today a brand refresh to underscore its fintech leadership as one of the pioneers of enterprise blockchain. The company unveiled a new visual identity introducing an icon to its logo highlighting its proprietary technology platform, which focuses on risk reduction, confidentiality, and operational efficiencies.
The brand refresh comes at a time of evolution and maturity of blockchain technology within the financial services industry overall. For Symbiont specifically, the brand refresh marks a new growth phase following the official launch of its smart-collateral product with Vanguard and State Street in December of 2021 to bring post-trade workflow automation, along with the expansion of its leadership, and an upcoming new release of its sophisticated and private Assembly platform. Symbiont's Assembly platform continues its evolution, enhancing simplicity, flexibility, stability, and overall performance to maintain its innovation status as the leading private enterprise blockchain platform for financial institutions.
Mark Smith, Co-Founder and CEO of Symbiont commented, "When my Co-Founders and I created Symbiont the idea was to develop a technology company that would represent the 'symbiotic' relationship between new decentralized technology within traditional financial markets and emerging tech. Eight years later, I'm delighted that we have successfully created a distributed ledger blockchain and smart contract technology within our custom permissioned technology platform, built with the purpose of fixing traditional capital markets issues."
"Today's rollout of our new brand identity is a nod to our team and the Assembly platform we created using risk-averse, secure fintech solutions to solve complex problems for banks, asset-managers, and financial marketplaces. The Symbiont team of engineers and financial services experts have been developing solutions to solve market problems in the FX, data, post-trade, and fixed income markets, with a goal of building the common market infrastructure of the future. We are gaining traction and more than ever focused on accelerating our smart collateral product adoption to automate back-office and regulatory operations to minimize counterparty/credit risk" he added.
Silvia Davi, Chief Marketing & Communications Officer of Symbiont commented, "Symbiont was an early visionary within the fintech community and one of the first to use blockchain technology as a solution to replace antiquated systems and solve complex market problems. Our brand refresh emphasizes our roots while introducing a new block icon to our visual identity to underscore our focus on security, problem- solving, decentralization and connectivity. Our CEO, CTO, myself and many other Symbiont team members were a part of the electronification within financial services early on in our careers and today our mission is to introduce a new phase of market infrastructure technology solutions to reduce risk and costs in the back-office, post-trade operations."
Chuck Ocheret, Chief Technology Officer of Symbiont said, "Our brand refresh aligns with the next generation of Symbiont's Assembly platform. This is our most advanced release to date, continuing to raise the bar for innovation and technical excellence. The unique use of 'io' within the Symbiont name is meant to emphasize our computer science origins and the concept of inputs/outputs."
"We highlight the IO in the Symbiont logo in orange to represent creativity and the color gray to highlight our market sophistication. It's rewarding to be among the first fintech companies to use innovations that have defined our legacy and left an indelible mark in the industry. Symbiont has reinvented smart securities to create intelligent markets, as our corporate motto suggests, and we are excited about broadening our market adoption in the year ahead." Silvia added.
Symbiont is a leading technology company focused on solving complex global finance problems using a novel enterprise blockchain solution. An early pioneer of smart contracts and distributed ledger technologies, Symbiont's Assembly™ blockchain is the first enterprise platform developed to remove operational friction from the life cycle of financial instruments, while enabling real-time data sharing with optimal security and privacy. Founded in New York with a global footprint, Symbiont is composed of a team of capital markets experts and engineers located all over the world with the common goal of creating market efficiencies to power the next generation of financial market innovation.
To learn more about Symbiont, please visit symbiont.io or contact the team at info@symbiont.io. Follow us on LinkedIn and Twitter.
Press Contact:
press@symbiont.io
Tel: 646-637-5924
View original content to download multimedia:
SOURCE Symbiont
|
https://www.whsv.com/prnewswire/2022/09/13/symbiont-unveils-brand-refresh-underscore-technology-origins-amp-fintech-leadership-building-global-market-infrastructure-future/
| 2022-09-13T11:37:13Z
|
Borrowing Capacity Increased to $1.0 Billion from $800 Million; No Amount Currently Outstanding
SCOTTSDALE, Ariz., Sept. 13, 2022 /PRNewswire/ -- Taylor Morrison Home Corporation (NYSE: TMHC), a leading national land developer and homebuilder, today announced that it entered into an amended credit agreement to increase the aggregate commitment available under its revolving credit facility from $800 million to $1.0 billion. The incremental borrowing capacity provides additional liquidity and financial flexibility, and no borrowings were outstanding as of the closing date.
"The increase in our revolving credit facility to $1.0 billion further enhances our strong capital position, with which we are well equipped to maintain a disciplined and opportunistic capital allocation approach," said Lou Steffens, Executive Vice President and Chief Financial Officer.
Headquartered in Scottsdale, Arizona, Taylor Morrison is one of the nation's leading developers and homebuilders. We serve a wide array of consumers from coast to coast, including first-time, move-up, luxury, and 55-plus active lifestyle homebuyers under our family of brands—including Taylor Morrison, Esplanade, Darling Homes Collection by Taylor Morrison, and Christopher Todd Communities built by Taylor Morrison. From 2016-2022, Taylor Morrison has been recognized as America's Most Trusted® Builder by Lifestory Research. Our strong commitment to sustainability, our communities, and our team is highlighted in our latest Environmental, Social, and Governance (ESG) Report on our website.
For more information about Taylor Morrison, please visit www.taylormorrison.com.
This press release includes "forward-looking statements." These statements are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, prospects or opportunities, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or implied by, these statements. You can identify these statements by the fact that they do not relate to matters of a strictly factual or historical nature and generally discuss or relate to forecasts, estimates or other expectations regarding future events. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "may," "can," "could," "might," "will" and similar expressions identify forward-looking statements, including statements related to expected financial, operating and performance results, planned transactions, planned objectives of management, future developments or conditions in the industries in which we participate and other trends, developments and uncertainties that may affect our business in the future. Forward-looking statements speak only as of the date they are made. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. All of our forward-looking statements are expressly qualified in their entirety by the cautionary statements contained or referenced in our most recent Annual Report on Form 10-K, including those described under the heading "Risk Factors" in Part I, Item 1A.
CONTACT: Investor Relations
Taylor Morrison Home Corporation
(480) 734-2060
investor@taylormorrison.com
View original content to download multimedia:
SOURCE Taylor Morrison
|
https://www.whsv.com/prnewswire/2022/09/13/taylor-morrison-increases-capacity-available-its-revolving-credit-facility/
| 2022-09-13T11:37:19Z
|
Former Slack director joins Veriff's executive team to scale global commercial legal efforts
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Veriff, a global identity verification provider, today announced that Tony Gatterman is Veriff's new Head of Commercial Legal. Gatterman will support Veriff's sales and partnership organizations, enhance the company's contracting process for global customers, and help scale Veriff's procurement arm.
Gatterman brings more than a decade of legal experience to his new role at Veriff. He joins Veriff from Calm, where he held the role of senior director of commercial legal. Prior to Calm, Gatterman spent five years at Slack in increasingly senior roles. As the second attorney hired at Slack, and the first commercial attorney, he scaled the commercial legal team to support the growth of the business from $30M to more than $900M (2021). Gatterman also spent more than four years at Salesforce supporting the commercial negotiations for salesforce.com's early stage and emerging businesses.
"As Veriff continues to expand globally, we want to ensure every aspect of our business effectively scales with it and is equipped to support the business and customers' needs, especially our commercial legal capabilities," said Kaarel Kotkas, founder and CEO of Veriff. "Tony has an amazing track record of helping tech companies successfully navigate the increasingly complex compliance environment and scale their legal functions. He will play a critical role in helping us achieve our mission of re-establishing trust online, and we're honored to have him join our team."
Committed to helping businesses of all sizes quickly and accurately verify customer identities and fight fraud online, Veriff has grown to a 550-person company that serves a global client base. The identity verification market continues to develop at a rapid pace as more companies and consumers recognize the need to instill trust and security in their online interactions. Gatterman's appointment to head of commercial legal will support the company as it continues to scale to the position of unquestioned market leader in identity verification.
"Throughout my career, I have aimed to work at organizations that add value to society, and Veriff's mission of building trust in a digital world reflects that and resonates with my values," said Gatterman. "I'm joining the company at an exciting time. Veriff is in an advantageous position to address current and future identity verification market challenges. We are a nimble organization that listens to customers and monitors the regulatory landscape, all to ensure that it is constantly evaluating and improving service offerings and delivering the best version of our product to customers worldwide. I'm thrilled to have the unique opportunity to join the Veriff team."
Gatterman has his Juris Doctor and Master of Science degrees in Negotiation and Dispute Resolution from Creighton University, and his Bachelor's Degree from Kansas State University.
About Veriff
Veriff is an industry leader in online identity verification, helping businesses to build trust with their customers. Veriff's intelligent decision engine analyzes thousands of technological and behavioral variables in seconds, matching people to more than 10,200 government-issued IDs from over 190 countries. Founded in 2015, Veriff serves a global portfolio of organizations across financial services, crypto, gaming and mobility sectors. Veriff's latest $100 million C-round investment brings its total funding to $200 million and its valuation to $1.5 billion. The investors include Tiger Capital, Alkeon, IVP, Accel, Mosaic Ventures, Y Combinator, and others. With offices in the U.S., UK, Spain and Estonia, Veriff employs over 550 people from 60 different nationalities who are dedicated to helping businesses to build a more secure world. To learn more, visit www.veriff.com.
Photo - https://mma.prnewswire.com/media/1896538/HOC_Legal_Veriff.jpg
Logo - https://mma.prnewswire.com/media/1875368/Veriff_Logo.jpg
View original content to download multimedia:
SOURCE Veriff
|
https://www.whsv.com/prnewswire/2022/09/13/tony-gatterman-joins-veriff-head-commercial-legal/
| 2022-09-13T11:37:26Z
|
New private company will focus on accelerating 3D printing innovation and global adoption of desktop 3D printing solutions
NEW YORK and UTRECHT, Netherlands, Sept. 13, 2022 /PRNewswire/ -- MakerBot and Ultimaker, two leaders in desktop 3D printing, today announced the completion of their merger. Under the new brand, UltiMaker, the company aims to provide easy-to-use and accessible 3D printing hardware, software, and materials for any application, driving the industry to a future state of responsible and sustainable manufacturing.
Combining both companies' products platform under one roof, UltiMaker will continue to offer a wide range of solutions to customers, with well-established brands such as the MakerBot METHOD®, MakerBot SKETCH®, and MakerBot Replicator® 3D printers, and MakerBot CloudPrint™ as well as the Ultimaker 2+ Connect, Ultimaker S3, Ultimaker S5, and Ultimaker S5 Pro Bundle. In addition, the open communities, Ultimaker Cura and MakerBot Thingiverse® will continue to be managed by the new company.
The newly formed entity will invest capital to accelerate growth, drive new product innovation, further research and development, and strengthen its presence across the Americas, EMEA, and Asia-Pacific through market expansions. Nadav Goshen will spearhead the new company as its CEO, while former Ultimaker CEO Jürgen von Hollen has decided to leave the business after assisting with the integration and transition plans for the new company over the coming months.
"As we begin the next chapter together as UltiMaker, we will continue to focus on developing 3D printing innovations to advance the availability of accessible and easy-to-use 3D printing solutions," said Nadav Goshen, CEO of UltiMaker. "By combining our teams and technical expertise, we can work towards developing and delivering a comprehensive portfolio of products to support professional, educational, and light-industrial applications."
"With the completion of the merger behind us, we can now focus on integrating the two businesses further and begin creating significant value for customers with leading 3D printing solutions," said Jürgen von Hollen. "During the next few months, I look forward to helping the teams get started and take maximum advantage of the newly afforded opportunities."
The completion of the merger allows UltiMaker to work towards consolidating both organizations and product lines. Combining both companies' product portfolios will allow UltiMaker to offer a wide range of products for different applications to customers across the globe. Additionally, the new company plans to amplify R&D efforts to develop new products for education and professional customers, with new hardware and software innovations on the close horizon.
The new company will continue to operate in New York and The Netherlands.
About MakerBot
MakerBot was a global leader in desktop 3D printing that redefined the standards for 3D printing for safety and emissions, reliability, accessibility, precision, and ease-of-use.
MakerBot, MakerBot CloudPrint, MakerBot METHOD, MakerBot SKETCH, MakerBot Replicator, and Thingiverse are trademarks or registered trademarks of MakerBot Industries, LLC. All other trademarks are the property of their respective owners.
About Ultimaker
Ultimaker was on a mission to accelerate the world's transformation to flexible, empowering and sustainable solutions with a platform that enabled customers to leverage diverse 3D printing products and services. Ultimaker provided a seamless integration of hardware, software and materials -including an Ecosystem of partners- that simply worked.
Photo - https://mma.prnewswire.com/media/1896623/Ultimaker_and_MakerBot.jpg
View original content to download multimedia:
SOURCE Ultimaker; MakerBot
|
https://www.whsv.com/prnewswire/2022/09/13/ultimaker-makerbot-announce-closing-merger/
| 2022-09-13T11:37:32Z
|
NEWPORT BEACH, Calif., Sept. 13, 2022 /PRNewswire/ -- Ventris Medical, a privately held orthobiologics and tissue regeneration company, today announced that the United States Food and Drug Administration has granted 510(k) clearance for Synthetic Bone Graft Putty (Amplify®). Amplify® represents a new class of synthetic biomaterials designed for the optimization of cell proliferation and bone formation and is comprised of Amplify® biphasic (HA/βTCP) ceramic granules suspended in an alkylene oxide polymer carrier. The device can be used either standalone or in combination with autograft bone (1:1 ratio) as a bone graft extender.
To enhance remodeling potential, the Amplify® granules undergo a patented surface activation process that creates an encompassing network of polygonal microfilaments that extend from the granule surface. This advanced surface texture acts as a bio-instructive vector that can entrap critical healing elements and guide cellular processes. Activation of the granule surface network increases the surface area, porosity, and dissolution rate of the granules, which creates more bioavailable surface interactions for cellular attachment, proliferation, and remodeling.
The mineral component in Amplify® comprises a hybrid mixture of surface-activated biphasic granules composed of two distinct HA-to-βTCP blends that resorb at different rates. These surface-activated granules are derived from conventional HA/BTCP granules with ratios of 20/80 (faster resorbing) and 60/40 (moderate resorption), resulting in a bimodal dissolution profile that nourishes the fusion site in the early stages of healing and supports progressive bone remodeling throughout the fusion process.
The proprietary polymer blend in Amplify® provides a cohesive, moldable matrix between the granules that facilitates accurate graft placement and containment at the defect site and can readily be mixed with autograft bone. After implantation, this highly biocompatible polymer resorbs into the surrounding tissues, allowing immediate access to the activated biphasic granules and their healing effects.
Russell Cook, CEO of Ventris Medical commented, "We are very pleased to receive FDA clearance for Amplify® Synthetic Bone Graft Putty. This technology combines 2 heavily studied biphasic mineral components which are surface activated through our patented process and suspended in our proprietary polymer carrier. In a market crowded with a plethora of commodity offerings, our company mission is to develop next generational devices that bring excitement to the surgeon community as well as our distribution partners."
John Brunelle, PhD, COO of Ventris Medical added: The Amplify technology platform is intended to address critical gaps in current treatment algorithms while bringing greater efficiency to the surgeon experience. Our surface-activated granules combine the established clinical efficacy of traditional biphasic materials with state-of-the-art processing techniques, providing a bone graft that is more synchronized with the natural healing process. This milestone sets the stage for future product developments and establishes Ventris as a key innovator in the orthobiologics space."
Ventris Medical is a leading medical device company focused on developing innovative proprietary platforms for tissue regeneration and bioresorbable bone graft products for a broad range of spinal and orthopedic fusion procedures. For additional information on Ventris Medical, please visit our website at www.ventrismedical.com
View original content:
SOURCE Ventris Medical
|
https://www.whsv.com/prnewswire/2022/09/13/ventris-medical-receives-510k-clearance-amplify-standalone-bone-graft-putty-bone-graft-extender/
| 2022-09-13T11:37:38Z
|
ST. LOUIS, Sept. 13, 2022 /PRNewswire/ -- Verde Resources Inc. (OTCQB: VRDR) Verde Resources, Inc (Verde) has appointed Jack Wong as its new President and CEO (left in pic), effective Oct 1st 2022.
"Jack's appointment serves as a 'catalyst' to realize our aspirations of 'Going Green and Beyond', and the board of directors believes he has what it takes – the energy, passion and leadership, to lead Verde to greater heights," said outgoing President Balakrishnan Muthu (right in pic), who has decided to step down.
Wong, 39, who was born and raised in Borneo before graduating with a bachelor's degree in Business Administration from Wichita State University, will oversee all of Verde's subsidiaries and operations in the United States and Asia Pacific. He said he was 'honored and humbled' to be assuming his new position and pledged for the continued pursuit of excellence in Verde's core businesses and delivering value for shareholders.
"Under the leadership of President Balakrishnan, Verde has over the past year made great strides in transitioning itself from mining to a global renewable energy player," said Wong, adding that Verde is now "in the next phase of accelerating the integration of SDGs (Sustainable Development Goals) into its core business management, and delivering positive impact in the ESG realm by generating and supplying verified Carbon Removal Credits."
Earlier this year, Verde acquired a 24.3-acre facility in Missouri via a lease-to-purchase agreement to establish a flagship Biofraction Pyrolysis facility, which would develop products and programs meant for decarbonization and regenerative agriculture.
Prior to this development, Wong has been serving as the CEO of The Wision Project, a subsidiary which was acquired by Verde in March 2022. His division has been instrumental in Verde's transition to the Carbon and CBD realm.
Wong also previously worked with Fun Characters International Pte.Ltd. (FCI), which was then the master licensee for Disney Consumer Products, Inc. in the ASEAN countries of Singapore, Malaysia, Indonesia, and Thailand. The company he represented then was granted third party rights to reproduce and use certain Disney characters, Disney materials, and Disney trademarks in connection with manufacturing, distribution, and sale of Disney consumer products in the region.
He then went on to build and run a seaside dive resort – Scuba Tiger, which is located 45 minutes away from one of the world's best dive spots – Sipadan island, in Sabah, Borneo, where he hosted scuba divers from all over the world, until the pandemic hit.
"While scuba diving with my guests over the years, I have seen up close and personal the devastating impacts of global warming have done to our marine and coastal ecosystems, and I felt partly responsible and helpless at the same time, as it takes beyond one individual, one company, or even one nation, to tackle it," said Wong. "Little did I know what I was doing in the past was a precursor to something greater, because if we can get our soils right, we can fix a lot of issues."
Healthy soils lead to healthy crops, which lead to healthy animals, healthy food, healthy water, healthy humans, and a fine healthy climate. The additional benefits when soils are improved include revenue through Carbon Removal Credits, reversing the catastrophic effects of global warming, while supporting food security and the secular economy.
Verde understands the importance of converting bio-waste into regenerative solutions as part of a progressive approach towards achieving Net Zero by 2050.
"I'm very determined to lead Verde and galvanize more stakeholders worldwide to turbocharge that initiative and help turn that vision into reality," added Wong.
For more information, visit www.verderesources.com
View original content to download multimedia:
SOURCE Verde Resources Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/verde-resources-appoint-jack-wong-new-president-ceo/
| 2022-09-13T11:37:45Z
|
CHANDLER, Ariz., Sept. 13, 2022 /PRNewswire/ -- (NASDAQ: VIAV) Viavi Solutions Inc. ("VIAVI") announced today that its Board of Directors has authorized a stock repurchase program of up to $300 million of VIAVI's common stock effective October 1, 2022 and will remain in effect until the amount authorized has been fully repurchased or until VIAVI suspends or terminates the program. This new program replaces the $200 million stock repurchase program that the Board previously authorized in September 2019 and which expires September 30, 2022. Under the new share repurchase program, the Company is authorized to repurchase shares through a variety of methods, including open market purchases, privately-negotiated transactions or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans. The timing of repurchases under the new program will depend upon business and financial market conditions.
Business Outlook
For the first quarter of fiscal 2023 ending October 01, 2022, VIAVI is reconfirming its guidance revenue of $317 million to $331 million, non-GAAP operating margin between 20.7%-22.1%, and non-GAAP earnings per share to be in the range of $0.22 to $0.24.
Analyst Day/Webcast
VIAVI is hosting its Analyst Day event today at 9:00am EDT (6:00am PDT) in Boston, Massachusetts. The Analyst Day presentation will be made available on VIAVI's website after the event and the live webcast and its archived replay can be viewed at www.viavisolutions.com/investors. This press release and the Analyst Day presentation are also being furnished in a Current Report on Form 8-K with the Securities and Exchange Commission, and will be available at www.sec.gov.
About VIAVI Solutions
VIAVI (NASDAQ: VIAV) is a global provider of network test, monitoring and assurance solutions for communications service providers, enterprises, network equipment manufacturers, original equipment manufacturers, government and avionics. We help these customers harness the power of instruments, automation, intelligence and virtualization. VIAVI is also a leader in light management solutions for the anti-counterfeiting, consumer electronics, industrial, government and automotive markets. Learn more about VIAVI at www.viavisolutions.com. Follow us on VIAVI Perspectives, LinkedIn, Twitter, YouTube and Facebook.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements including statements about the amount and timing of repurchases under the Company's share purchase program and the methods to execute such repurchases are based on management's current opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or results, including, but not limited to, VIAVI's ESG-related commitments, strategies, and initiatives; business plans and strategy; technology, products, and services; opportunities for growth; and stakeholder engagement efforts. These forward-looking statements involve risks and uncertainties that could cause actual results, levels of activity, performance, achievements, and events to differ materially from those stated, anticipated, or implied by such forward-looking statements. For more information on the risks and uncertainties associated with VIAVI please refer to the "Risk Factors" sections of VIAVI's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. The forward-looking statements contained in this press release are made as of the date thereof and VIAVI assumes no obligation to update such statements.
Contact Information
Investors:
Sagar Hebbar
408-404-4507
sagar.hebbar@viavisolutions.com
Press:
Amit Malhotra
202-341-8624
amit.malhotra@viavisolutions.com
View original content to download multimedia:
SOURCE VIAVI Financials
|
https://www.whsv.com/prnewswire/2022/09/13/viavi-announces-300-million-common-stock-repurchase-program-reconfirms-business-outlook-announces-analyst-day-webcast/
| 2022-09-13T11:37:52Z
|
Cumulative Donation Exceeds $1.8 Million to Support Breast Cancer Research
MORRIS PLAINS, N.J., Sept. 13, 2022 /PRNewswire/ -- The Weichert Family of Companies successfully raised $150,000 during its 22nd Annual Charity Outing to benefit the American Cancer Society (ACS) and breast cancer research. Proceeds from the event bring the grand total that Weichert has raised for the ACS and breast cancer research to a remarkable $1.887 million since the annual fundraiser began in 2001.
"We were thrilled to return to top form this year, with participation and generous monetary support from our Weichert friends, family, colleagues and sponsors," said charity committee chairperson Joe McDonald, a regional vice president of Weichert, Realtors. "Thanks go out to all our residential sales offices across multiple states who contributed with their own community-based events, as well as all the many volunteers, sponsors and individuals who donated their time, effort and funds to make this year's Charity Outing an incredible success."
Held at the picturesque Fiddler's Elbow Country Club in Bedminster, NJ, this year's outing hosted more than 250 golfers, as well as dozens of attendees who enjoyed a Member for the Day, paint-and-sip, or golf clinic packages. All participants enjoyed a buffet luncheon and three-hour cocktail reception with raffle drawings, which included a grand prize of a 70" LCD TV and dozens of silent auction items.
A powerful highlight of the Charity Outing was special guest speaker and breast cancer survivor Sylvia Ferraro, a sales associate with Weichert, Realtors' Toms River, NJ, office. Ferraro shared her personal story at the event with her husband, Robert, and daughters Ashley, Amanda and Olivia by her side. "Hearing Sylvia's inspiring story was a reminder that so many of us know someone who has been directly or indirectly impacted by breast cancer," McDonald said.
According to McDonald, the Annual Charity Outing is the embodiment of the Weichert culture, which has always been one of giving back to the community. "It's always humbling to see the extent to which the extended Weichert Community supports our charity efforts," McDonald said.
Numerous Weichert sales offices across the Northeast held supporting events throughout the summer, while 86 organizations supported the fundraiser through various forms of sponsorship.
Top sponsors included Cumberland Mutual Insurance Co.; Customers Bank; DefinedLogic; Joyce Van Lines; National General, an Allstate Company; Radian; Reindeer Logistics, LLC; Risk Strategies Corp./UNIRISC & EMS; Safeco Insurance; and Travelers. Other sponsors included Ace Relocation Systems Inc.; Arch Mortgage Insurance; Armstrong Moving Ltd.; ATSG; Centric Benefits Consulting; Chubb; Collins Brothers Moving Corp.; Essent Guaranty; Executive Class, a Division of the Beltmann Relocation Group; Fidelity National Title; Foremost Insurance; Hanover Insurance Group; Henricksen; ICC; Mackie Moving Systems/Kings Transfer; Mesirow Financial Inc.; Morgan Engineering, LLC; Morstan General Agency; Mullen & Reynolds, LLC; Optimal Blue; Peckar & Abramson, P.C.; Plymouth Rock Assurance; Prism Digital Communications; Progressive Insurance; Ribbon Home; South Street Securities; Tanium; Universal Property & Casualty Insurance Co.; and Wells Fargo Funding.
Those who would still like to help support breast cancer research may send donations payable to the American Cancer Society to Weichert, Realtors, 1625 Route 10 East, Morris Plains, NJ 07950, Attn: Laura Metro ‒ Weichert Charity Outing. Donations can also be made through Weichert's Charity Outing page.
The 23rd Annual Charity Outing will be held August 17, 2023.
For more information about Weichert, Realtors or to find your local office, visit www.weichert.com.
Since 1969, Weichert, Realtors has grown from a single office into one of the nation's leading providers of homeownership services by putting its customers first. A family of 18 full-service real estate-related companies, Weichert provides an integrated real estate, mortgage, insurance and title settlement solution — branded as All Under One Roof ℠— to simplify the home purchase experience for buyers and sellers, in most markets. Weichert leverages its customer website, www.weichert.com, one of the most visited real estate websites in the nation, to help families and individuals realize the dream of homeownership through quick and easy access to listing information and the services of its real estate professionals nationwide. Like other family-owned and -operated businesses, Weichert enjoys greater public trust according to several national surveys. For more information, Weichert's customer service center can be reached at 1-800-USA-SOLD.
View original content to download multimedia:
SOURCE Weichert Co.
|
https://www.whsv.com/prnewswire/2022/09/13/weicherts-22nd-annual-charity-outing-raises-150000-american-cancer-society/
| 2022-09-13T11:37:58Z
|
RALEIGH, N.C., Sept. 13, 2022 /PRNewswire/ -- In recognition of Employee Appreciation Week (August 22 – August 26), WellCare of North Carolina employees took time to celebrate by volunteering with local community-based organizations including Beds for Kids, Note in the Pocket, Habitat for Humanity, the Food Bank of Central and Eastern North Carolina and Second Harvest Food Bank.
"Service is at the heart of our culture," said Troy Hildreth, WellCare of North Carolina's Plan President and CEO. "At WellCare, we aim to deliver excellent care and service, and we welcome opportunities to partner with organizations who share in and support our mission. We were honored to give back to these organizations and to our community through a day devoted entirely to community service."
Among the highlights from WellCare's Employee Appreciation Week:
- Food Bank of Durham – WellCare volunteers sorted 2,000 pounds of drinks which will be distributed to people in need in the Durham area.
- Habitat for Humanity – In total, WellCare volunteers worked a total of 60 hours to help construct homes for families in need.
- Note in the Pocket – Volunteers sorted 1,300 pounds of clothing for children in need, which will be disseminated through their social workers.
- Habitat for Humanity ReStore – Volunteers helped stock the store floor and organize departments, which makes it easier for shoppers to see in-demand items. This helps in raising more funds for Habitat for Humanity's mission of building affordable homes in the community.
Pictures from these events will be posted on WellCare of North Carolina's Facebook page, https://www.facebook.com/WellCareNC.
Headquartered in Raleigh, WellCare of North Carolina provides government-sponsored managed care services to families, children, seniors, and individuals with complex needs primarily through Medicaid as one of the state's Medicaid Prepaid Health Plans (WellCare of North Carolina), Marketplace (WellCare of North Carolina by Celtic Insurance Company), Medicare Advantage (Wellcare), and Medicare Prescription Drug Plans (Wellcare). WellCare of North Carolina is a wholly owned subsidiary of Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. For more information, visit www.wellcarenc.com.
View original content:
SOURCE WellCare of North Carolina
|
https://www.whsv.com/prnewswire/2022/09/13/wellcare-gives-back-local-communities-during-annual-employee-appreciation-week/
| 2022-09-13T11:38:05Z
|
The Irish Whiskey's Newest Campaign in More Than a Decade Will Make its U.S. Debut and Features Irish Actor & Comedian Aisling Bea
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Today Jameson introduced its biggest U.S. campaign in more than a decade, titled Widen the Circle. As a brand that believes in a world where there are no strangers, only friends you have yet to meet, the new campaign is an open invitation to seek out and embrace those spontaneous, serendipitous moments that spark new connections and cherished memories.
"Jameson has always understood the power of togetherness, especially those that are seemingly random or unexpected," said Pam Forbus, SVP, Chief Marketing Officer, Pernod Ricard North America. "Widen the Circle is a celebration of those powerful encounters that authentically bring new friends together and ultimately make the world feel like a smaller place."
Widen the Circle builds upon the world's number one Irish Whiskey's 240-year legacy of craftmanship, collaboration and celebration of life's everyday moments, both big and small. Anchoring the campaign is a :30 second TV spot starring Irish comedian, actor and writer Aisling Bea – the creator and star of BAFTA award-winning show 'This Way Up' and star of Netflix's 'Living with Yourself' – whose witty tone raises a toast to those who embrace authentic, unexpected and often cheeky moments when people find their kindred spirits.
"As a comedian and performer, I always look to connect with my audience. It's those small moments when you recognize a kindred spirit in the crowd that make for the most memorable sets," said Aisling. "And when that unspoken bond happens over a Jameson Whiskey? Well, there's nothing better in my opinion."
Created by TBWA\Dublin, "Widen the Circle" is a 360-degree campaign, running on TV, online video, social and e-commerce. Jameson believes that life is better shared with friends, family and a glass of Jameson Irish Whiskey. To learn more about the new campaign, please visit JamesonWhiskey.com/Widen-the-Circle and check out the new TVC on YouTube.
About Jameson ® Irish Whiskey
Jameson is the world's most awarded* and bestselling Irish whiskey, ranked in the top 4 global whiskey brands and number 9 in spirits. Leading the Irish Whiskey category with a 67% market share and having experienced 30 years of consecutive growth up until 2019, Jameson reached unprecedented sales of 10 million cases in March 2022.
The Jameson portfolio is led by its core expression of Jameson Original, with dynamic growth being experienced with its Super Premium offering, Jameson Black Barrel. The range also includes ultra-premium offerings such as Jameson 18 Years, as well as some recently added flavored whiskeys, Jameson Orange and Jameson Cold Brew.
Triple distilled and twice as smooth, every bottle of Jameson is distilled and matured at the world renowned Midleton Distillery in County Cork, Ireland.
Follow @Jameson_US and visit JamesonWhiskey.com for the latest from Jameson.
* Based on the tasting results of the six most influential tasting competitions over the past 10 years (2011-2021), including The Irish Whiskey Masters, IWSC, ISC, Beverage Testing Institute, San Francisco World Spirits Competition and Ultimate Spirits Challenge.
TASTE RESPONSIBLY. JAMESON ® Irish Whiskey. 40% Alc./Vol. (80 Proof). Product of Ireland. ©2020 Imported by John Jameson Import Company, New York, NY
About Pernod Ricard USA ®
Pernod Ricard USA is the premium spirits and wine company in the U.S., and the largest subsidiary of Paris, France-based Pernod Ricard SA., the world's second-largest spirits and wine company. Pernod Ricard employs approximately 19,000 people worldwide, is listed on Euronext (Ticker: RI) and is part of the CAC 40 index. The company's leading spirits include such prestigious brands as Absolut ® Vodka, Avión ® Tequila, Chivas Regal ® Scotch Whisky, The Glenlivet ® Single Malt Scotch Whisky, Jameson ® Irish Whiskey, Kahlúa ® Liqueur, Malibu ®, Martell ® Cognac, Olmeca Altos ® Tequila , Beefeater ® Gin, Del Maguey ® Single Village Mezcal, Monkey 47 ® Gin, Plymouth ® Gin, Seagram's ® Extra Dry Gin, Malfy ® Gin, Hiram Walker ® Liqueurs, Midleton ® Irish Whiskey, Powers ® Irish Whiskey, Redbreast ® Irish Whiskey, Aberlour ® Single Malt Scotch Whisky; Lillet ®; Smithworks ® Vodka, Jefferson's ® Bourbon, Smooth Ambler ® Whiskey, Rabbit Hole ® Whiskey, Pernod ® and Ricard ®; such superior wines as Jacob's Creek ®, Kenwood ® Vineyards, Campo Viejo ® and Brancott Estate ®; and such exquisite champagnes and sparkling wines as Perrier-Jouët ® Champagne, G.H. Mumm™ Champagne and Mumm Napa ® sparkling wines.
Pernod Ricard USA is headquartered in New York, New York, and has more than 700 employees across the country. As "creators of conviviality," we are committed to sustainable and responsible business practices in service of our customers, consumers, employees and the planet. Pernod Ricard USA urges all adults to consume its products responsibly and has an active program to promote responsible drinking. For more information on this, please visit: www.responsibility.org.
Media contact:
Blaine Rueber, blaine.rueber@pernod-ricard.com
Gabby Deitsch, gdeitsch@webershandwick.com
View original content to download multimedia:
SOURCE Pernod Ricard USA
|
https://www.whsv.com/prnewswire/2022/09/13/widen-circle-with-jameson-irish-whiskey-jamesons-new-campaign-celebrates-spark-friendship-that-brings-people-together/
| 2022-09-13T11:38:11Z
|
DUBAI, UAE, Sept. 13, 2022 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the leading voice-centric social networking and entertainment platform in the Middle East and North Africa (MENA), today announced that Mr. Saifi Ismail, Yalla Group's President, has been named one of the region's most inspiring business leaders of 2022 by the prestigious magazine Arabian Business. This accolade acknowledges Mr. Ismail's achievements as a visionary leader who has leveraged his influence, experience and expertise to drive digital transformation in the MENA region.
"It is an immense honor to be recognized by this esteemed publication alongside such outstanding leaders," said Mr. Ismail. "I would like to sincerely thank Arabian Business for their commendation on behalf of the entire Yalla team. As the leading voice-centric social networking and entertainment platform in the MENA region, we are proud of our commitment to launching products tailored to local user preferences, expanding partnerships with local channels, and working with local communities to help grow the digital economy and the Internet industry over the past six years. With our group's vision in mind, we will remain dedicated to serving MENA users' increasing online demands and assisting our stakeholders as they steer the region toward a brighter future."
Arabian Business is the Middle East region's premier resource for informed news, features, and commentary. Its extensive output includes interviews with some of the world's leading business people, long-form features from around the Middle East and respected commentary on the issues of the day. Annual awards ceremonies and its high-profile Power Lists add to the brand's prestige, forward-thinking approach and reputation for integrity, helping Arabian Business sustain a loyal following across all its platforms.
About Yalla Group Limited
Yalla Group Limited is the largest voice-centric social networking and entertainment platform in the Middle East and Northern Africa (MENA). The Company operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games, popular in MENA, with in-game voice chat and localized Majlis functionality. Building on the success of Yalla and Yalla Ludo, the Company has expanded its content, creating a regionally-focused, integrated ecosystem dedicated to fulfilling MENA users' evolving online social networking and entertainment needs. The ecosystem includes YallaChat, an IM product tailored for Arabic users; Waha, a social networking product designed for the metaverse; and games such as Yalla Baloot and 101 Okey Yalla, developed to sustain vibrant local gaming communities in the region. Yalla is also actively exploring outside of MENA, having launched Yalla Parchis, a Ludo game designed for the South American markets. Yalla's mobile applications deliver a seamless experience that fosters a sense of loyalty and belonging, establishing highly devoted and engaged user communities through close attention to detail and localized appeal that profoundly resonates with its users. In addition, through its holding subsidiary, Yalla Game Limited, the Company has expanded its capabilities in mid-core and hard-core game distribution in the MENA region, leveraging its local expertise to bring exciting new content to its users.
For more information, please visit: https://ir.yallagroup.com.
For investor and media inquiries, please contact:
Yalla Group Limited
Investor Relations
Kerry Gao – IR Director
Tel: +86-571-8980-7962
Email: ir@yallatech.ae
The Piacente Group, Inc.
Yang Song
Tel: +86-10-6508-0677
Email: yalla@tpg-ir.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
Email: yalla@tpg-ir.com
View original content:
SOURCE Yalla Group Limited
|
https://www.whsv.com/prnewswire/2022/09/13/yalla-president-named-2022-most-inspiring-business-leader/
| 2022-09-13T11:38:18Z
|
Trial begins for woman accused of killing expectant mother, cutting unborn baby out of her
NEW BOSTON, Texas (KSLA/Gray News) - The trial is underway in the capital murder trial of a Texas woman accused of killing a pregnant woman and the fetus she allegedly cut out of the woman’s womb, KSLA reports.
Taylor Parker, 29, faces the death penalty if convicted of the October 2020 death of Reagan Hancock, 21, and the kidnapping of the unborn baby, Braxlynn, who was later pronounced dead at an Oklahoma hospital.
On Monday, Parker entered the courtroom to face a jury on the charges.
The day started with Parker pleading not guilty.
In opening statements, attorneys with the prosecution said Parker committed the crimes not because she wanted a baby but because she did not want to lose her boyfriend.
The attorneys also said Hancock was stabbed and cut around 100 times, with a scalpel being used to remove the fetus.
Witnesses said Parker was unable to carry a child after having a hysterectomy. According to witnesses, Parker offered them $100,000 to be surrogates.
The prosecution said Parker ordered from the internet a suit that made her look pregnant, faking pregnancy for nearly 10 months, all while hunting for a victim.
Defense attorneys said this is a complicated case, both factually and emotionally, and asked the jury to be fair.
Officials say it could take a couple of weeks to try this case.
Copyright 2022 Gray Media Group, Inc. All rights reserved.
|
https://www.whsv.com/2022/09/13/trial-begins-woman-accused-killing-expectant-mother-cutting-unborn-baby-out-her/
| 2022-09-13T12:17:51Z
|
Ukraine piles pressure on retreating Russian troops
KHARKIV, Ukraine (AP) — Ukrainian troops piled pressure on retreating Russian forces on Tuesday, pressing a counteroffensive that has produced major gains and a stunning blow to Moscow’s military prestige.
It was not yet clear if the Ukrainian blitz in the northeast after months of little discernible movement could signal a turning point in the nearly seven-month war. But the country’s officials were buoyant, releasing footage showing their forces burning Russian flags and inspecting abandoned charred tanks. In one video, border guards tore down a poster that read, “We are one people with Russia.”
Momentum has switched back and forth before, and Ukraine’s American allies, for one, were careful not to declare a premature victory since Russian President Vladimir Putin still has troops and resources to tap.
Still, the Kremlin struggled to respond to the defeat, its largest since its forces abandoned a botched attempt to capture Kyiv early in the war.
Late Monday, President Volodymyr Zelenskyy said his troops have retaken more than 6,000 square kilometers (2,300 square miles) — an area more than twice the size of Luxembourg — in a matter of weeks.
“The movement of our troops continues,” he said.
In the latest claim, Ukraine’s border guard services said the army took control of Vovchansk — a town just 3 kilometers (2 miles) from Russia seized on the first day of the war.
While every individual claim of military success could not be verified, Russia acknowledged that it has withdrawn troops from areas in the northeastern region of Kharkiv in recent days.
Reports of chaos abounded as Russian troops pulled out — as well as claims that they were surrendering en masse. Ukraine officials have said they have captured so many soldiers that they are struggling to house them. The claim could not be immediately verified.
Ukrainian Deputy Minister of Defense Hanna Maliar said Kyiv is trying to persuade even more Russian soldiers to give up, launching shells filled with flyers ahead of their advance.
“Russians use you as cannon fodder. Your life doesn’t mean anything for them. You don’t need this war. Surrender to Armed Forces of Ukraine,” the flyers read.
In one indication of the blow sustained by Moscow, British intelligence said that one premier force, the 1st Guards Tank Army, had been “severely degraded” during the invasion and that “Russia’s conventional force designed to counter NATO is severely weakened. It will likely take years for Russia to rebuild this capability.”
The retreat didn’t stop Russia from pounding Ukrainian positions, however. Early Tuesday, it shelled the city of Lozova in the Kharkiv region, killing three people and injuring nine, said regional governor Oleh Syniehubov.
And Ukrainian officials said Russia kept up shelling around Europe’s largest nuclear facility, where fighting has raised fears of a nuclear disaster. The Nikopol area, which is across the Dnieper River from the Zaporizhzhia nuclear power plant, was shelled six times during the night but no injuries were immediately reported, said regional governor Valentyn Reznichenko.
Strikes have also continued unabated on the city of Kharkiv, Ukraine’s second-largest and one that has been hammered by artillery for months.
Zelenskyy specifically criticized Russia for targeting energy infrastructure in its attacks over the past days. “Hundreds and thousands of Ukrainians found themselves in the dark — without electricity. Houses, hospitals, schools, communal infrastructure … sites that have absolutely nothing to do with the infrastructure of the armed forces of our country.”
He said it could only point to one thing. “This is a sign of the desperation of those who contrived this war. This is how they react to the defeat of Russian forces in the Kharkiv region. They can’t do anything to our heroes on the battlefield.”
The counteroffensive has provoked rare public criticism of Putin’s war. Meanwhile, some of its defenders in Russia played down the idea that the success belonged to Ukraine, blaming instead Western weapons and fighters for the losses.
“It’s not Ukraine that attacked Izium, but NATO,” read a headline in the state-supported Komsomolskaya Pravda newspaper, referring to one of the areas where Russia said it has withdrawn troops.
Elsewhere, residents of a Russian village just across the border from Ukraine were evacuated after shelling by Ukrainian troops killed one person, according to Russia’s Tass news agency.
The report cited the head of the local administration in Logachevka, who said Ukrainian troops opened fire at a border checkpoint.
___
Arhirova reported from Kyiv.
___
Follow AP war coverage at https://apnews.com/hub/russia-ukraine
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.whsv.com/2022/09/13/ukraine-piles-pressure-retreating-russian-troops/
| 2022-09-13T12:17:57Z
|
Officials at a Texas border crossing found the cheese hidden under a blanket in the backseat of a woman's car. She had declared 10 wheels of cheese, but agents found 50 more.
Copyright 2022 NPR
Officials at a Texas border crossing found the cheese hidden under a blanket in the backseat of a woman's car. She had declared 10 wheels of cheese, but agents found 50 more.
Copyright 2022 NPR
|
https://www.wyomingpublicmedia.org/2022-09-13/contraband-cheese-will-cost-a-woman-trying-to-enter-the-u-s-from-mexico-1-000
| 2022-09-13T12:40:23Z
|
Ukraine reclaims more territory as its counteroffensive gains momentum. The Justice Department issues new subpoenas in the Jan. 6 investigation. Thousands of nurses strike at 15 Minnesota hospitals.
Copyright 2022 NPR
Ukraine reclaims more territory as its counteroffensive gains momentum. The Justice Department issues new subpoenas in the Jan. 6 investigation. Thousands of nurses strike at 15 Minnesota hospitals.
Copyright 2022 NPR
|
https://www.wyomingpublicmedia.org/2022-09-13/news-brief-ukraines-war-tactic-doj-subpoenas-trump-aides-minn-nurses-strike
| 2022-09-13T12:40:29Z
|
President Biden laid out his plan for a national fight against cancer, setting a goal of cutting the death rate in half over the next quarter century.
Copyright 2022 NPR
President Biden laid out his plan for a national fight against cancer, setting a goal of cutting the death rate in half over the next quarter century.
Copyright 2022 NPR
|
https://www.wyomingpublicmedia.org/2022-09-13/on-the-anniversary-of-jfks-man-on-the-moon-speech-biden-touts-cancer-moonshot
| 2022-09-13T12:40:36Z
|
Behind Ukraine's dramatic battlefield push and Russia's rapid retreat is a surprise tactic. With public attention focused on movements in Ukraine's south, Ukrainian forces struck in the east.
Copyright 2022 NPR
Behind Ukraine's dramatic battlefield push and Russia's rapid retreat is a surprise tactic. With public attention focused on movements in Ukraine's south, Ukrainian forces struck in the east.
Copyright 2022 NPR
|
https://www.wyomingpublicmedia.org/2022-09-13/ukraine-played-a-game-of-misdirection-and-caught-russian-forces-off-guard
| 2022-09-13T12:40:42Z
|
NPR's A Martinez talks to Sergey Radchenko, professor of Russian history at Johns Hopkins School of Advanced International Studies, about President Putin's supporters questioning Russia's strategy.
Copyright 2022 NPR
NPR's A Martinez talks to Sergey Radchenko, professor of Russian history at Johns Hopkins School of Advanced International Studies, about President Putin's supporters questioning Russia's strategy.
Copyright 2022 NPR
|
https://www.wyomingpublicmedia.org/2022-09-13/ukraines-counteroffensive-has-some-russian-officials-calling-for-putin-to-resign
| 2022-09-13T12:40:49Z
|
Local Blood Cancer Survivors Offered Tuition Scholarship
LLS Gulf Coast invites blood cancer patients and survivors diagnosed at age 25 or younger to apply online at LLS.org/LLS-Scholarship-Blood-Cancer-Survivors. The application is open to U.S. citizens and permanent residents attending or planning to attend qualified programs. Applicants will answer a series of questions and submit an essay, recommendation and verification of diagnosis to qualify.
The awards provide up to $7,500 toward tuition for virtual or in-person vocational, two-year or four-year undergraduate education for the 2023-24 academic year. The application deadline is Oct. 28, and applicants will be notified of awards in spring 2023. Students who earned 2022 awards can also apply for renewal in the spring.
LLS is drawing attention to this scholarship opportunity amid Blood Cancer Awareness Month in September.
|
https://www.bizneworleans.com/local-blood-cancer-survivors-offered-tuition-scholarship/
| 2022-09-13T12:53:25Z
|
NOLA Coalition Weighs in on Mayor’s Plan to Support NOPD
NEW ORLEANS – From the NOLA Coalition:
Last week, Mayor LaToya Cantrell announced a significant plan to support the New Orleans Police Department and public safety. The proposal includes $80M in new salary and benefits to recruit and retain officers, reassignments to place more officers on the street, leadership changes at the Public Integrity Bureau and additional improvements as recommended by experts from the New York City Police Department.
The NOLA Coalition, representing a diverse cross-section of over 400 New Orleans organizations, recognizes the urgency of our situation and believes this plan includes concrete steps towards a better working environment for our officers and safer streets for our residents. Many elements of the Mayor’s plan reflect the coalition’s priorities, including improving recruiting and retention, improving pay and benefits, and optimizing resources.
At the same time, the coalition sees the need for more detail on the plan, specifically on how some elements, such as civilianization, will be implemented. The coalition also encourages further study and explanation of how the pay and benefits increases will be sustained over time.
Finally, while support for NOPD is central to the coalition’s two-part plan, other elements are equally critical, including accountability and coordination across the entire criminal justice system —and investment in youth services to drive generational change.
Big moves towards better pay, enhanced working conditions, and smarter resourcing are welcome. The NOLA Coalition is hopeful that last week’s announcement represents a first step towards a detailed strategy and implementation plan, for sustained reform and safety.
More on The NOLA Coalition at NOLAcoalition.info.
|
https://www.bizneworleans.com/nola-coalition-weighs-in-on-mayors-plan-to-support-nopd/
| 2022-09-13T12:53:31Z
|
Burger King has $400M plan to make you fall in love with the Whopper again
(CNN) - Burger King is getting a $400 million upgrade following a rough few years that have seen the fast food giant lag behind its competitors.
Executives are hoping a major investment in restaurants and advertising will strengthen the brand and spark new growth.
Over the next two years, they plan to pump $150 million into advertising and digital products and $250 million into updating restaurant technology, kitchens and remodeling.
A key part of the plan is to make diners fall in love with the Whopper again.
That includes ensuring consistency and beefing up training on making the best possible Whopper.
The branding push will remind customers the burger chain is the “home of the Whopper.”
Burger King will remodel and modernize roughly 800 restaurants and has already changed its logo, packaging, signage and uniforms.
Copyright 2022 CNN Newsource. All rights reserved.
|
https://www.whsv.com/2022/09/13/burger-king-has-400m-plan-make-you-fall-love-with-whopper-again/
| 2022-09-13T13:01:22Z
|
Twitter whistleblower brings his critiques to Congress
WASHINGTON (AP) — A former security chief at Twitter will appear before Congress Tuesday with alarming allegations that the social platform misled regulators about its cyber defenses and efforts to control millions of fake accounts.
Peiter “Mudge” Zatko, a respected cybersecurity expert, will appear Tuesday before the Senate Judiciary Committee to lay out his concerns. Zatko’s claims could also affect Tesla billionaire Elon Musk’s attempt to back out of his $44 billion deal to acquire the social platform. Musk claims that Twitter has long underreported spam bots on its platform and cites that as a reason to nix the deal he struck in April.
Zatko was the head of security for the influential platform until he was fired early this year. He filed a whistleblower complaint in July with Congress, the Justice Department, the Federal Trade Commission and the Securities and Exchange Commission. Among his most serious accusations is that Twitter violated the terms of a 2011 FTC settlement by falsely claiming that it had put stronger measures in place to protect the security and privacy of its users.
The Judiciary Committee chairman, Illinois Democrat Sen. Dick Durbin, called Zatko’s accusations “serious business.”
“If it’s anywhere along the lines that (he) suggested, I think it’s a matter of grave personal-privacy concern,” Durbin told reporters Monday. “The question is whether information gathered by Twitter has been used for purposes which we’re not aware of.”
Many of Zatko’s claims are uncorroborated and appear to have little documentary support. Twitter has called Zatko’s description of events “a false narrative ... riddled with inconsistencies and inaccuracies” and lacking important context.
Zatko also accuses the company of deception in its handling of automated “spam bots,” or fake accounts. That allegation is at the core of billionaire tycoon Elon Musk’s attempt to back out of his $44 billion deal to buy Twitter. Musk and Twitter are locked in a bitter legal battle, with Twitter having sued Musk to force him to complete the deal. The Delaware judge overseeing the case ruled last week that Musk can include new evidence related to Zatko’s allegations in the high-stakes trial, which is set to start Oct. 17.
Zatko, 51, first gained prominence in the 1990s as an ethical hacker and later worked in senior positions at an elite Defense Department research unit and at Google. He joined Twitter in late 2020 at the urging of then-CEO Jack Dorsey.
___
Follow Marcy Gordon at https://twitter.com/mgordonap
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.whsv.com/2022/09/13/twitter-whistleblower-brings-his-critiques-congress/
| 2022-09-13T13:01:28Z
|
What’s left as Jan. 6 panel sprints to year-end finish
WASHINGTON (AP) — With only three months left in the year, the House Jan. 6 committee is eyeing a close to its work and a final report laying out its findings about the U.S. Capitol insurrection. But the investigation is not over.
The committee has already revealed much of its work at eight hearings over the summer, showing in detail how former President Donald Trump ignored many of his closest advisers and amplified his false claims of election fraud after he lost the 2020 election to Joe Biden. Witnesses interviewed by the panel — some of them Trump’s closest allies — recounted in videotaped testimony how the former president declined to act when hundreds of his supporters violently attacked the Capitol as Congress certified Biden’s victory on Jan. 6, 2021.
Lawmakers say there is more to come. The nine-member panel — seven Democrats and two Republicans — interviewed witnesses through all of August, and they are planning at least one hearing this month. Members are expected to meet and discuss some of their next steps on Tuesday.
Because the Jan. 6 panel is a temporary, or “select,” committee, it expires at the end of the current Congress. If Republicans take the majority in November’s elections, as they are favored to do, they are expected to dissolve the committee in January. So the panel is planning to issue a final report by the end of December.
What’s left for the committee in 2022:
HEARINGS
The committee is expected to hold at least one hearing, maybe more, before the end of the month. Wyoming Rep. Liz Cheney, the Republican vice chairwoman, said the committee “has far more evidence to share with the American people and more to gather.”
“Doors have opened, new subpoenas have been issued and the dam has begun to break,” Cheney said at a July 21 hearing that was held in prime time and watched by 17.7 million people. “We have considerably more to do.”
It’s unclear if the next hearings will provide a general overview of what the panel has learned or if they will be focused on new information and evidence. The committee conducted several interviews at the end of July and into August with Trump’s Cabinet secretaries, some of whom had discussed invoking the constitutional process in the 25th Amendment to remove Trump from office after the insurrection.
WITNESSES
The panel has already interviewed more than 1,000 people, but lawmakers and staff are still pursuing new threads. The committee just recently spoke to several of the Cabinet secretaries, including former Treasury Secretary Steven Mnuchin in July and former Secretary of State Mike Pompeo and former Transportation Secretary Elaine Chao in August.
The committee also wants to get to the bottom of missing Secret Service texts from Jan. 5-6, 2021, which could shed further light on Trump’s actions during the insurrection, particularly after earlier testimony about his confrontation with security as he tried to join supporters at the Capitol.
“We anticipate talking to additional members of the president’s Cabinet,” Cheney said at the beginning of August. “We anticipate talking to additional members of his campaign. Certainly, we’re very focused as well on the Secret Service.”
The committee has also pursued an interview with conservative activist Virginia “Ginni” Thomas, who’s married to Supreme Court Justice Clarence Thomas. Lawmakers want to know more about her role in trying to help Trump overturn the election. She contacted lawmakers in Arizona and Wisconsin as part of that effort.
FINAL REPORT
The committee must shut down within a month after issuing a final report, per its rules. But lawmakers could issue some smaller reports before then, perhaps even before the November elections. Rep. Bennie Thompson, D-Miss., the panel’s chairman, has said there may be an interim report in the fall.
The release of the final report will likely come close to the end of the year so the panel can maximize its time. While much of the findings will already be known, the report is expected to thread the story together in a definitive way that lays out the committee’s conclusions for history.
TRUMP AND PENCE
Members of the committee are still debating how aggressively to pursue testimony from Trump and former Vice President Mike Pence.
Some have have questioned whether calling Pence — he resisted Trump’s pressure to try and block Biden’s certification on Jan. 6 — is needed since many of his closest aides have already testified. His top lawyer at the White House, Greg Jacob, testified at one of the committee’s hearings in June and characterized much of Pence’s thought process during the time when Trump was pressuring him.
The panel has been in discussions with Pence’s lawyers for months, without any discernible progress. Still, the committee could invite Pence for closed-door testimony or ask him to answer written questions.
The calculation is different for the former president. Members have debated whether they need to call Trump, who is the focus of their probe but also a witness who has railed against the investigation, denied much of the evidence and who has floated the idea of presidential pardons for Jan. 6 rioters. He is also facing scrutiny in several other investigations, including at the Justice Department and over the classified documents he took to his private club.
HOUSE REPUBLICANS
Another bit of unfinished business is the committee’s subpoenas to five House Republicans, including Minority Leader Kevin McCarthy.
In May the panel subpoenaed McCarthy, R-Calif., and Reps. Jim Jordan of Ohio, Scott Perry of Pennsylvania, Andy Biggs of Arizona and Mo Brooks of Alabama. The panel has investigated McCarthy’s conversations with Trump the day of the attack and meetings the four other lawmakers had with the White House beforehand as Trump and his aides worked to overturn his election defeat.
The five Republicans, all of whom have repeatedly downplayed the investigation’s legitimacy, have simply ignored the request to testify. But the Jan. 6 committee seems unlikely to meet their defiance with contempt charges, as they have with other witnesses, in the weeks before the November elections. Not only would it be a politically risky move, but it is unclear what eventual recourse the panel would have against its own colleagues.
LEGISLATIVE RECOMMENDATIONS
The committee is expected to weigh in on possible legislative changes to the Electoral Count Act, which governs how a presidential election is certified by Congress.
A bipartisan group of senators released proposed changes over the summer that would clarify the way states submit electors and the vice president tallies the votes. Trump and his allies tried to find loopholes in that law ahead of Jan. 6 as the former president worked to overturn his defeat to Biden and unsuccessfully pressured Pence to go along.
The Jan. 6 panel’s final report is expected to include a larger swath of legislative recommendations.
___
Associated Press writers Lisa Mascaro and Farnoush Amiri contributed to this report.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.whsv.com/2022/09/13/whats-left-jan-6-panel-sprints-year-end-finish/
| 2022-09-13T13:01:34Z
|
RPM solution helps monitor, measure and support at-risk populations in their homes to improve access to care, drive better outcomes and lower costs
BALA CYNWYD, Pa., Sept. 13, 2022 /PRNewswire/ -- 100Plus, a Connect America company and Remote Patient Monitoring (RPM) platform for clinicians and patients, announced today that Sweetwater Medical Associates has improved patient adherence and clinical health metrics through its artificial intelligence (AI) assisted RPM platform. By using the platform, the medical practice has seen statistically significant improvements in patients' health metrics over 180 days, including an average blood pressure reduction for patients with hypertension of 5.80 mmHg, and for patients with obesity, a mean weight loss of 3.45 lbs.
Sweetwater Medical Associates is a medical facility devoted to family practice and internal medicine in Sugar Land, Texas. After a thorough evaluation of competing RPM vendors, Sweetwater chose the 100Plus solution for its ease-of-use, cost-effectiveness, and strong customer support.
In addition to Sweetwater benefitting from these patient health metric improvements, the medical facility is also seeing reduced administrative burdens on providers and staff. For example, previously obtaining patients' physiological data such as blood pressure readings required patients to meet with providers for in-office or telehealth visits. Now, patients can take readings on their own – at home – through the 100plus AI-assisted platform and the results are automatically shared with their provider.
"As a busy family practice with time-strapped providers and staff, we often found it challenging to monitor our at-risk patients for signs of impending problems," said Eric Navarette, Practice Manager at Sweetwater Medical Associates. "100Plus' AI based solution has helped us dramatically improve our ability to monitor patients, resulting in improved outcomes and reduced administrative burden on providers and staff."
"We understand the high value of provider and staff time, as well as the heavy toll that unnecessary calls and emails exact on medical practices," said Janet Dillione, CEO of Connect America. "The 100Plus RPM platform delivers an around-the-clock virtual assistant that enables practices to overcome these barriers by monitoring and analyzing patients' behaviors and connecting with them outside of traditional clinical settings. We are pleased Sweetwater has seen such outstanding improvements in patients' health metrics by using the 100plus platform, in addition to easing burden on staff."
The 100Plus RPM platform utilizes AI to assist medical practices with patient outreach, device setup, enrollment, engagement, and education, ensuring that patients test regularly and stay compliant. The platform features an AI-enabled, text message-based chatbot that helps practices scale RPM programs faster, and better educate patients on the value of RPM. With AI outreach, practices more than double RPM adoption rates among patients.
100Plus, a Connect America company, is the leading AI-assisted remote patient monitoring (RPM) platform that enables healthcare providers to remotely monitor and manage their patients' health conditions. Our complete end-to-end solution makes it easy for practices to implement a successful RPM program quickly, including full-service monitoring, eligibility, enrollment, device setup and delivery, and white-glove service. With actionable insights that help clinicians identify and treat at-risk patients faster and an AI-enabled virtual health assistant that supports patient compliance, the result is higher adherence, fewer hospitalizations, and better health outcomes. To learn more, visit www.100plus.com.
CONTACT:
Mardi Larson
Amendola Communications for Connect America/100plus
mlarson@acmarketingpr.com
View original content to download multimedia:
SOURCE 100Plus
|
https://www.whsv.com/prnewswire/2022/09/13/100plus-enables-sweetwater-medical-associates-improve-patient-adherence-health-metrics-with-ai-assisted-remote-patient-monitoring/
| 2022-09-13T13:01:41Z
|
PHILADELPHIA, Sept. 13, 2022 /PRNewswire/ -- A recent survey of the celiac disease community by Beyond Celiac, the leading catalyst for a celiac disease cure, reveals the ongoing challenges those with the disease are facing on National Celiac Disease Awareness Day, Sept. 13, and the overwhelming desire for new treatments and a cure.
The only current celiac disease treatment, which is only partially effective, is to follow a strict, gluten-free diet. However, the survey of 1,255 Americans who have been diagnosed with celiac disease by a medical provider showed that while 93% of respondents never intentionally eat gluten, nearly 73% still have exposure to gluten each year, resulting in symptoms. 36% report accidentally ingesting gluten as often as 1-5 times a month. Over 66% of respondents have very severe or bad symptoms as a result of gluten exposure, with gastrointestinal (84%), neurological (56%) and psychological (40%) symptoms being the most common.
"Although necessary as the only option for now, following a gluten-free diet is burdensome, not fully effective, and can negatively impact day-to-day living in a world full of gluten," said Alice Bast, Beyond Celiac CEO. "We need real therapies and a cure for celiac disease so that those with the disease can live full lives and eat without fear."
Survey respondents say gluten-free food is expensive (80%) and dining out is difficult due to lack of gluten-free options (91%), causing an even bigger barrier to socializing and living normally. Almost two-thirds (61%) of respondents said there should be therapeutic treatments instead of, or in addition to, the gluten-free diet.
"As we continue our mission to advance research and find a cure, we want the public to have a better understanding of celiac disease as a serious disease and the implications of living with this devastating condition," said Bast.
Often misunderstood and frequently misdiagnosed, celiac disease remains a mystery for many. A nationwide benchmark survey of the general public conducted earlier this year by The Harris Poll on behalf of Beyond Celiac revealed that only half of Americans (50%) know anything about celiac disease and/or gluten sensitivity. The report on The Harris Poll survey, "The Mystery of Celiac Disease: The Need for Greater Awareness and Accelerating the Quest for a Cure" can be found at www.beyondceliac.org/2022celiacreport. The report also presents facts about the disease and outlines how Beyond Celiac is taking steps to accelerate the quest for a cure.
Celiac disease is a serious autoimmune condition. The disease causes damage to the small intestine, resulting in debilitating symptoms, and if left untreated can lead to a number of serious, long-term health problems including brain damage, infertility and some types of cancer. Celiac disease affects one in 133 Americans.1
Founded in 2003, Beyond Celiac is the leading catalyst for a celiac disease cure in the United States, serving as a patient advocacy and research-driven organization working to drive diagnosis and accelerate the discovery of new treatments. By engaging with the top scientists in the field, making the right investments in research and supporting the broad community of those with celiac disease and gluten sensitivity, Beyond Celiac envisions a world in which people can live healthy lives and eat without fear – a world Beyond Celiac. www.BeyondCeliac.org.
Media Contact:
Claire Baker, 267.419.2111
cbaker@beyondceliac.org
Angela Miller, 319.331.5090
amiller@kaisermarketinggroup.com
View original content:
SOURCE Beyond Celiac
|
https://www.whsv.com/prnewswire/2022/09/13/73-celiac-disease-patients-still-exposed-gluten-every-year-highlighting-need-cure-national-celiac-disease-awareness-day/
| 2022-09-13T13:01:47Z
|
SAN MATEO, Calif., Sept. 13, 2022 /PRNewswire/ -- Rocketlane, the leading customer onboarding platform, today shared several significant company achievements that reflect outstanding midyear momentum.
Among these achievements is Rocketlane's ongoing rapid growth. Since securing its series A funding earlier this year, the company continued its upward trajectory by expanding its product capabilities. Rocketlane added status templates to its templatization capabilities, launched the slack integration for seamless customer collaboration, and introduced resource management for effective resource planning and forecasting.
The company has seen strong growth in the SaaS, fintech, healthcare, and services verticals, among others. Some of the notable new customers include Chargebee, Mosaic, Solvvy, Mixmax, and nCloud Integrators, Clari being the latest addition to the list.
Robert Block, Group Vice President of Professional Services & Customer Support at Clari, said, "Rocketlane helps us deliver more for less. It is shifting our customer onboarding experience into high gear, taking us from just task management to strategic delivery with greater visibility and collaboration on project activities, ultimately driving up CSAT. We now have better visibility into project statuses and are equipped with data that helps to continuously innovate our professional services packaging and selling."
Rocketlane has also been ramping up on its leadership hires. The company recently announced the appointment of Ben Brutsch as VP of Sales. Ben brings over 18 years of sales leadership experience from companies including Pluralsight and Podium. Rocketlane has also stepped up hiring globally across development and go-to-market functions, as the business continues to accelerate.
"Rocketlane's growth across multiple areas is a testament of our category-leading product, and execution across functions," said Srikrishnan Ganesan, CEO and co-founder of Rocketlane. "Our recent wins and continued momentum indicate the market's preference for our solution. We'll continue to innovate and present a fresh take as we execute on our product roadmap to streamline customer onboarding and implementations for businesses serving midmarket and enterprise companies."
A number of industry accolades acknowledge the positive impact Rocketlane has made on companies. These awards include:
- Leader in Client Onboarding by G2 in the Summer 2022 report
- Named a Gartner Cool Vendor in the Technology Go-to-Market report
Rocketlane has been investing in creating learning avenues for its domain: This year the company launched its maiden Propel event, the first and only dedicated conference for customer onboarding and implementation which attracted 1,300 attendees and 3,000-plus registrations. They also run Preflight, a 2000-plus member Slack community that offers opportunities to network and learn for customer onboarding leaders and practitioners. Preflight recently hosted over 120 professionals across their in-person community meetups in San Francisco, New York, and Boston, branded "Preflight Huddle."
Rocketlane is also a Super Gold sponsor at SaaStr (booth #220) and will deliver a talk, "How to avoid the MVP trap."'
For more information on Rocketlane, click here.
Rocketlane is a purpose-built customer onboarding platform that helps businesses accelerate their time to value, boost customer satisfaction, and thereby reduce churn. The platform replaces generic project management and document collaboration tools with a unique, unified workspace that improves communication, collaboration, and project visibility for businesses and their customers. It equips teams with trends and benchmarks across projects, which in turn helps them develop and optimize playbooks and best practices.
Media Contact:
Courtney Merolle
courtney@bospar.com
754.715.0747
View original content:
SOURCE Rocketlane Corp
|
https://www.whsv.com/prnewswire/2022/09/13/addition-new-features-customers-vp-sales-signals-rocketlanes-accelerating-momentum/
| 2022-09-13T13:01:54Z
|
NEARLY 20,000 PEOPLE RESPONDED TO AN OPEN CASTING CALL FOR A CHANCE TO BE FEATURED IN THE UPCOMING CAMPAIGN FOR THE NUMBER ONE SELLING PRODUCT OF ITS KIND
IRVINE, Calif., Sept. 13, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is unveiling the 25 real patients – of all forms, genders, ethnicities and backgrounds – who were selected to participate in the latest iteration of the BOTOX® Cosmetic 'See Yourself' campaign. After receiving nearly 20,000 submissions to its first-ever open casting call, BOTOX® Cosmetic, the #1 selling product of its kind1, is creating a content series that captures inspiring and intimate accounts of people speaking candidly about how they see themselves and their motivation for being treated with BOTOX® Cosmetic.
"We were thrilled by the huge influx of responses we received to our open casting call in January of this year," said Carrie Strom, Senior Vice President, AbbVie and President, Global Allergan Aesthetics. "It was moving to see how BOTOX® Cosmetic continues to impact so many lives across the country. Our mission continues to be rooted in showing up authentically, sharing candid, sincere stories and content highlighting our real patients' reasons for getting treated and how they feel about treatment. At a time when people want transparency and honesty, we are giving them just that, real patients with real results."
The newly released content includes testimonial footage, before and after treatment, behind the scenes footage, self-filmed treatment diaries, a new before & after series for YouTube and social first reels. The videos provide candid interviews with the cast members — one before their BOTOX® Cosmetic treatment and a second interview 30 days post-treatment.
"I am so happy BOTOX® Cosmetic is helping to pull back the curtain on what the treatment experience is really like and answering key questions so many of my patients have," said Sherly Soleiman, M.D. "The reality is my patients don't want to see more models staring into the camera while striking a posh pose. They want to see people they can fully relate to because they have similar challenges, desires and hopes in life. I choose BOTOX® Cosmetic because I believe in the product, the level of scientific rigor behind it and the results it delivers. This campaign gives me yet another reason to continue to choose BOTOX® Cosmetic for myself and my patients."
Research shows that people are curious about aesthetic treatments and want to learn more. Recent data shows that 83% of aesthetic neurotoxin considerers moved from consideration of treatment to a neurotoxin treatment in the past year.2,* So, in addition to sharing their stories, the cast answered the 10 most common questions about BOTOX® Cosmetic that people search online in a special content series that will appear online.
BOTOX® Cosmetic is the first and only product of its kind that is approved by the U.S. Food and Drug Administration (FDA) to treat three areas, temporarily improving the appearance of moderate to severe forehead lines, glabellar lines and crow's feet in adults.3-6 Backed with 20 years of experience and science,7 BOTOX® Cosmetic has established itself as a trusted8,** and reliable brand for real people and real results.
Watch 'See Yourself' at www.BOTOXCosmetic.com, @BotoxCosmetic on social and on the brand's YouTube channel. New stories and content continue to unveil throughout the year. To learn more about BOTOX® Cosmetic or to find a provider, please visit www.BOTOXCosmetic.com.
Consumers who receive aesthetic treatment with BOTOX® Cosmetic can also enroll in Allē, Allergan Aesthetics' loyalty rewards program. Allē is the first and only loyalty program in the aesthetics market to offer consumers the ability to earn points on over 40 non-Allergan Aesthetics treatments and brands. To learn more about Allē, visit www.alle.com.
*Based on an online survey of 14,388 adults, aged 18-75 years, who answered questions about neurotoxin injection in 2020 and 2021.2 6.4M (2021 Q. When was your most recent treatment with each of the following? "Neurotoxin injection—within the past 12 months") / 7.7M (2020 Q. When would you consider doing each of the following procedures? "Neurotoxin injection–within the next year") = 83% (Past 1 year conversion rate calculation)
**Based on a 2018 survey of 381 healthcare providers in which 86% reported they agree the brand has earned their trust (top-2 box on a 6-point scale of agreement).8
BOTOX® Cosmetic Important Information
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to weakening of associated muscles, can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.
- Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow's feet lines, and/or forehead lines.
BOTOX® Cosmetic may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of taking BOTOX® Cosmetic. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Serious and/or immediate allergic reactions have been reported. They include: itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you are wheezing or have asthma symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if you: are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the planned injection site.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects including difficulty swallowing and difficulty breathing from typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions, including: plans to have surgery; had surgery on your face; have trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby); are breast-feeding or plan to (it is not known if BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc®, Dysport®, or Xeomin® in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.
Other side effects of BOTOX® Cosmetic include: dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; and eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows, swelling of your eyelids and dry eyes.
APPROVED USES
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, and frown lines between the eyebrows in adults.
For more information refer to the Medication Guide or talk with your doctor.
To report a side effect, please call Allergan at 1-800-678-1605.
Please see BOTOX® Cosmetic full Product Information including Boxed Warning and Medication Guide.
About Allergan Aesthetics
Allergan Aesthetics, an AbbVie company, develops, manufactures, and markets a portfolio of leading aesthetics brands and products. Their aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Their goal is to consistently provide customers worldwide with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
References
- Data on File. AbbVie. Neurotoxin Monthly Tracker Report, July 2022.
- Data on File, Allergan; EOY Aesthetic Market Sizing Study, 2021.
- BOTOX® Cosmetic Prescribing Information, July 2020.
- Dysport® Prescribing Information, 2020.
- Xeomin® Prescribing Information, 2020.
- Jeuveau® Prescribing Information, 2020.
- Data on File. AbbVie. FDA Product Approval Information, 2019.
- Data on file, Allergan; Facial Injectable MD Landscape Study, April 2018.
View original content to download multimedia:
SOURCE AbbVie
|
https://www.whsv.com/prnewswire/2022/09/13/allergan-aesthetics-botox-cosmetic-onabotulinumtoxina-reveal-new-see-yourself-campaign-cast-spotlighting-25-real-people-their-stories/
| 2022-09-13T13:02:00Z
|
BEIJING, Sept. 13, 2022 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or the "Company") (NYSE American: AMBO), a leading cross-border career educational and technology service provider, today announced that one of its wholly-owned subsidiaries in China won its bid for Guizhou University's integrated circuit (IC) design and simulation platform project. The winning bid totaled RMB26.98 million.
In order to implement national IC industry development guidelines and accelerate the development of China's IC design technology and industry, this innovative IC design and simulation platform project will aim to serve China's major national strategies and regional economic development. The project will focus on expanding the frontiers of IC disciplines, breaking down disciplinary barriers to strengthen cross-integration, pioneer core technologies and cultivate urgently needed talents in China. In accordance with the guidelines of "international vision, superior demonstration, collaborative education, domestic chip design and production, and service to the local community," the project will leverage talent training, industrial services, innovation, entrepreneurship and scientific research, and take full advantage of the integration of industry and education to support and lead the rapid development of the IC industry in the western region.
In recent years, Ambow has distinguished itself in bidding projects by delivering high-quality services which are widely well-perceived by users and customers. The Guizhou University project is Ambow's third recent win of a university collaboration project. Ambow's previous wins include two contracts for the project to upgrade Hulunbuir College's intelligent classroom solutions and the procurement of a new recording system for the Inner Mongolia University of Science and Technology, Baotou Medical College.
Dr. Jin Huang, President and CEO of Ambow, commented, "Our winning bids for multiple college projects clearly demonstrate our solid foundation and comprehensive strength in the educational services industry. Supported by a wealth of experience accumulated in the career education business over the past two decades, we will further expand our business capabilities, develop advanced education technologies and share our educational achievements. As always, we are committed to providing schools, teachers and students nationwide with world-class education resources and services."
About Ambow Education Holding Ltd.
Ambow Education Holding Ltd. is a leading national provider of educational and career enhancement services in China, offering high-quality, individualized services and products. With its extensive network of regional service hubs complemented by a dynamic proprietary learning platform and distributors, Ambow provides its services and products to students in 15 out of the 34 provinces and autonomous regions within China.
Follow us on Twitter: @Ambow_Education
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the outlook and quotations from management in this announcement, as well as Ambow's strategic and operational plans, contain forward-looking statements. Ambow may also make written or oral forward-looking statements in its reports filed or furnished to the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statements, including but not limited to the following: the Company's goals and strategies, expansion plans, the expected growth of the content and application delivery services market, the Company's expectations regarding keeping and strengthening its relationships with its customers, and the general economic and business conditions in the regions where the Company provides its solutions and services. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Ambow undertakes no duty to update such information except as required under applicable law.
For investor and media inquiries, please contact:
Ambow Education Holding Ltd.
Tel: +86 10-6206-8000
The Piacente Group | Investor Relations
Tel: +1 212-481-2050 or +86 10-6508-0677
Email: ambow@tpg-ir.com
View original content:
SOURCE Ambow Education Holding Ltd.
|
https://www.whsv.com/prnewswire/2022/09/13/ambow-wins-bid-guizhou-university-ic-design-simulation-platform-project/
| 2022-09-13T13:02:07Z
|
Kenney scores one of the largest pay-outs for a woman poker player in history.
SAN JOSE, Costa Rica, Sept. 13, 2022 /PRNewswire/ -- America's Cardroom (ACR) Team Pro Ebony Kenney became one of the winningest women poker players in history with her $1.7 million score yesterday finishing in 5th place in the Coin Rivet Invitational at the Triton Super High Roller Series in Northern Cyprus.
The big score was Kenney's largest win of her career and the fifth largest cash win for a woman in poker history, pushing her into 16th position in the Women's All Time Money List.
One of the few women in the tournament and the only woman at the final table, Kenney eliminated well-known poker personalities including Antanas "Tony G" Guoga to take her place at star-studded nine handed final table, which included Seth Davies, Fedor Holz, Sam Grafton, Karl Chappe-Gatien, Tom Vogelsang, Elias Talvitie, Aleksejs Ponakovs and Linus Loeliger.
Kenney entered the tournament at the invitation of Americas Cardroom CEO Phil Nagy, who was eliminated earlier in the tournament when is pocket aces were cracked by an opponent.
"I am so grateful to Phil Nagy for giving me this opportunity," Kenney said. "He believed in me in a spot when almost no one else did. I still can't believe it and I will be soaking this one in for a long time, and it still hasn't fully hit me."
The Coin Rivet Invitational took place from September 10-12 at the Triton Super High Roller Series at Merit Royal Diamond, North Cyprus. The event was a $200,000 NLH single re-entry and sees professional players paired with wealthy recreational players. Each player paid the entry and the tournament had 90 entries. On day one, the professional players and recreational players were separated before the fields were merged on day two.
Look back on all the action here: https://www.twitch.tv/tritonpoker
About Americas Cardroom
Americas Cardroom joined the Winning Poker Network in 2011. The Winning Poker Network has one of the longest and trusted online names in the industry and has been in existence since 2001. Americas Cardroom accepts players from the US market and the rest of the world. Rated first place for payment processing and cashout reliability repeatedly over the last few years, Americas Cardroom offers outstanding customer service and a friendly environment for all poker players around the world.
Contact: mmoser@imail.ag
View original content to download multimedia:
SOURCE America’s Cardroom
|
https://www.whsv.com/prnewswire/2022/09/13/americas-cardroom-pro-ebony-kenney-wins-17-million-coin-rivet-invitational-poker-tournament-becomes-one-winningest-women-poker/
| 2022-09-13T13:02:13Z
|
RALEIGH, N.C., Sept. 13, 2022 /PRNewswire/ -- Automoblog, a consumer-focused automotive resource, recently released a list of the top 10 cities with the highest rate of car ownership. The article's methodology ranks each city by the percentage of households with access to a vehicle. Some of the key takeaways from the article include:
- Raleigh, NC was listed as the number 1 city in the country for car ownership. 96.1% of households in Raleigh have access to a vehicle.
- Southern cities dominate the list, occupying 7 of the 10 spots.
- North Carolina and Texas both had more than one city listed.
Automoblog also details other statistics for each city listed in the article. This includes the percentage of workers who commute by car, the average commute time, and the average time lost in rush-hour traffic.
Automoblog is an online automotive resource that helps people make informed decisions about cars and car ownership. To learn more about the publication, click here.
Media Contact:
Jennifer Chonillo
344324@email4pr.com
(919) 283-9316
View original content:
SOURCE Automoblog
|
https://www.whsv.com/prnewswire/2022/09/13/automoblog-releases-list-cities-with-highest-rates-car-ownership/
| 2022-09-13T13:02:20Z
|
SANTA FE, N.M., Sept. 13, 2022 /PRNewswire/ -- In response to growing interest for intelligent energy management at home, BayWa r.e. announced today it is working with Google Nest to distribute smart thermostats to installers through its solar and energy storage distribution arm in the U.S. The partnership is a first in the solar industry, pairing BayWa r.e. -- a leading global renewable energy developer, services and systems provider -- with one of the nation's leading smart home brands. This collaboration comes at a time when solar installers are expanding their services to fill the role of energy advisers in the residential market.
BayWa r.e. will be supplying the Nest Learning Thermostat, the flagship product for homeowners, and the Nest Thermostat E, a thermostat now exclusively available through professional installers. With usage insights and a suite of personalized solutions for the smart home, products like those from Google Nest have become strong drivers of residential energy efficiency and are propelling collective action to achieve U.S. climate goals.
"The future of energy is clean, personalized, and connected. Smart home technology enables this future by empowering customers to understand and act on their energy management, which is key to a cleaner and more reliable U.S. power grid," said David Dunlap, VP of product strategy at BayWa r.e. Solar Systems LLC. "Our partnership with Google Nest allows BayWa r.e. to take an active role in simplifying energy management at scale by providing new tools to solar installers--the direct point of contact for customers who want to prioritize efficient energy usage for lower energy bills and help with the goal of reducing grid emissions."
Smart thermostats are one of the top products for energy efficiency and demand-response initiatives, designed to allow homeowners to reduce or shift their energy usage during peak periods. By expanding the distribution of smart home tools through the burgeoning solar and storage channels, BayWa r.e. and Google Nest aim to help build out energy systems that are flexible and reliable, a critical step to modernizing the U.S. power grid and boosting the adoption of renewable energy resources in the system.
The Google Nest Learning Thermostat and the Google Nest Thermostat E are now available through BayWa r.e. Solar Systems LLC online store.
At BayWa r.e. we r.e.think energy -- how it is produced, stored and can be best used to enable the global renewable energy transition that is essential to the future of our planet. We are a leading global developer, service supplier, distributor and solutions provider and have brought over 4.5 GW of energy online and manage over 10 GW of assets. We are also an Independent Power Producer with an expanding energy trading business. BayWa r.e. works with businesses worldwide to provide tailored renewable solutions. Operating 100% carbon neutral, we are also committed to our own sustainability journey. Our shareholders are BayWa AG, a $23.5 billion global business, and Energy Infrastructure Partners, a leader in energy infrastructure investment. BayWa r.e. Solar Systems LLC is a leading U.S. distributor of top-tier solar and energy storage components and systems. For more information, visit http://solar-distribution.com.
View original content to download multimedia:
SOURCE BayWa r.e. Solar Systems, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/baywa-re-distribute-google-nest-smart-home-technology-solar-installer-network/
| 2022-09-13T13:02:26Z
|
NEW YORK, Sept. 13, 2022 /PRNewswire/ --Wolf Haldenstein Adler Freeman & Herz LLP is investigating whether Bed Bath & Beyond, Inc. ("Bed Bath" or the "Company") (NASDAQ: BBBY) complied with federal securities laws.
If you purchased or sold Bed Bath & Beyond securities between March 25, 2022 and August 19, 2022, please call Gregory Stone at (800) 575-0735 or (212) 545-4774, email gstone@whafh.com or submit this form:
On March 6, 2022, through his investment firm RC Ventures LLC, Ryan Cohen, the billionaire co-founder of Chewy Inc. who also serves as chairman of GameStop Corp., sent a letter to Bed Bath & Beyond's board which announced that he owned a 9.8% stake in Bed Bath & Beyond and in which he criticized the Company's management. On this news Bed Bath & Beyond stock to closed 34% higher on March 7, 2022 compared to its close on March 4, 2022, the previous trading day, on extremely heavy trading volume. On March 25, 2022, Bed Bath & Beyond added three new directors appointed by Ryan Cohen's investment firm, RC Ventures LLC.
On August 15, 2022, Ryan Cohen, through his investment firm RC Ventures LLC, announced in an SEC filing purchases of over one million January 2023 call options with exercise prices at $60, $75, and $80-significantly higher than Bed Bath & Beyond shares were trading. On this news, Bed Bath & Beyond stock closed 29% higher.
Then, on August 18, 2022, Ryan Cohen, through his investment firm RC Ventures LLC, announced that he would sell his entire stake in Bed Bath & Beyond. Also on August 18, 2022, Bloomberg published an article entitled "Bed Bath & Beyond Taps Kirkland & Ellis for Help Addressing Debt Load" which revealed the Company hired a law firm for help with its debt.
On this news, Bed Bath & Beyond shares fell $4.53 per share, or 19%, to close at $18.55 per share on August 18, 2022. Bed Bath & Beyond shares continued to drop on August 19, 2022, falling $7.52 per share, or 40%, from its August 18, 2022 close, to close at $11.03 per share.
Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this investigation, or have any questions regarding your rights and interests in this situation, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.
Wolf Haldenstein Adler Freeman & Herz LLP
Gregory Stone, Director of Case and Financial Analysis
Patrick Donovan, Esq.
Email: gstone@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.
View original content to download multimedia:
SOURCE Wolf Haldenstein Adler Freeman & Herz LLP
|
https://www.whsv.com/prnewswire/2022/09/13/bed-bath-amp-beyond-inc-investigation-alert-wolf-haldenstein-adler-freeman-amp-herz-llp-is-investigating-potential-securities-fraud-claims-behalf-shareholders-bed-bath-amp-beyond-inc/
| 2022-09-13T13:02:32Z
|
Company recently hired over 300 new consultants to provide beauty services to customers
CHARLOTTE, N.C., Sept. 13, 2022 /PRNewswire/ -- With the holiday shopping season soon upon us, Belk is renewing its commitment to the beauty department by offering customers a unique experience to connect with product experts at its upcoming Beauty Bash events. The events will be held at 105 store locations starting Thursday, September 15th and run through Sunday, September 18th, giving customers the opportunity to ask questions, experiment with their favorite beauty products, and try out new ones.
"Beauty continues to be a main sales driver for retailers, even as ongoing macro-economic pressures force consumers to be more cost-conscious," said Belk CEO Don Hendricks. "At Belk, we're always looking for ways to best serve our customers, which is why we're revitalizing our approach to beauty by adding more staff, as well as unveiling new product lines in the future."
Over the past few months, Belk has hired more than 300 beauty consultants across its 16-state footprint to add even more expertise to the beauty department, while also bringing back more personal experiences customers had come to love while shopping at Belk before the COVID-19 pandemic. The new hires consist of full and part-time positions and span across sales, beauty, and operational positions with a specific focus on cosmetic beauty advisors and counter manager positions.
"We're so excited to be growing our beauty department and giving customers more of what's most important to them," said Karen Patton, VP Division Merchandise Manager, Beauty at Belk. "We know people feel their best when they look their best, and we look forward to helping our customers achieve their beauty goals."
Customers will receive 20% off their beauty purchases at Belk Beauty Bash (exclusions do apply), and those who make a purchase of $75 or more will get a free "Wake Up and Make Up" bag while supplies last. To learn more about the event and which stores in your area are participating, please visit http://events.belk.com/belkbeautybash1.
Charlotte-based Belk, Inc., a privately-owned department store, opened its first store in 1888, beginning a legacy of selling great products at great prices, treating customers like family, and giving back to the community. Today, Belk serves customers at nearly 300 Belk stores in 16 Southeastern states, at belk.com and through the mobile app. For over 130 years, Belk has proudly put customers and community at the center of what they do, supporting local charities, organizations, and families when they need it most.
For more information visit https://newsroom.belk.com/.
To shop, find your local store at https://www.belk.com/stores/, visit belk.com or download the Belk app in Google Play or Apple Store.
View original content to download multimedia:
SOURCE Belk, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/belk-hosts-beauty-bash-events-part-retailers-renewed-focus-growing-beauty-department/
| 2022-09-13T13:02:38Z
|
FORT WORTH, Texas, Sept. 13, 2022 /PRNewswire/ -- Today, Ben E. Keith announces the hiring of Aimee Lakotas as Vice President of Marketing.
A 25-year marketing veteran, with vast experience in strategic marketing and brand building, Lakotas will report to David Werner, Senior Vice President, Independent Sales and Marketing. She will join the company effective September 7, 2022.
"Ben E. Keith Foods continues to grow in a highly competitive marketplace, and to retain our leadership position requires compelling, innovative and well-targeted cross-channel marketing," said Werner. "Aimee Lakotas, with her proven expertise in brand marketing, is the perfect person to ensure we are reaching the right audiences at the right time with creative and impactful marketing programs."
Lakotas comes to Ben E. Keith Foods from 2nd Avenue Thrift Superstore and Greendrop, an innovative retail model that combines thrift stores with recycling distribution centers, for which she served as Vice President of Marketing.
Previously, she spent more than a decade in marketing leadership roles at retailing giant JCPenney. She rose to the position of Senior Director, Brand Marketing, and led an 18-person team responsible for brand building and communications. Earlier in her career, Lakotas specialized in sports marketing by developing and managing professional sports partnerships for several Fortune 500 clients.
A Dallas resident, Lakotas is a graduate of Georgia Southern University with a master's degree in business – sports marketing; and a graduate of Ohio University with a bachelor's degree in communications.
For more information about Ben E. Keith Foods, visit https://www.benekeith.com/food.
Established in Fort Worth, Texas in 1906, Ben E. Keith is the nation's fifth largest broad line foodservice distributor and operates today with nine divisions shipping to 17 states throughout the country.
For more information about Ben E. Keith contact:
David Werner, Vice President, Marketing, wdwerner@benekeith.com
View original content to download multimedia:
SOURCE Ben E. Keith Foods
|
https://www.whsv.com/prnewswire/2022/09/13/ben-e-keith-foods-names-aimee-lakotas-vice-president-marketing/
| 2022-09-13T13:02:45Z
|
COLUMBIA, Md., Sept. 13, 2022 /PRNewswire/ -- Vheda Health, a national chronic care company using advanced monitoring to decrease medical costs and increase member engagement, HEDIS, and STARs scores for underserved Medicaid and SNP populations, today announced it has hired healthcare industry veteran Bill Henderson as their next Senior Vice President of Business Development.
Bill joins Vheda Health after a standout 15-year career with Liberty Dental Plan. As Liberty's SVP of Business Development, he was responsible for growing the company's government and commercial business to all 50 states; from 40,000 to over 6 million covered lives nationally. Welsh, Carson, Anderson, and Stowe purchased a majority stake in Liberty Dental Plan early this year. Prior to Liberty, Bill held numerous C-Suite level roles with PrimeVision, and OptiCare, leading these organization through key growth stages, including scaling, IPO and acquisition.
"Vheda Health is a special company. What attracted me to the organization is their unrelenting mission of delivering access to care for underserved Medicaid and SNP members using advanced monitoring. Using the power of an iPhone, their chronic care programs continue to set the gold standard for engagement, compliance, and medical cost savings. I am looking forward to building and expanding nationwide partnerships that empower our members every day to live their best life," Bill Henderson, SVP of Business Development of Vheda Health.
Payers across the country are drawn to Vheda Health's ability to rapidly engage Medicaid and SNP members, keep them engaged for an extended period of time, and lower their costs.
"Bill is an energetic and passionate executive with an incredible knowledge of government payors. His ability to story tell, combined with executing sales strategies that generate strong return is the best in our industry; I am humbled to have him on our team," Shameet Luhar, CEO Vheda Health.
Vheda Health is a leading chronic care company empowering people with chronic conditions to live their best life. Using advanced monitoring, our programs increase member engagement, HEDIS, and STARs scores for Medicaid and SNP populations. For close to a decade, Vheda Health has formed strategic partnerships with the largest and most recognizable government payors, delivering 84% member compliance and an average 3:1 return on investment. For more information, please visit https://www.vheda.com/
Contact:
Vheda Health Partnerships
partnership@vheda.com
View original content to download multimedia:
SOURCE Vheda Health
|
https://www.whsv.com/prnewswire/2022/09/13/bill-henderson-joins-vheda-health-senior-vice-president-business-development/
| 2022-09-13T13:02:51Z
|
Program teaches underserved creators how to monetize their work online
BROOKLYN, N.Y., Sept. 13, 2022 /PRNewswire/ -- In April, Black Web Fest, a non-profit organization highlighting Black creators, launched the Black Web Fest x Web Monetization program to educate creators about web monetization. Through the program, the organization is providing several independent Black filmmakers unrestricted grant funding and marketing support.
According to an article by the Americans for the Arts, The Impact of Covid-19 on Internationally Marginalized Artists and Creative Workers, BIPOC creators are less likely to monetize their work online. "We created this program out of necessity. As venues, businesses, and in-person events shuttered during the pandemic; many Black creators struggled economically. Due to the digital divide, some artists did not have access to technology, the internet, or the skills to transition from traditional methods. Through this program, we provided over 40 Black filmmakers the tools to monetize their work online" said Victoria Coker, Founder of Black Web Fest.
This year marks Black Web Fest's sixth annual festival, which will be held from September 30 to October 1. The event will also feature films and series from the web monetization program. To learn more about Black Web Fest 2022, visit: https://blackwebfest.org/bwf-2022/
Here is the list of Black Web Fest x Web Monetization program grantees:
Shoutout 2 My Therapist, Stefanie Philpott
SEX, VLOGS, AND KIDNAPPINGS, Kyla Sylvers
QuaranDream!, Jeffrey Elizabeth Copeland
Marooned, Christopher Lamadieu
Hide & Seek, Ajoké Adebesin
LOOP, Ivan Mbakop
VICTUS, Yolanda Ross
Church: A Film by Mac Infinity, BDe'Auan (de-on) McClaine
Boxed, Wanjiru Njendu
One Hundred Days and Thinking, Conrad Khalil
REAL MEN DON'T…: An exploration of modern manhood and masculinity., Elton Loud
Why I Turf", formally "Turfin, Latiece Brown
A grant from the Interledger Foundation funded the Black Web Fest x Web Monetization program. The Interledger Foundation is a non-profit advocate for the web, promoting innovation, creativity, and inclusion by advancing open payment standards and technologies that seamlessly connect the global society.
The Black Web Fest is an organization that helps Black creators build sustainable careers by providing accessible programs and services. Their core themes are new media and technology. Black Web Fest events include film screenings, panels, game jams, and more. The organization previously held events in New York, Atlanta, and London. To learn more visit blackwebfest.org.
View original content to download multimedia:
SOURCE Black Web Fest
|
https://www.whsv.com/prnewswire/2022/09/13/black-web-fest-awards-over-20000-black-creators/
| 2022-09-13T13:02:57Z
|
SHENZHEN, China, Sept. 13, 2022 /PRNewswire/ -- Recently, Blackview, the world-leading rugged phone brand, announced the launch of the Blackview Super Brand Day promotion from September 14th to 15th on AliExpress. This campaign will cover the hot-sell products, including the Blackview BL8800 series, Blackview BV7100, and Blackview Tab 13.
Blackview BL8800 & Blackview BL8800 Pro: 5G Rugged Phone Flagship
In May this year, Blackview put the Blackview BL8800 series (BL8800 and BL8800 Pro) on the shelves. Featuring top-notch specifications, the series crushes the use limits that rugged phones can't withstand. Shortly after the premiere, both swept the 5G rugged phone market with great popularity.
Unmatched Toughness
The BL8800 series meets the industry-leading IP68 & IP69K waterproof rating and the MIL-STD-810H military standard. For those living an active lifestyle or working in environments full of unpredictable elements like the forest, ships, and construction sites, the BL8800 series is a no-brainer. Moreover, the Glove Mode makes it easier to operate whenever wearing gloves.
Night Vision/Thermal Imaging
Blackview BL8800 series goes the extra mile in photography. Blackview BL8800 features night vision to take pictures or videos in complete darkness, while the BL8800 Pro features a FLIR® Lepton® thermal camera to measure heat, day or night, providing unimaginable fun to explore the world and serving as a mighty troubleshooting tool for electrical inspection, plumbing issues, and more.
8380mAh Battery Demon
Blackview BL8800 series adopts an astonishing 8380mAh that can last a whole day on binge use, perfect for outdoor goers who travel a lot. 33W fast charge can fully refill the giant battery in just 1.5 hours, equal to a mealtime. More surprisingly, it supports a reverse charge function -- effectively the 8380mAh power bank -- to lend juice to another device.
Silky-Smooth Operation
Blackview BL8800 series runs the 5G MediaTek Dimensity 700 with 8GB RAM and 128GB ROM to enhance almost everything you do -- faster uploads, downloads, streaming, and gaming. And with brand-new Doke OS 3.0, based on Android 11 -- smarter, swifter, and more intuitive, everything is fast, smooth, and efficient.
Blackview BV7100: the 13000mAh Battery Beast
Blackview BV7100 is borns to be mighty by incorporating more than a year of efforts from Blackview's R&D team. Embracing a 13000mAh battery, superior ruggedness, and more powerful features such as up to 10GB RAM, MediaTek Helio G85, and Doke OS 3.0 based on Android 12, Blackview BV7100 changes the rugged lifestyle for users.
Blackview Tab 13: Latest Tablet Flagship
Blackview Tab 13 is Blackview's first-ever 4G LTE tablet flagship with SIMO Internet to access the internet anytime, up to 10GB RAM, TÜV Rheinland Low Blue Light certified 10.1-inch FHD+ display, Doke OS P_3.0 based on Android 12, and PC Mode, which redraws boundaries of the Blackview tablet experience on convenience smoothness for work and play.
Price and Availability
From September 14th to 15th, the first 100 orders of the Blackview BL8800 series, Blackview BV7100, and Blackview Tab 13 will enjoy a coupon (only for the U.S.A). The final price of the BL8800 reaches $232.99, the BL8800 Pro at $297.98, the BV7100 at $159.99, and the Tab 13 at $134.99. When the coupons run out, the price will rise to $259.99 (BL8800), $324.98 (BL8800 Pro), $179.99 (BV7100), and $149.99 (Tab 13).
View original content to download multimedia:
SOURCE Blackview
|
https://www.whsv.com/prnewswire/2022/09/13/blackview-super-brand-day-kicks-off-with-5g-rugged-phone-flagship-blackview-bl8800-series/
| 2022-09-13T13:03:03Z
|
Limited Re-Release Celebrates Stitzel-Weller Distillery and National Bourbon Heritage Month
LOUISVILLE, Ky., Sept. 13, 2022 /PRNewswire/ -- Blade and Bow has re-released its highly sought-after 22-Year-Old Kentucky Straight Bourbon Whiskey. Aged and bottled at the historic Stitzel-Weller Distillery, this iconic American bourbon is available in 14 markets and at the Stitzel-Weller Distillery and Garden & Gun Club in Louisville, KY., while supplies last.
"An ultra-premium bourbon, Blade and Bow 22-Year-Old is complex and enticing. I liken 22-Year-Old's tasting notes to a freshly baked apple pie, fragrant and delicious," said Doug Kragel, Lead Educator for Blade and Bow. "With an aroma layered with oak, caramel, and fresh stone fruit, this highly acclaimed bourbon is sweet and smoky, accented with well-balanced tasting notes of torched sugar and apples baked in honey and spices."
Blade and Bow's 22-Year-Old Kentucky Straight Bourbon is released annually in September, in time for National Bourbon Heritage Month. During this month-long celebration, Blade and Bow pays homage to the craftsmanship, history, and tradition that Stitzel-Weller Distillery represents to the bourbon industry. Whiskey aficionados will be delighted with the rich history tangible in every sip of Blade and Bow 22-Year-Old.
Due to the finite amount of liquid available, the anticipated demand for 22-Year-Old is extremely high. As a result, there is no guaranteed timeframe for how long this in-demand bourbon will be accessible. Consumers can try 22-Year-Old for themselves year-round at The Garden & Gun Club at the Stitzel-Weller Distillery. The 22-Year-Old Tasting Experience includes one ounce of Blade and Bow 22-Year-Old in a handcrafted Terrane glass, alongside a signature wool tartan bag, Blade and Bow enamel pin and tasting notes guide.
Blade and Bow 22-Year-Old Kentucky Straight Bourbon Whiskey is available now in the following markets: California, Colorado, District of Columbia, Florida, Georgia, Illinois, Kentucky, New Jersey, North Carolina, Oregon, South Carolina, Tennessee, Texas, Virginia, and at the Stitzel-Weller Distillery.
Learn more by following @bladeandbowwhiskey on Instagram or visiting BladeandBowWhiskey.com.
This remarkable bourbon is best enjoyed slowly and responsibly.
Blade and Bow pays homage to the artful passion and renowned craftsmanship of the legendary Stitzel-Weller Distillery in Louisville, Kentucky. Blade and Bow whiskey is currently available in two variants: Blade and Bow Kentucky Straight Bourbon Whiskey and Blade and Bow 22-Year-Old Limited Release Kentucky Straight Bourbon Whiskey. With their unique solera system, Blade and Bow seeks to continue the story of Stitzel-Weller by providing whiskey aficionados with an inspired piece of Kentucky history.
PLEASE SIP RESPONSIBLY.
Blade and Bow Kentucky Straight Bourbon Whiskey 45.5-46% Alc/Vol
©2022 STITZEL-WELLER DISTILLING CO., LOUISVILLE, KY.
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Crown Royal, Bulleit and Buchanan's whiskies, Smirnoff, Cîroc and Ketel One vodkas, Casamigos, DeLeon and Don Julio tequilas, Captain Morgan, Baileys, Tanqueray and Guinness.
Diageo is listed on both the New York Stock Exchange (NYSE: DEO) and the London Stock Exchange (LSE: DGE) and their products are sold in more than 180 countries around the world.
For more information about Diageo, their people, brands, and performance, visit www.diageo.com. Visit Diageo's global responsible drinking resource,www.DRINKiQ.com, for information, initiatives, and ways to share best practice. Follow at Twitter and Instagram for news and information about Diageo North America: @Diageo_NA.
Celebrating life, every day, everywhere.
Diageo Contact:
Allison Fleischer
allison.fleischer@diageo.com
803-984-6434
Media Contact:
Lauren Anesta
lauren@goldenword.co
703-856-5064
View original content to download multimedia:
SOURCE Blade and Bow
|
https://www.whsv.com/prnewswire/2022/09/13/blade-bow-re-releases-rare-22-year-old-kentucky-straight-bourbon-whiskey/
| 2022-09-13T13:03:10Z
|
A Partnership Between Kbean® and the Gahoe Museum Could Transform the Art and Museum Industry
SAN FRANCISCO, Sept. 13, 2022 /PRNewswire/ -- Kbean®, San Francisco CA partnered with Gahoe Museum, Seoul South Korea to showcase 19th century's Korean folk arts, "Minwha" through MicroNFT™, a secure cryptographic solution based on Blockchain technology. This marriage of Minhwa and blockchain technology has enabled consumers to experience their own piece of historical and cultural contents at home around the world. This partnership is an important milestone for the art industry and will expand the reach of museums to a global level.
Kbean®, is a technology company based in the San Francisco Bay area. Kbean® has invented a digital asset management solution named MicroNFT™ and has launched a social marketplace with TV streaming services for creative digital media and arts including paintings, films, mixed media and photography. The company puts a heavy emphasis on protecting the assets, intellectual property of artists and content creators and broader security of the marketplace.
Gahoe Museum, a traditional Korean art museum at Seoul, South Korea, has collected and maintained many Minhwa arts that carry historical significance. More importantly, these are important artifacts and depictions of culture, belief, and ways of living. Gahoe has been actively communicating and educating various local communities for generations.
While Gahoe Museum still welcomes visitors, it enabled a new strategy for reaching its customers globally. Through a partnership with Kbean®, Gahoe was able to deliver its Minhwa collections digitally, allowing customers around the world to access their collections in the most affordable and secure manner.
"Times have changed. The digital versions of the Minhwa, once used for promotional purposes, must be protected and recorded in a ledger to be its own asset," Said the Director of Gahoe Museum, Mr. Yul Soo Yoon. "Kbean®'s Blockchain and NFT TV solutions were the answer, and that's why we have formed the partnership."
The cofounder of Kbean® and a Minwha artist, Kate Nam, noted that "It's exciting that the art form considered as "people's art" dating back to the 18th century was solved by the decentralized Blockchain technology."
Broader adoption of crypto technology is yet to come, and this partnership is an important milestone enabling consumers to experience, or even own, a piece of historical and cultural contents at home.
For more information: www.kbean.com and Kbean® apps available on mobile phones, Apple TV and Amazon Fire TV.
Kbean® is a social marketplace platform for all creative digital media through MicroNFT™ technology. It is an open yet close-knit social network dedicated to bringing the diverse art community together.
View original content to download multimedia:
SOURCE Kbean
|
https://www.whsv.com/prnewswire/2022/09/13/blockchain-nft-technology-meets-peoples-art-19th-century/
| 2022-09-13T13:03:17Z
|
With Extensive Experience in SaaS Product Leadership,
Anirban Will Deliver Focus on Accelerating Product Growth and Supercharging Innovation Across the Bloomreach Commerce Experience Cloud
MOUNTAIN VIEW, Calif., Sept. 13, 2022 /PRNewswire/ -- Bloomreach, the world's #1 Commerce Experience Cloud, today announced it has appointed Anirban Bardalaye as Chief Product Officer, effective immediately. In this role, Anirban will further accelerate the growth of the company's three product pillars — Discovery, Engagement, and Content — as it continues to scale its Commerce Experience Cloud to serve businesses around the world. Anirban previously served as Vice President of Product Management, Commerce Cloud, at Salesforce, and in addition to his success as a Y Combinator-backed entrepreneur, has nearly 15 years of experience leading product strategy for SaaS companies.
"We're thrilled to have Anirban joining the team to lead Bloomreach into its next era of product leadership," said Raj De Datta, co-founder and CEO, Bloomreach. "His background in product strategy within the digital commerce and marketing space will be an invaluable asset to Bloomreach as we scale our offerings across a growing customer base. We look forward to seeing the continued innovation our product team will achieve under his leadership, and the tangible ways in which that innovation will benefit our Bloomreach customers around the world."
"Bloomreach has made massive strides in product innovation these past few years alone, and now, it's poised to further redefine what an incredible commerce experience can achieve for businesses when driven by the right technology," said Anirban Bardalaye. "I'm very excited to join this talented team in delivering new, advanced product innovation, helping businesses everywhere to drive measurable growth and sustained customer loyalty through the personalized digital experiences Bloomreach makes possible."
About Anirban Bardalaye
Anirban Bardalaye has served as Vice President of Product Management, Commerce Cloud, at Salesforce since 2019. Having first led strategy and delivery of Salesforce B2B Commerce and its core commerce platform, his responsibilities later grew to include industry product strategy and execution for the entire Commerce Cloud portfolio. Prior to Salesforce, Anirban served as Head of Product, Platform Ecosystem & Marketplace, at Guidewire, where he helped build the Guidewire Marketplace as well as its developer platform, DevConnect. Before that, he co-founded VaycayHero, Inc., a platform for aggregating professionally managed vacation rentals, which was backed by prominent technology startup accelerator Y Combinator. Anirban also led product management at Serena Software, a SaaS and on-premise Business Process Management platform. Anirban began his career as a software engineer, having built software at early stage startups and global software companies. He holds an MBA from the University of Chicago Booth School of Business, a dual MS in Systems Science and Mechanical Engineering from Louisiana State University, and a BE in Mechanical Engineering from National Institute of Technology, Rourkela.
About Bloomreach
Bloomreach is the world's #1 Commerce Experience Cloud, empowering brands to deliver customer journeys so personalized, they feel like magic. It offers a suite of products that drive true personalization and digital commerce growth, including: Discovery, offering AI-driven search and merchandising; Content, offering a headless CMS; and Engagement, offering a leading CDP and marketing automation solutions. Together, these solutions combine the power of unified customer and product data with the speed and scale of AI-optimization, enabling revenue-driving digital commerce experiences that convert on any channel and every journey. Bloomreach serves over 850 global brands including Albertsons, Bosch, Puma, FC Bayern München, and Marks & Spencer. The company was recently named to the 2022 Inc. 5000 List of America's Fastest-Growing Private Companies and also earned a 2022 Great Place to Work Certification™ in the U.S. For more information, visit Bloomreach.com.
Media Contact:
Michelle DeMaio
Bloomreach
Corporate Communications
michelle.demaio@bloomreach.com
View original content to download multimedia:
SOURCE Bloomreach
|
https://www.whsv.com/prnewswire/2022/09/13/bloomreach-appoints-anirban-bardalaye-chief-product-officer/
| 2022-09-13T13:03:23Z
|
Sensitive Lotion SPF 50+ Wins "Body" in the Highly Coveted Beauty Awards
JOHNSON CITY, Tenn., Sept. 13, 2022 /PRNewswire/ -- Blue Lizard Australian Sunscreen, renowned for its quality sun-protection that is safe for consumers and the environment, is proud to announce that its Sensitive Lotion SPF 50+ is an Allure "Best of Beauty" Award recipient in the "Body" category.
Established in 1996 with its signature stamp of approval, the Allure "Best of Beauty" Awards are considered to be the most prestigious and influential distinction in the health and beauty industry. As universally respected authorities in the world of beauty, Allure's editors are recognized for their knowledge, insight, and recommendations. Allure researches and tests thousands of products – from mass to prestige, classic to cutting-edge – to identify the best-of-the-best. Each year the award winners represent the most effective and innovative products in the marketplace.
"We are thrilled to be recognized by Allure and receive the coveted 'Best of Beauty' Award for the second year in a row," said Steve Gallopo, Crown Therapeutic Skincare's EVP & General Manager. "We strive to develop products that a multitude of consumers will love and repurchase time and time again, and are proud that one of our best-selling products, Sensitive Lotion SPF 50+, is being recognized this year."
Designed with dermatologists in mind, Blue Lizard's Sensitive Lotion SPF 50+ zinc oxide and titanium dioxide mineral formula provides broad spectrum protection from 98% of the sun's burning rays. The formulation is carefully crafted to omit skin-irritating chemical UV filters such as oxybenzone and octinoxate. In addition to its award-winning Lotion, the Sensitive formula is also available in stick and spray forms.
Blue Lizard Australian Sunscreen was born in Australia out of necessity. The harsh climate of extreme UV rays requires strong sun protection that you can depend on. For over 20 years, Blue Lizard has earned the trust of countless dermatologists and continues to deliver highly effective and safe mineral and mineral-based sunscreens for head-to-toe sun protection. Because we love the reef, Blue Lizard has completely omitted oxybenzone and octinoxate from its formulas. Featuring Smart Bottle™ and Smart Cap™ Technology, Blue Lizard product packaging also lets consumers know when harmful UV rays are present and reminds them to reapply. For more information, please visit www.BlueLizardSunscreen.com.
Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown's unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become a leader in Dermatology and Aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for nine years and has expanded its distribution to over 41 countries. For more information, visit www.crownlaboratories.com.
View original content to download multimedia:
SOURCE Crown Laboratories, Inc.
|
https://www.whsv.com/prnewswire/2022/09/13/blue-lizard-australian-sunscreen-wins-prestigious-2022-allure-best-beauty-award/
| 2022-09-13T13:03:29Z
|
HOUSTON, Sept. 13, 2022 /PRNewswire/ -- Boomerang Interests (www.boomeranginterests.com), CenterSquare Investment Management (www.centersquare.com) and Lineage Logistics (www.lineagelogistics.com) today announced that they have entered into a full-building lease for Houston ColdPort, a 315,111 square foot cold storage warehouse speculatively developed by Boomerang.
"We're pleased to partner with Boomerang on this important project in a critical market for our customers," said Brian Beattie, President, North America – West of Lineage Logistics. "Houston ColdPort further expands our leading presence in the Houston Metro area and strengthens our capabilities to efficiently import and export customer product through the Port of Houston. We are excited to drive additional value to our customers' supply chains in Texas and beyond via the ColdPort project."
Houston ColdPort, a joint venture between Boomerang and CenterSquare Investment Management, is constructed on a 22.5-acre site at the Northwest corner of Beltway 8 and US-90. The site is strategically located in the heavy-haul corridor of Port Houston and provides unparalleled access to the Barbours Cut and Bayport terminals and major US east-west and north-south thoroughfares – Beltway 8, US-90, Interstate 10 and Interstate 69.
"The supply-demand imbalance and aging inventory of cold storage facilities in Houston initially attracted us to the industry; these dynamics have accelerated during construction of Houston ColdPort," said Andy Cyrus, Co-Founder and Managing Partner of Boomerang. "What an honor to see our thesis validated by Lineage Logistics, the preeminent cold storage operator. As we pursue cold storage development in other markets, we hope this is one of many future partnerships with the Lineage team."
ARCO Design/Build designed and constructed Houston ColdPort. Houston ColdPort features a 50-foot clear height warehouse, a 60-foot-deep cold dock, 38 dock positions with vertical storing hydraulic dock leveler equipment, LED lighting throughout, a Tyco Quell dry fire sprinkler system, a 200-foot-deep truck court with 57 trailer parking spaces and ample automobile parking.
"Our conviction in the cold storage space remains extremely high as evidenced by our investments in the sector across our listed and private platforms," said Jeffrey Reder, Managing Director of CenterSquare. "We couldn't be prouder of the value created in Houston ColdPort through our partnerships with Boomerang and Lineage, and we look forward to future opportunities to replicate this success.
Boomerang Interests is a Houston-based real estate development firm specializing in cold storage industrial development. Boomerang pursues speculative development, build-to-suit development, joint venture opportunities or a hybrid of the foregoing to deliver cold storage solutions to underserved markets. Boomerang's target customer segments include 3PLs, food manufacturers, food retailers, food wholesalers and other industries that utilize cold storage. For more information, visit www.boomeranginterests.com.
Lineage Logistics is one of the world's leading temperature-controlled industrial REITs and logistics solutions providers. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity which spans 20 countries across North America, Europe and Asia-Pacific. Lineage's industry-leading expertise in end-to-end logistical solutions, its real estate network, and development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and most importantly, as a Visionary Partner of Feeding America, help feed the world. For more information, visit www.lineagelogistics.com.
For more information about Houston ColdPort, please contact:
View original content:
SOURCE Boomerang Interests , LLC
|
https://www.whsv.com/prnewswire/2022/09/13/boomerang-interests-inks-full-building-lease-houston-coldport/
| 2022-09-13T13:03:35Z
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.